<td class='article_title' rowspan='2'>
Nucleocytoplasmic	JJ	<unknown>
transport	NN	transport
in	IN	in
C9orf72-mediated	JJ	<unknown>
ALS/FTD	NN	<unknown>
.	SENT	.
</td>
A	DT	a
GGGGCC	NP	<unknown>
hexanucleotide	NN	<unknown>
repeat	NN	repeat
expansion	NN	expansion
in	IN	in
<span class='gene'>
C9orf72	NP	<unknown>
</span>
is	VBZ	be
the	DT	the
most	RBS	most
common	JJ	common
genetic	JJ	genetic
cause	NN	cause
of	IN	of
familial	JJ	familial
<span class='disease'>
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
(	(	(
<span class='disease'>
ALS	NN	<unknown>
</span>
)	)	)
and	CC	and
<span class='disease'>
frontotemporal	JJ	<unknown>
dementia	NN	dementia
</span>
(	(	(
<span class='disease'>
FTD	NP	<unknown>
</span>
)	)	)
.	SENT	.
Recent	JJ	Recent
studies	NNS	study
indicate	VBP	indicate
that	IN	that
disruption	NN	disruption
of	IN	of
nucleocytoplasmic	JJ	<unknown>
transport	NN	transport
pathways	NNS	pathway
play	VBP	play
a	DT	a
critical	JJ	critical
role	NN	role
in	IN	in
the	DT	the
pathogenesis	NN	pathogenesis
of	IN	of
C9orf72-mediated	JJ	<unknown>
ALS/FTD	JJ	<unknown>
(C9-ALS)	NN	<unknown>
.	SENT	.
Here	RB	here
,	,	,
we	PP	we
discuss	VBP	discuss
mechanisms	NNS	mechanism
by	IN	by
which	WDT	which
<span class='gene'>
C9orf72	NP	<unknown>
</span>
mutations	NNS	mutation
cause	VBP	cause
nucleocytoplasmic	JJ	<unknown>
transport	NN	transport
deficits	NNS	deficit
and	CC	and
contribute	VB	contribute
to	TO	to
disease	NN	disease
pathogenesis	NN	pathogenesis
.	SENT	.
We	PP	we
review	VBP	review
the	DT	the
current	JJ	current
literature	NN	literature
regarding	VBG	regard
nucleocytoplasmic	JJ	<unknown>
transport	NN	transport
disruption	NN	disruption
in	IN	in
C9-ALS	NP	<unknown>
,	,	,
and	CC	and
discuss	VB	discuss
implications	NNS	implication
and	CC	and
directions	NNS	direction
for	IN	for
future	JJ	future
research	NN	research
.	SENT	.
<td class='article_title' rowspan='2'>
Diseases	NNS	disease
Neglected	JJ	neglected
by	IN	by
the	DT	the
Media	NP	Media
in	IN	in
Espírito	NP	<unknown>
Santo	NP	Santo
,	,	,
Brazil	NP	Brazil
in	IN	in
2011-2012	CD	@card@
.	SENT	.
</td>
The	DT	the
aims	VBZ	aim
of	IN	of
the	DT	the
present	JJ	present
study	NN	study
were	VBD	be
to	TO	to
identify	VB	identify
and	CC	and
analyse	VB	analyse
the	DT	the
Diseases	NP	<unknown>
Neglected	NP	<unknown>
by	IN	by
the	DT	the
Media	NP	Media
(	(	(
DNMs	NP	<unknown>
)	)	)
via	IN	via
a	DT	a
comparison	NN	comparison
between	IN	between
the	DT	the
most	RBS	most
important	JJ	important
health	NN	health
issues	NNS	issue
to	TO	to
the	DT	the
population	NN	population
of	IN	of
Espírito	NP	<unknown>
Santo	NP	Santo
,	,	,
Brazil	NP	Brazil
,	,	,
from	IN	from
the	DT	the
epidemiological	JJ	epidemiological
perspective	NN	perspective
(	(	(
health	NN	health
value	NN	value
)	)	)
and	CC	and
their	PP$	their
effective	JJ	effective
coverage	NN	coverage
by	IN	by
the	DT	the
print	NN	print
media	NNS	medium
,	,	,
and	CC	and
to	TO	to
analyse	VB	analyse
the	DT	the
DNMs	NP	<unknown>
considering	VBG	consider
the	DT	the
perspective	NN	perspective
of	IN	of
key	JJ	key
journalists	NNS	journalist
involved	VBN	involve
in	IN	in
the	DT	the
dissemination	NN	dissemination
of	IN	of
health	NN	health
topics	NNS	topic
in	IN	in
the	DT	the
state	NN	state
media.Morbidity	NN	<unknown>
and	CC	and
mortality	NN	mortality
data	NNS	datum
were	VBD	be
collected	VBN	collect
from	IN	from
official	JJ	official
documents	NNS	document
and	CC	and
from	IN	from
Health	NP	Health
Information	NP	Information
Systems	NPS	Systems
.	SENT	.
In	IN	in
parallel	NN	parallel
,	,	,
the	DT	the
diseases	NNS	disease
reported	VBD	report
in	IN	in
the	DT	the
two	CD	two
major	JJ	major
newspapers	NNS	newspaper
of	IN	of
Espírito	NP	<unknown>
Santo	NP	Santo
in	IN	in
2011-2012	CD	@card@
were	VBD	be
identified	VBN	identify
from	IN	from
10,771	CD	@card@
news	NN	news
articles	NNS	article
.	SENT	.
Concomitantly	RB	concomitantly
,	,	,
eight	CD	eight
interviews	NNS	interview
were	VBD	be
conducted	VBN	conduct
with	IN	with
reporters	NNS	reporter
from	IN	from
the	DT	the
two	CD	two
newspapers	NNS	newspaper
to	TO	to
understand	VB	understand
the	DT	the
journalists	NNS	journalist
'	POS	'
reasons	NNS	reason
for	IN	for
the	DT	the
coverage	NN	coverage
or	CC	or
neglect	NN	neglect
of	IN	of
certain	JJ	certain
health/disease	NN	<unknown>
topics.Quantitatively	RB	<unknown>
,	,	,
the	DT	the
DNMs	NP	<unknown>
identified	VBD	identify
diseases	NNS	disease
associated	VBN	associate
with	IN	with
poverty	NN	poverty
,	,	,
including	VBG	include
<span class='disease'>
tuberculosis	NN	tuberculosis
</span>
,	,	,
<span class='disease'>
leprosy	NN	leprosy
</span>
,	,	,
<span class='disease'>
schistosomiasis	NN	schistosomiasis
</span>
,	,	,
<span class='disease'>
leishmaniasis	NN	leishmaniasis
</span>
,	,	,
and	CC	and
trachoma	NN	trachoma
.	SENT	.
Apart	RB	apart
from	IN	from
these	DT	these
,	,	,
diseases	NNS	disease
with	IN	with
outbreaks	NNS	outbreak
in	IN	in
the	DT	the
period	NN	period
evaluated	VBD	evaluate
,	,	,
including	VBG	include
<span class='disease'>
whooping	JJ	whooping
cough	NN	cough
</span>
and	CC	and
<span class='symptom'>
meningitis	NN	meningitis
</span>
,	,	,
some	DT	some
cancers	NNS	cancer
,	,	,
respiratory	JJ	respiratory
diseases	NNS	disease
,	,	,
ischaemic	JJ	<unknown>
heart	NN	heart
disease	NN	disease
,	,	,
and	CC	and
<span class='symptom'>
stroke	NN	stroke
</span>
,	,	,
were	VBD	be
also	RB	also
seldom	RB	seldom
addressed	VBN	address
by	IN	by
the	DT	the
media	NNS	medium
.	SENT	.
In	IN	in
contrast	NN	contrast
,	,	,
<span class='disease'>
dengue	NN	dengue
fever	NN	fever
</span>
,	,	,
acquired	VBD	acquire
<span class='symptom'>
immune	JJ	immune
deficiency	NN	deficiency
</span>
syndrome	NN	syndrome
(	(	(
AIDS	NP	AIDS
)	)	)
,	,	,
diabetes	NN	diabetes
,	,	,
<span class='symptom'>
breast	NN	breast
cancer	NN	cancer
</span>
,	,	,
<span class='symptom'>
prostate	NN	prostate
cancer	NN	cancer
</span>
,	,	,
tracheal	JJ	tracheal
<span class='symptom'>
cancer	NN	cancer
</span>
,	,	,
and	CC	and
bronchial	JJ	bronchial
and	CC	and
lung	NN	lung
cancers	NNS	cancer
were	VBD	be
broadly	RB	broadly
covered	VBN	cover
in	IN	in
the	DT	the
period	NN	period
analysed	VBD	analyse
,	,	,
corroborating	VBG	corroborate
the	DT	the
tradition	NN	tradition
of	IN	of
media	NNS	medium
disclosure	NN	disclosure
of	IN	of
these	DT	these
diseases	NNS	disease
.	SENT	.
Qualitatively	RB	qualitatively
,	,	,
the	DT	the
DNMs	NP	<unknown>
included	VBD	include
rare	JJ	rare
diseases	NNS	disease
,	,	,
such	JJ	such
as	IN	as
<span class='disease'>
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
(	(	(
<span class='disease'>
ALS	NP	<unknown>
</span>
)	)	)
,	,	,
<span class='disease'>
leishmaniasis	NN	leishmaniasis
</span>
,	,	,
<span class='disease'>
Down	IN	down
syndrome	NN	syndrome
</span>
,	,	,
and	CC	and
verminoses	NNS	<unknown>
.	SENT	.
The	DT	the
reasons	NNS	reason
for	IN	for
the	DT	the
neglect	NN	neglect
of	IN	of
these	DT	these
topics	NNS	topic
by	IN	by
the	DT	the
media	NNS	medium
included	VBD	include
the	DT	the
political	JJ	political
and	CC	and
economic	JJ	economic
interests	NNS	interest
of	IN	of
the	DT	the
newspapers	NNS	newspaper
,	,	,
their	PP$	their
editorial	JJ	editorial
line	NN	line
,	,	,
and	CC	and
the	DT	the
organizational	JJ	organizational
routine	NN	routine
of	IN	of
the	DT	the
newsrooms.Media	NN	<unknown>
visibility	NN	visibility
acts	VBZ	act
as	IN	as
a	DT	a
strategy	NN	strategy
for	IN	for
legitimising	VBG	legitimise
priorities	NNS	priority
and	CC	and
contextualizing	VBG	contextualize
various	JJ	various
realities	NNS	reality
.	SENT	.
Therefore	RB	therefore
,	,	,
we	PP	we
propose	VBP	propose
that	IN	that
the	DT	the
health	NN	health
problems	NNS	problem
identified	VBN	identify
should	MD	should
enter	VB	enter
the	DT	the
public	JJ	public
agenda	NN	agenda
and	CC	and
begin	VB	begin
to	TO	to
be	VB	be
recognized	VBN	recognize
as	IN	as
legitimate	JJ	legitimate
demands	NNS	demand
.	SENT	.
<td class='article_title' rowspan='2'>
Does	VBZ	do
Botulinum	NP	<unknown>
neurotoxin	NP	<unknown>
type	NN	type
A	DT	a
treatment	NN	treatment
for	IN	for
sialorrhea	NN	<unknown>
change	NN	change
oral	JJ	oral
health	NN	health
?	SENT	?
</td>
Botulinum	NP	<unknown>
neurotoxin	NP	<unknown>
type	NN	type
A	NP	A
(	(	(
BNT-A	NP	<unknown>
)	)	)
intrasalivary	JJ	<unknown>
gland	NN	gland
injections	NNS	injection
in	IN	in
patients	NNS	patient
with	IN	with
neurological	JJ	neurological
disorders	NNS	disorder
have	VBP	have
been	VBN	be
known	VBN	know
to	TO	to
effectively	RB	effectively
treat	VB	treat
hypersalivation	NN	<unknown>
.	SENT	.
However	RB	however
,	,	,
oral	JJ	oral
health	NN	health
can	MD	can
be	VB	be
compromised	VBN	compromise
with	IN	with
increasing	VBG	increase
the	DT	the
dose	NN	dose
.	SENT	.
The	DT	the
aim	NN	aim
of	IN	of
this	DT	this
study	NN	study
was	VBD	be
to	TO	to
find	VB	find
out	RP	out
the	DT	the
therapeutic	JJ	therapeutic
effect	NN	effect
of	IN	of
low-dose	NN	low-dose
,	,	,
ultrasonography-controlled	JJ	<unknown>
BNT-A	NP	<unknown>
injections	NNS	injection
into	IN	into
the	DT	the
bilateral	JJ	bilateral
parotid	NN	parotid
and	CC	and
submandibular	JJ	<unknown>
glands	NNS	gland
on	IN	on
oral	JJ	oral
health	NN	health
in	IN	in
the	DT	the
treatment	NN	treatment
of	IN	of
<span class='symptom'>
sialorrhea	NN	<unknown>
</span>
.Twenty	NN	<unknown>
patients	NNS	patient
diagnosed	VBN	diagnose
with	IN	with
Parkinson	NP	Parkinson
's	POS	's
disease	NN	disease
(	(	(
PD	NP	PD
)	)	)
,	,	,
<span class='disease'>
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
(	(	(
<span class='disease'>
ALS	NP	<unknown>
</span>
)	)	)
,	,	,
and	CC	and
other	JJ	other
neurological	JJ	neurological
disorders	NNS	disorder
,	,	,
including	VBG	include
<span class='symptom'>
stroke	NN	stroke
</span>
or	CC	or
birth	NN	birth
trauma	NN	trauma
,	,	,
received	VBD	receive
BNT-A	NP	<unknown>
injections	NNS	injection
with	IN	with
salivary	JJ	salivary
tests	NNS	test
before	IN	before
and	CC	and
1	CD	1
month	NN	month
after	IN	after
the	DT	the
injections	NNS	injection
.	SENT	.
<span class='symptom'>
Drooling	VBG	drool
</span>
was	VBD	be
evaluated	VBN	evaluate
using	VBG	use
subjective	JJ	subjective
scales	NNS	scale
and	CC	and
objective	JJ	objective
assessment	NN	assessment
of	IN	of
salivary	JJ	salivary
flow	NN	flow
rate	NN	rate
and	CC	and
oral	JJ	oral
health	NN	health
(	(	(
salivary	JJ	salivary
composition	NN	composition
and	CC	and
cariogenic	JJ	cariogenic
bacterial	JJ	bacterial
counts).A	NN	<unknown>
significant	JJ	significant
decrease	NN	decrease
was	VBD	be
found	VBN	find
in	IN	in
salivary	JJ	salivary
flow	NN	flow
rate	NN	rate
at	IN	at
1-	CD	@card@
and	CC	and
3-month	JJ	<unknown>
follow-up	NN	follow-up
in	IN	in
the	DT	the
BNT-A	NP	<unknown>
treated	VBD	treat
group	NN	group
.	SENT	.
There	EX	there
was	VBD	be
no	DT	no
significant	JJ	significant
change	NN	change
in	IN	in
salivary	JJ	salivary
composition	NN	composition
or	CC	or
cariogenic	JJ	cariogenic
bacterial	JJ	bacterial
counts.BNT-A	NN	<unknown>
injections	NNS	injection
according	VBG	accord
to	TO	to
the	DT	the
current	JJ	current
protocol	NN	protocol
can	MD	can
effectively	RB	effectively
manage	VB	manage
<span class='symptom'>
sialorrhea	NN	<unknown>
</span>
while	IN	while
maintaining	VBG	maintain
oral	JJ	oral
health.Oral	JJ	<unknown>
health	NN	health
can	MD	can
be	VB	be
considered	VBN	consider
the	DT	the
mirror	NN	mirror
of	IN	of
general	JJ	general
human	JJ	human
health	NN	health
,	,	,
as	IN	as
the	DT	the
cause	NN	cause
of	IN	of
many	JJ	many
diseases	NNS	disease
.	SENT	.
Saliva	NP	Saliva
plays	VBZ	play
a	DT	a
crucial	JJ	crucial
role	NN	role
in	IN	in
protecting	VBG	protect
the	DT	the
oral	JJ	oral
cavity	NN	cavity
.	SENT	.
The	DT	the
present	JJ	present
study	NN	study
is	VBZ	be
of	IN	of
high	JJ	high
clinical	JJ	clinical
relevance	NN	relevance
because	IN	because
,	,	,
although	IN	although
earlier	JJR	early
research	NN	research
has	VBZ	have
proved	VBN	prove
the	DT	the
effect	NN	effect
of	IN	of
Botulinum	NP	<unknown>
neurotoxin	NN	<unknown>
type	NN	type
A	DT	a
injections	NNS	injection
on	IN	on
reduction	NN	reduction
in	IN	in
saliva	NN	saliva
flow	NN	flow
,	,	,
data	NNS	datum
about	IN	about
the	DT	the
risks	NNS	risk
of	IN	of
the	DT	the
treatment	NN	treatment
method	NN	method
to	TO	to
the	DT	the
oral	JJ	oral
condition	NN	condition
through	IN	through
affecting	VBG	affect
saliva	NN	saliva
composition	NN	composition
has	VBZ	have
so	RB	so
far	RB	far
been	VBN	be
missing	VBG	miss
.	SENT	.
<td class='article_title' rowspan='2'>
ALS	FW	als
:	:	:
Recent	JJ	Recent
Developments	NNS	development
from	IN	from
Genetics	NP	Genetics
Studies	NPS	Studies
.	SENT	.
</td>
<span class='disease'>
Amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
(	(	(
<span class='disease'>
ALS	NN	<unknown>
</span>
)	)	)
is	VBZ	be
a	DT	a
fatal	JJ	fatal
disorder	NN	disorder
that	WDT	that
is	VBZ	be
characterized	VBN	characterize
by	IN	by
a	DT	a
progressive	JJ	progressive
degeneration	NN	degeneration
of	IN	of
the	DT	the
upper	JJ	upper
and	CC	and
lower	JJR	low
motor	NN	motor
neurons	NNS	neuron
.	SENT	.
Most	JJS	most
cases	NNS	case
appear	VBP	appear
to	TO	to
be	VB	be
sporadic	JJ	sporadic
,	,	,
but	CC	but
5-10	CD	@card@
%	NN	%
of	IN	of
cases	NNS	case
have	VBP	have
a	DT	a
family	NN	family
history	NN	history
of	IN	of
the	DT	the
disease	NN	disease
.	SENT	.
High-throughput	NP	<unknown>
DNA	NP	DNA
sequencing	NP	sequencing
and	CC	and
related	JJ	related
genomic	JJ	<unknown>
capture	NN	capture
tools	NNS	tool
are	VBP	be
methodological	JJ	methodological
advances	NNS	advance
which	WDT	which
have	VBP	have
rapidly	RB	rapidly
contributed	VBN	contribute
to	TO	to
an	DT	an
acceleration	NN	acceleration
in	IN	in
the	DT	the
discovery	NN	discovery
of	IN	of
genetic	JJ	genetic
risk	NN	risk
factors	NNS	factor
for	IN	for
both	DT	both
familial	JJ	familial
and	CC	and
sporadic	JJ	sporadic
<span class='disease'>
ALS	NN	<unknown>
</span>
.	SENT	.
It	PP	it
is	VBZ	be
interesting	JJ	interesting
to	TO	to
note	VB	note
that	IN	that
as	IN	as
the	DT	the
number	NN	number
of	IN	of
<span class='disease'>
ALS	JJ	<unknown>
</span>
genes	NNS	gene
grows	VBZ	grow
,	,	,
many	JJ	many
of	IN	of
the	DT	the
proteins	NNS	protein
they	PP	they
encode	VBP	encode
are	VBP	be
in	IN	in
shared	VBN	share
intracellular	JJ	intracellular
processes	NNS	process
.	SENT	.
This	DT	this
review	NN	review
will	MD	will
summarize	VB	summarize
some	DT	some
of	IN	of
the	DT	the
recent	JJ	recent
advances	NNS	advance
and	CC	and
gene	NN	gene
discovery	NN	discovery
made	VBN	make
in	IN	in
<span class='disease'>
ALS	NN	<unknown>
</span>
.	SENT	.
<td class='article_title' rowspan='2'>
Gain	NN	gain
of	IN	of
Toxicity	NN	toxicity
from	IN	from
ALS/FTD-Linked	JJ	<unknown>
Repeat	NN	repeat
Expansions	NNS	expansion
in	IN	in
C9ORF72	NP	<unknown>
Is	VBZ	be
Alleviated	JJ	<unknown>
by	IN	by
Antisense	NP	<unknown>
Oligonucleotides	NP	<unknown>
Targeting	NP	<unknown>
GGGGCC-Containing	NP	<unknown>
RNAs	NP	<unknown>
.	SENT	.
</td>
Hexanucleotide	NN	<unknown>
expansions	NNS	expansion
in	IN	in
<span class='gene'>
C9ORF72	NP	<unknown>
</span>
are	VBP	be
the	DT	the
most	RBS	most
frequent	JJ	frequent
genetic	JJ	genetic
cause	NN	cause
of	IN	of
<span class='disease'>
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
and	CC	and
<span class='disease'>
frontotemporal	JJ	<unknown>
dementia	NN	dementia
</span>
.	SENT	.
Disease	NN	disease
mechanisms	NNS	mechanism
were	VBD	be
evaluated	VBN	evaluate
in	IN	in
mice	NNS	mouse
expressing	VBG	express
<span class='gene'>
C9ORF72	NP	<unknown>
</span>
RNAs	NP	<unknown>
with	IN	with
up	IN	up
to	TO	to
450	CD	@card@
GGGGCC	NP	<unknown>
repeats	NNS	repeat
or	CC	or
with	IN	with
one	CD	one
or	CC	or
both	DT	both
<span class='gene'>
C9orf72	NP	<unknown>
</span>
alleles	NNS	allele
inactivated	VBD	inactivate
.	SENT	.
Chronic	NN	chronic
50	CD	@card@
%	NN	%
reduction	NN	reduction
of	IN	of
<span class='gene'>
C9ORF72	NP	<unknown>
</span>
did	VBD	do
not	RB	not
provoke	VB	provoke
disease	NN	disease
,	,	,
while	IN	while
its	PP$	its
absence	NN	absence
produced	VBD	produce
<span class='symptom'>
splenomegaly	NN	splenomegaly
</span>
,	,	,
enlarged	JJ	enlarged
lymph	NN	lymph
nodes	NNS	node
,	,	,
and	CC	and
mild	JJ	mild
social	JJ	social
interaction	NN	interaction
deficits	NNS	deficit
,	,	,
but	CC	but
not	RB	not
motor	NN	motor
dysfunction	NN	dysfunction
.	SENT	.
Hexanucleotide	NN	<unknown>
expansions	NNS	expansion
caused	VBD	cause
age-	NN	<unknown>
,	,	,
repeat-length-	NN	<unknown>
,	,	,
and	CC	and
expression-level-dependent	JJ	<unknown>
accumulation	NN	accumulation
of	IN	of
RNA	NP	RNA
foci	NNS	focus
and	CC	and
dipeptide-repeat	NN	<unknown>
proteins	NNS	protein
synthesized	VBN	synthesize
by	IN	by
AUG-independent	JJ	<unknown>
translation	NN	translation
,	,	,
accompanied	VBN	accompany
by	IN	by
loss	NN	loss
of	IN	of
hippocampal	JJ	hippocampal
neurons	NNS	neuron
,	,	,
increased	VBN	increase
<span class='symptom'>
anxiety	NN	anxiety
</span>
,	,	,
and	CC	and
impaired	JJ	impaired
cognitive	JJ	cognitive
function	NN	function
.	SENT	.
Single-dose	JJ	<unknown>
injection	NN	injection
of	IN	of
antisense	NN	antisense
oligonucleotides	NNS	<unknown>
(	(	(
ASOs	NP	<unknown>
)	)	)
that	IN	that
target	NN	target
repeat-containing	VBG	<unknown>
RNAs	NP	<unknown>
but	CC	but
preserve	VB	preserve
levels	NNS	level
of	IN	of
mRNAs	NNS	<unknown>
encoding	VBG	encode
<span class='gene'>
C9ORF72	NP	<unknown>
</span>
produced	VBD	produce
sustained	JJ	sustained
reductions	NNS	reduction
in	IN	in
RNA	NP	RNA
foci	NNS	focus
and	CC	and
dipeptide-repeat	NN	<unknown>
proteins	NNS	protein
,	,	,
and	CC	and
ameliorated	VBD	ameliorate
behavioral	JJ	behavioral
deficits	NNS	deficit
.	SENT	.
These	DT	these
efforts	NNS	effort
identify	VBP	identify
gain	NN	gain
of	IN	of
toxicity	NN	toxicity
as	IN	as
a	DT	a
central	JJ	central
disease	NN	disease
mechanism	NN	mechanism
caused	VBN	cause
by	IN	by
repeat-expanded	JJ	<unknown>
<span class='gene'>
C9ORF72	NN	<unknown>
</span>
and	CC	and
establish	VB	establish
the	DT	the
feasibility	NN	feasibility
of	IN	of
ASO-mediated	JJ	<unknown>
therapy	NN	therapy
.	SENT	.
<td class='article_title' rowspan='2'>
Elevation	NN	elevation
of	IN	of
serum	NN	serum
heat-shock	NN	<unknown>
protein	NN	protein
levels	NNS	level
in	IN	in
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
.	SENT	.
</td>
Heat-shock	NP	<unknown>
proteins	NNS	protein
(	(	(
HSPs	NP	<unknown>
)	)	)
have	VBP	have
been	VBN	be
implicated	VBN	implicate
in	IN	in
the	DT	the
pathogenesis	NN	pathogenesis
of	IN	of
<span class='disease'>
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
(	(	(
<span class='disease'>
ALS	NN	<unknown>
</span>
)	)	)
.	SENT	.
In	IN	in
this	DT	this
study	NN	study
,	,	,
we	PP	we
aimed	VBD	aim
to	TO	to
examine	VB	examine
whether	IN	whether
the	DT	the
serum	NN	serum
levels	NNS	level
of	IN	of
HSPs	NP	<unknown>
(	(	(
HSP27	NP	<unknown>
,	,	,
HSP70	NP	<unknown>
,	,	,
and	CC	and
HSP90	NP	<unknown>
)	)	)
are	VBP	be
altered	VBN	alter
in	IN	in
patients	NNS	patient
with	IN	with
<span class='disease'>
ALS	NN	<unknown>
</span>
.	SENT	.
We	PP	we
included	VBD	include
58	CD	@card@
patients	NNS	patient
diagnosed	VBN	diagnose
with	IN	with
<span class='disease'>
ALS	NN	<unknown>
</span>
and	CC	and
85	CD	@card@
control	NN	control
individuals	NNS	individual
.	SENT	.
Serum	NP	Serum
<span class='disease'>
HSP	NP	<unknown>
</span>
levels	NNS	level
of	IN	of
patients	NNS	patient
and	CC	and
controls	NNS	control
were	VBD	be
determined	VBN	determine
using	VBG	use
enzyme-linked	JJ	enzyme-linked
immunosorbent	JJ	immunosorbent
assay	NN	assay
.	SENT	.
The	DT	the
serum	NN	serum
levels	NNS	level
of	IN	of
HSP70	NP	<unknown>
and	CC	and
HSP90	NP	<unknown>
were	VBD	be
significantly	RB	significantly
higher	JJR	high
in	IN	in
patients	NNS	patient
than	IN	than
in	IN	in
controls	NNS	control
.	SENT	.
In	IN	in
contrast	NN	contrast
,	,	,
serum	NN	serum
levels	NNS	level
of	IN	of
HSP27	JJ	<unknown>
did	VBD	do
not	RB	not
differ	VB	differ
significantly	RB	significantly
between	IN	between
the	DT	the
patient	NN	patient
and	CC	and
control	NN	control
groups	NNS	group
.	SENT	.
Moreover	RB	moreover
,	,	,
serum	NN	serum
levels	NNS	level
of	IN	of
HSP70	NP	<unknown>
and	CC	and
HSP90	NP	<unknown>
in	IN	in
patients	NNS	patient
remained	VBD	remain
high	JJ	high
throughout	IN	throughout
the	DT	the
duration	NN	duration
of	IN	of
the	DT	the
disease	NN	disease
.	SENT	.
Taken	VBN	take
together	RB	together
,	,	,
our	PP$	our
findings	NNS	finding
suggest	VBP	suggest
that	IN	that
HSPs	NP	<unknown>
might	MD	might
have	VB	have
a	DT	a
role	NN	role
in	IN	in
<span class='disease'>
ALS	JJ	<unknown>
</span>
progression	NN	progression
throughout	IN	throughout
the	DT	the
course	NN	course
of	IN	of
the	DT	the
disease	NN	disease
.	SENT	.
Further	JJR	further
studies	NNS	study
are	VBP	be
needed	VBN	need
to	TO	to
clarify	VB	clarify
the	DT	the
role	NN	role
of	IN	of
HSPs	NP	<unknown>
in	IN	in
the	DT	the
pathogenesis	NN	pathogenesis
of	IN	of
<span class='disease'>
ALS	NN	<unknown>
</span>
.	SENT	.
<td class='article_title' rowspan='2'>
Noninvasive	JJ	noninvasive
ventilation	NN	ventilation
in	IN	in
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
:	:	:
effects	NNS	effect
on	IN	on
sleep	NN	sleep
quality	NN	quality
and	CC	and
quality	NN	quality
of	IN	of
life	NN	life
.	SENT	.
</td>
Little	RB	little
is	VBZ	be
known	VBN	know
about	IN	about
the	DT	the
effects	NNS	effect
of	IN	of
noninvasive	JJ	noninvasive
ventilation	NN	ventilation
(	(	(
NIV	NP	<unknown>
)	)	)
on	IN	on
sleep	NN	sleep
quality	NN	quality
in	IN	in
<span class='disease'>
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
(	(	(
<span class='disease'>
ALS	NN	<unknown>
</span>
)	)	)
.	SENT	.
We	PP	we
aim	VBP	aim
to	TO	to
evaluate	VB	evaluate
the	DT	the
long-term	JJ	long-term
effects	NNS	effect
of	IN	of
NIV	NP	<unknown>
on	IN	on
sleep	NN	sleep
quality	NN	quality
and	CC	and
quality	NN	quality
of	IN	of
life	NN	life
in	IN	in
patients	NNS	patient
with	IN	with
<span class='disease'>
ALS	JJ	<unknown>
</span>
.In	NN	<unknown>
this	DT	this
prospective	JJ	prospective
observational	JJ	observational
study	NN	study
,	,	,
13	CD	@card@
<span class='disease'>
ALS	JJ	<unknown>
</span>
patients	NNS	patient
were	VBD	be
followed	VBN	follow
for	IN	for
one	CD	one
year	NN	year
after	IN	after
initiating	VBG	initiate
NIV	NP	<unknown>
.	SENT	.
We	PP	we
evaluated	VBD	evaluate
sleep	NN	sleep
quality	NN	quality
,	,	,
quality	NN	quality
of	IN	of
life	NN	life
and	CC	and
functional	JJ	functional
status	NN	status
with	IN	with
several	JJ	several
questionnaires	NNS	questionnaire
:	:	:
Epworth	NN	<unknown>
sleepiness	NN	sleepiness
Scale	NP	Scale
(	(	(
ESS	NP	<unknown>
)	)	)
,	,	,
Pittsburg	NP	Pittsburg
sleep	NN	sleep
quality	NN	quality
index	NN	index
(	(	(
PSQI	NP	<unknown>
)	)	)
,	,	,
Short	JJ	short
Form	NP	Form
36	CD	@card@
Health	NP	Health
Questionnaire	NP	<unknown>
(	(	(
SF-36	NP	<unknown>
)	)	)
,	,	,
McGill	NP	McGill
Quality	NP	Quality
of	IN	of
Life	NP	Life
questionnaire	NN	questionnaire
(	(	(
McGillQoL	NP	<unknown>
)	)	)
and	CC	and
revised	VBD	revise
<span class='disease'>
Amyotrophic	NP	<unknown>
Lateral	NP	<unknown>
Sclerosis	NP	<unknown>
</span>
Functional	NP	<unknown>
Rating	NP	<unknown>
Scale	NP	Scale
scores	NNS	score
(ALSFRS-R).Median	JJ	<unknown>
and	CC	and
interquartile	JJ	<unknown>
range	NN	range
(	(	(
IQR	NP	<unknown>
)	)	)
at	IN	at
the	DT	the
start	NN	start
of	IN	of
NIV	NP	<unknown>
was	VBD	be
59	CD	@card@
(	(	(
53-65	CD	@card@
)	)	)
years	NNS	year
.	SENT	.
The	DT	the
ALSFRS-R	NP	<unknown>
at	IN	at
start	NN	start
was	VBD	be
30	CD	@card@
(	(	(
24-37	CD	@card@
)	)	)
(	(	(
median	NN	median
,	,	,
IQR	NP	<unknown>
)	)	)
,	,	,
with	IN	with
three	CD	three
patients	NNS	patient
having	VBG	have
severe	JJ	severe
bulbar	JJ	bulbar
impairment	NN	impairment
(	(	(
ALSFRS-R-bulbar	NP	<unknown>
≤	NN	<unknown>
9)	NN	<unknown>
.	SENT	.
The	DT	the
PaCO2	NN	<unknown>
at	IN	at
start	NN	start
of	IN	of
NIV	NP	<unknown>
treatment	NN	treatment
was	VBD	be
48	CD	@card@
(	(	(
43-52	CD	@card@
)	)	)
mmHg	NN	<unknown>
(	(	(
median	JJ	median
,	,	,
IQR)	NP	<unknown>
.	SENT	.
During	IN	during
the	DT	the
one-year	JJ	one-year
follow-up	NN	follow-up
period	NN	period
,	,	,
a	DT	a
significant	JJ	significant
decrease	NN	decrease
in	IN	in
the	DT	the
ALSFRS-R	NP	<unknown>
was	VBD	be
observed	VBN	observe
.	SENT	.
The	DT	the
<span class='gene'>
impact	NN	impact
</span>
of	IN	of
NIV	NP	<unknown>
in	IN	in
a	DT	a
short	JJ	short
term	NN	term
(	(	(
1	CD	1
month	NN	month
)	)	)
revealed	VBD	reveal
a	DT	a
statistically	RB	statistically
significant	JJ	significant
decrease	NN	decrease
in	IN	in
ESS	NP	<unknown>
,	,	,
decrease	NN	decrease
in	IN	in
total	JJ	total
PSQI	NP	<unknown>
and	CC	and
of	IN	of
four	CD	four
PSQI	NP	<unknown>
subscales	NNS	<unknown>
and	CC	and
improvement	NN	improvement
of	IN	of
almost	RB	almost
all	DT	all
subscales	NNS	<unknown>
of	IN	of
the	DT	the
McGill	NP	McGill
questionnaire	NN	questionnaire
.	SENT	.
Long-term	JJ	long-term
analyses	NNS	analysis
(	(	(
9	CD	9
months	NNS	month
to	TO	to
1	CD	1
year	NN	year
)	)	)
revealed	VBD	reveal
that	DT	that
amelioration	NN	amelioration
in	IN	in
ESS	NN	<unknown>
and	CC	and
total	JJ	total
PSQI	NP	<unknown>
was	VBD	be
sustained.We	NNS	<unknown>
conclude	VBP	conclude
that	IN	that
accurately	RB	accurately
titrated	VBN	titrate
NIV	NP	<unknown>
in	IN	in
<span class='disease'>
ALS	JJ	<unknown>
</span>
patients	NNS	patient
can	MD	can
stabilize	VB	stabilize
sleep	NN	sleep
quality	NN	quality
and	CC	and
quality	NN	quality
of	IN	of
life	NN	life
for	IN	for
at	IN	at
least	JJS	least
one	CD	one
year	NN	year
,	,	,
despite	IN	despite
significant	JJ	significant
disease	NN	disease
progression	NN	progression
.	SENT	.
<td class='article_title' rowspan='2'>
Oral	JJ	oral
motor	NN	motor
functions	NNS	function
,	,	,
speech	NN	speech
and	CC	and
communication	NN	communication
before	IN	before
a	DT	a
definitive	JJ	definitive
diagnosis	NN	diagnosis
of	IN	of
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
.	SENT	.
</td>
The	DT	the
aim	NN	aim
of	IN	of
this	DT	this
study	NN	study
was	VBD	be
to	TO	to
explore	VB	explore
the	DT	the
cranial	JJ	cranial
nerve	NN	nerve
symptoms	NNS	symptom
,	,	,
speech	NN	speech
disorders	NNS	disorder
and	CC	and
communicative	JJ	communicative
effectiveness	NN	effectiveness
of	IN	of
Finnish	JJ	Finnish
patients	NNS	patient
with	IN	with
diagnosed	VBN	diagnose
or	CC	or
possible	JJ	possible
<span class='disease'>
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
(	(	(
<span class='disease'>
ALS	NN	<unknown>
</span>
)	)	)
at	IN	at
their	PP$	their
first	JJ	first
assessment	NN	assessment
by	IN	by
a	DT	a
speech-language	NN	<unknown>
pathologist	NN	pathologist
.	SENT	.
The	DT	the
group	NN	group
studied	VBD	study
consisted	VBN	consist
of	IN	of
30	CD	@card@
participants	NNS	participant
who	WP	who
had	VBD	have
clinical	JJ	clinical
signs	NNS	sign
of	IN	of
bulbar	JJ	bulbar
deterioration	NN	deterioration
at	IN	at
the	DT	the
beginning	NN	beginning
of	IN	of
the	DT	the
study	NN	study
.	SENT	.
They	PP	they
underwent	VBD	undergo
a	DT	a
thorough	JJ	thorough
clinical	JJ	clinical
speech	NN	speech
and	CC	and
communication	NN	communication
examination	NN	examination
.	SENT	.
The	DT	the
cranial	JJ	cranial
nerve	NN	nerve
symptoms	NNS	symptom
and	CC	and
ability	NN	ability
to	TO	to
communicate	VB	communicate
were	VBD	be
compared	VBN	compare
in	IN	in
14	CD	@card@
participants	NNS	participant
with	IN	with
probable	JJ	probable
or	CC	or
definitive	JJ	definitive
<span class='disease'>
ALS	NN	<unknown>
</span>
and	CC	and
in	IN	in
16	CD	@card@
participants	NNS	participant
with	IN	with
suspected	JJ	suspected
or	CC	or
possible	JJ	possible
<span class='disease'>
ALS	NN	<unknown>
</span>
.	SENT	.
The	DT	the
initial	JJ	initial
type	NN	type
of	IN	of
<span class='disease'>
ALS	NN	<unknown>
</span>
was	VBD	be
also	RB	also
assessed	VBN	assess
.	SENT	.
More	JJR	more
deterioration	NN	deterioration
in	IN	in
soft	JJ	soft
palate	NN	palate
function	NN	function
was	VBD	be
found	VBN	find
in	IN	in
participants	NNS	participant
with	IN	with
possible	JJ	possible
<span class='disease'>
ALS	NN	<unknown>
</span>
than	IN	than
with	IN	with
diagnosed	VBN	diagnose
<span class='disease'>
ALS	NN	<unknown>
</span>
.	SENT	.
Likewise	RB	likewise
,	,	,
a	DT	a
slower	JJR	slow
speech	NN	speech
rate	NN	rate
combined	VBN	combine
with	IN	with
more	JJR	more
severe	JJ	severe
<span class='symptom'>
dysarthria	NNS	<unknown>
</span>
was	VBD	be
observed	VBN	observe
in	IN	in
possible	JJ	possible
<span class='disease'>
ALS	NN	<unknown>
</span>
.	SENT	.
In	IN	in
both	DT	both
groups	NNS	group
,	,	,
there	EX	there
was	VBD	be
some	DT	some
deterioration	NN	deterioration
in	IN	in
communicative	JJ	communicative
effectiveness	NN	effectiveness
.	SENT	.
In	IN	in
the	DT	the
possible	JJ	possible
<span class='disease'>
ALS	NN	<unknown>
</span>
group	NN	group
the	DT	the
diagnostic	JJ	diagnostic
delay	NN	delay
was	VBD	be
longer	JJR	long
and	CC	and
speech	NN	speech
therapy	NN	therapy
intervention	NN	intervention
actualized	VBD	actualize
later	RBR	later
.	SENT	.
The	DT	the
participants	NNS	participant
with	IN	with
<span class='disease'>
ALS	NP	<unknown>
</span>
showed	VBD	show
multidimensional	JJ	multidimensional
decline	NN	decline
in	IN	in
communication	NN	communication
at	IN	at
their	PP$	their
first	JJ	first
visit	NN	visit
to	TO	to
the	DT	the
speech-language	NN	<unknown>
pathologist	NN	pathologist
,	,	,
but	CC	but
impairments	NNS	impairment
and	CC	and
activity	NN	activity
limitations	NNS	limitation
were	VBD	be
more	RBR	more
severe	JJ	severe
in	IN	in
suspected	JJ	suspected
or	CC	or
possible	JJ	possible
<span class='disease'>
ALS	NN	<unknown>
</span>
.	SENT	.
The	DT	the
majority	NN	majority
of	IN	of
persons	NNS	person
with	IN	with
bulbar-onset	NN	<unknown>
<span class='disease'>
ALS	NN	<unknown>
</span>
in	IN	in
this	DT	this
study	NN	study
were	VBD	be
in	IN	in
the	DT	the
latter	JJ	latter
diagnostic	JJ	diagnostic
group	NN	group
.	SENT	.
This	DT	this
suggests	VBZ	suggest
that	IN	that
they	PP	they
are	VBP	be
more	RBR	more
susceptible	JJ	susceptible
to	TO	to
delayed	JJ	delayed
diagnosis	NN	diagnosis
and	CC	and
delayed	JJ	delayed
speech	NN	speech
therapy	NN	therapy
assessment	NN	assessment
.	SENT	.
It	PP	it
is	VBZ	be
important	JJ	important
to	TO	to
start	VB	start
speech	NN	speech
therapy	NN	therapy
intervention	NN	intervention
during	IN	during
the	DT	the
diagnostic	JJ	diagnostic
processes	NNS	process
particularly	RB	particularly
if	IN	if
the	DT	the
person	NN	person
already	RB	already
shows	VBZ	show
bulbar	JJ	bulbar
symptoms	NNS	symptom
.	SENT	.
<td class='article_title' rowspan='2'>
Redox	NN	redox
Imbalance	NP	<unknown>
and	CC	and
Viral	NP	<unknown>
Infections	NNS	infection
in	IN	in
Neurodegenerative	NP	<unknown>
Diseases	NPS	<unknown>
.	SENT	.
</td>
Reactive	JJ	reactive
oxygen	NN	oxygen
species	NNS	specie
(	(	(
ROS	NP	Ros
)	)	)
are	VBP	be
essential	JJ	essential
molecules	NNS	molecule
for	IN	for
many	JJ	many
physiological	JJ	physiological
functions	NNS	function
and	CC	and
act	NN	act
as	IN	as
second	JJ	second
messengers	NNS	messenger
in	IN	in
a	DT	a
large	JJ	large
variety	NN	variety
of	IN	of
tissues	NNS	tissue
.	SENT	.
An	DT	an
imbalance	NN	imbalance
in	IN	in
the	DT	the
production	NN	production
and	CC	and
elimination	NN	elimination
of	IN	of
ROS	NP	Ros
is	VBZ	be
associated	VBN	associate
with	IN	with
human	JJ	human
diseases	NNS	disease
including	VBG	include
neurodegenerative	JJ	<unknown>
disorders	NNS	disorder
.	SENT	.
In	IN	in
the	DT	the
last	JJ	last
years	NNS	year
the	DT	the
notion	NN	notion
that	IN	that
neurodegenerative	JJ	<unknown>
diseases	NNS	disease
are	VBP	be
accompanied	VBN	accompany
by	IN	by
chronic	JJ	chronic
viral	JJ	viral
infections	NNS	infection
,	,	,
which	WDT	which
may	MD	may
result	VB	result
in	IN	in
an	DT	an
increase	NN	increase
of	IN	of
neurodegenerative	JJ	<unknown>
diseases	NNS	disease
progression	NN	progression
,	,	,
emerged	VBD	emerge
.	SENT	.
It	PP	it
is	VBZ	be
known	VBN	know
in	IN	in
literature	NN	literature
that	IN	that
enhanced	JJ	enhanced
viral	JJ	viral
infection	NN	infection
risk	NN	risk
,	,	,
observed	VBN	observe
during	IN	during
<span class='symptom'>
neurodegeneration	NN	<unknown>
</span>
,	,	,
is	VBZ	be
partly	RB	partly
due	JJ	due
to	TO	to
the	DT	the
increase	NN	increase
of	IN	of
ROS	NP	Ros
accumulation	NN	accumulation
in	IN	in
brain	NN	brain
cells	NNS	cell
.	SENT	.
However	RB	however
,	,	,
the	DT	the
molecular	JJ	molecular
mechanisms	NNS	mechanism
of	IN	of
viral	JJ	viral
infection	NN	infection
,	,	,
occurring	VBG	occur
during	IN	during
the	DT	the
progression	NN	progression
of	IN	of
<span class='symptom'>
neurodegeneration	NN	<unknown>
</span>
,	,	,
remain	VBP	remain
unclear	JJ	unclear
.	SENT	.
In	IN	in
this	DT	this
review	NN	review
,	,	,
we	PP	we
discuss	VBP	discuss
the	DT	the
recent	JJ	recent
knowledge	NN	knowledge
regarding	VBG	regard
the	DT	the
role	NN	role
of	IN	of
influenza	NN	influenza
,	,	,
herpes	NN	herpes
simplex	JJ	simplex
virus	NN	virus
type-1	NN	<unknown>
,	,	,
and	CC	and
retroviruses	NNS	retrovirus
infection	NN	infection
in	IN	in
ROS/RNS-mediated	NP	<unknown>
Parkinson	NP	Parkinson
's	POS	's
disease	NN	disease
(	(	(
PD	NP	PD
)	)	)
,	,	,
Alzheimer	NP	Alzheimer
's	POS	's
disease	NN	disease
(	(	(
AD	NP	Ad
)	)	)
,	,	,
and	CC	and
<span class='disease'>
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
(	(	(
<span class='disease'>
ALS	NN	<unknown>
</span>
)	)	)
.	SENT	.
<td class='article_title' rowspan='2'>
Structural	JJ	structural
Dynamics	NPS	Dynamics
of	IN	of
Human	NP	Human
Argonaute2	NP	<unknown>
and	CC	and
Its	PP$	its
Interaction	NP	Interaction
with	IN	with
siRNAs	NP	<unknown>
Designed	NP	<unknown>
to	TO	to
Target	NP	Target
Mutant	NP	<unknown>
tdp43	NN	<unknown>
.	SENT	.
</td>
The	DT	the
human	JJ	human
Argonaute2	JJ	<unknown>
protein	NN	protein
(	(	(
Ago2	NP	<unknown>
)	)	)
is	VBZ	be
a	DT	a
key	JJ	key
player	NN	player
in	IN	in
RNA	NP	RNA
interference	NN	interference
pathway	NN	pathway
and	CC	and
small	JJ	small
RNA	NP	RNA
recognition	NN	recognition
by	IN	by
Ago2	NP	<unknown>
is	VBZ	be
the	DT	the
crucial	JJ	crucial
step	NN	step
in	IN	in
siRNA	NP	<unknown>
mediated	VBD	mediate
gene	NN	gene
silencing	VBG	silence
mechanism	NN	mechanism
.	SENT	.
The	DT	the
present	JJ	present
study	NN	study
highlights	VBZ	highlight
the	DT	the
structural	JJ	structural
and	CC	and
functional	JJ	functional
dynamics	NNS	dynamics
of	IN	of
human	JJ	human
Ago2	NP	<unknown>
and	CC	and
the	DT	the
interaction	NN	interaction
mechanism	NN	mechanism
of	IN	of
Ago2	NP	<unknown>
with	IN	with
a	DT	a
set	NN	set
of	IN	of
seven	CD	seven
siRNAs	NNS	<unknown>
for	IN	for
the	DT	the
first	JJ	first
time	NN	time
.	SENT	.
The	DT	the
human	JJ	human
Ago2	NP	<unknown>
protein	NN	protein
adopts	VBZ	adopt
two	CD	two
conformations	NNS	conformation
such	JJ	such
as	IN	as
"	``	"
open	JJ	open
"	''	"
and	CC	and
"	``	"
close	JJ	close
"	''	"
during	IN	during
the	DT	the
simulation	NN	simulation
of	IN	of
25	CD	@card@
ns	NNS	<unknown>
.	SENT	.
One	CD	One
of	IN	of
the	DT	the
domains	NNS	domain
named	VBN	name
as	IN	as
PAZ	NP	Paz
,	,	,
which	WDT	which
is	VBZ	be
responsible	JJ	responsible
for	IN	for
anchoring	VBG	anchor
the	DT	the
3'-end	JJ	<unknown>
of	IN	of
siRNA	NN	<unknown>
guide	NN	guide
strand	NN	strand
,	,	,
is	VBZ	be
observed	VBN	observe
as	IN	as
a	DT	a
highly	RB	highly
flexible	JJ	flexible
region	NN	region
.	SENT	.
The	DT	the
interaction	NN	interaction
between	IN	between
Ago2	NP	<unknown>
and	CC	and
siRNA	NP	<unknown>
,	,	,
analyzed	VBD	analyze
using	VBG	use
a	DT	a
set	NN	set
of	IN	of
siRNAs	NNS	<unknown>
(	(	(
targeting	VBG	target
at	IN	at
positions	NNS	position
128	CD	@card@
,	,	,
251	CD	@card@
,	,	,
341	CD	@card@
,	,	,
383	CD	@card@
,	,	,
537	CD	@card@
,	,	,
1113	CD	@card@
,	,	,
and	CC	and
1115	CD	@card@
of	IN	of
mRNA	NN	<unknown>
)	)	)
designed	VBN	design
to	TO	to
target	VB	target
tdp43	JJ	<unknown>
mutants	NNS	mutant
causing	VBG	cause
<span class='disease'>
Amyotrophic	NP	<unknown>
Lateral	NP	<unknown>
Sclerosis	NP	<unknown>
</span>
(	(	(
<span class='disease'>
ALS	NP	<unknown>
</span>
)	)	)
disease	NN	disease
,	,	,
revealed	VBD	reveal
the	DT	the
stable	JJ	stable
and	CC	and
strong	JJ	strong
recognition	NN	recognition
of	IN	of
siRNA	NN	<unknown>
by	IN	by
the	DT	the
Ago2	JJ	<unknown>
protein	NN	protein
during	IN	during
dynamics	NNS	dynamics
.	SENT	.
Among	IN	among
the	DT	the
studied	VBN	study
siRNAs	NNS	<unknown>
,	,	,
the	DT	the
siRNA341	NN	<unknown>
is	VBZ	be
identified	VBN	identify
as	IN	as
a	DT	a
potent	JJ	potent
siRNA	NN	<unknown>
to	TO	to
recognize	VB	recognize
Ago2	JJ	<unknown>
and	CC	and
hence	RB	hence
could	MD	could
be	VB	be
used	VBN	use
further	RBR	further
as	IN	as
a	DT	a
possible	JJ	possible
siRNA	NN	<unknown>
candidate	NN	candidate
to	TO	to
target	VB	target
the	DT	the
mutant	JJ	mutant
tdp43	NN	<unknown>
protein	NN	protein
for	IN	for
the	DT	the
treatment	NN	treatment
of	IN	of
<span class='disease'>
ALS	JJ	<unknown>
</span>
patients	NNS	patient
.	SENT	.
<td class='article_title' rowspan='2'>
Physical	JJ	physical
activity	NN	activity
,	,	,
and	CC	and
physical	JJ	physical
activity	NN	activity
related	VBN	relate
to	TO	to
sports	NNS	sport
,	,	,
leisure	NN	leisure
and	CC	and
occupational	JJ	occupational
activity	NN	activity
as	IN	as
risk	NN	risk
factors	NNS	factor
for	IN	for
ALS	NN	<unknown>
:	:	:
a	DT	a
systematic	JJ	systematic
review	NN	review
.	SENT	.
</td>
<span class='disease'>
Amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
(	(	(
<span class='disease'>
ALS	NN	<unknown>
</span>
)	)	)
is	VBZ	be
considered	VBN	consider
a	DT	a
multifactorial	JJ	multifactorial
,	,	,
multisystem	JJ	<unknown>
<span class='symptom'>
neurodegenerative	JJ	<unknown>
disease	NN	disease
</span>
due	JJ	due
to	TO	to
an	DT	an
interaction	NN	interaction
between	IN	between
environmental	JJ	environmental
and	CC	and
genetic	JJ	genetic
factors	NNS	factor
.	SENT	.
This	DT	this
systematic	JJ	systematic
review	NN	review
aims	VBZ	aim
at	IN	at
gathering	VBG	gather
all	DT	all
available	JJ	available
evidence	NN	evidence
on	IN	on
the	DT	the
association	NN	association
between	IN	between
physical	JJ	physical
activity	NN	activity
(	(	(
PA	NP	Pa
)	)	)
and	CC	and
the	DT	the
risk	NN	risk
of	IN	of
<span class='disease'>
ALS	JJ	<unknown>
</span>
.Relevant	JJ	<unknown>
literature	NN	literature
published	VBN	publish
up	RP	up
to	TO	to
January	NP	January
2015	CD	@card@
was	VBD	be
gathered	VBN	gather
through	IN	through
structured	JJ	structured
searches	NNS	search
on	IN	on
Medline	NP	<unknown>
,	,	,
The	DT	the
Cochrane	NP	Cochrane
Library	NP	Library
,	,	,
and	CC	and
the	DT	the
ISI	NP	ISI
Web	NP	Web
of	IN	of
Science	NP	Science
databases	NNS	database
.	SENT	.
Studies	NNS	study
considering	VBG	consider
any	DT	any
type	NN	type
of	IN	of
PA	NP	Pa
as	IN	as
the	DT	the
main	JJ	main
exposure	NN	exposure
and	CC	and
a	DT	a
diagnosis	NN	diagnosis
of	IN	of
<span class='disease'>
ALS	NN	<unknown>
</span>
or	CC	or
motor	NN	motor
neuron	NN	neuron
disease	NN	disease
were	VBD	be
selected	VBN	select
.	SENT	.
Data	NNS	datum
were	VBD	be
extracted	VBN	extract
in	IN	in
standardized	JJ	standardized
forms	NNS	form
,	,	,
and	CC	and
the	DT	the
quality	NN	quality
of	IN	of
included	JJ	included
studies	NNS	study
was	VBD	be
assessed	VBN	assess
using	VBG	use
the	DT	the
Newcastle-Ottawa	NP	<unknown>
Scale	NP	Scale
(NOS).Bibliographic	JJ	<unknown>
searches	NNS	search
yielded	VBD	yield
3168	CD	@card@
records	NNS	record
.	SENT	.
Nineteen	CD	nineteen
case	NN	case
control	NN	control
studies	NNS	study
and	CC	and
7	CD	7
cohort	NN	cohort
studies	NNS	study
met	VBD	meet
the	DT	the
inclusion	NN	inclusion
criteria	NNS	criterion
,	,	,
and	CC	and
were	VBD	be
included	VBN	include
in	IN	in
the	DT	the
analysis	NN	analysis
.	SENT	.
Evidence	NN	evidence
on	IN	on
cumulative	JJ	cumulative
measures	NNS	measure
of	IN	of
PA	NP	Pa
as	IN	as
a	DT	a
risk	NN	risk
factor	NN	factor
for	IN	for
<span class='disease'>
ALS	NNS	<unknown>
</span>
remain	VBP	remain
inconclusive	JJ	inconclusive
.	SENT	.
However	RB	however
,	,	,
cohort	NN	cohort
studies	NNS	study
report	VBP	report
a	DT	a
significantly	RB	significantly
higher	JJR	high
number	NN	number
of	IN	of
cases	NNS	case
of	IN	of
<span class='disease'>
ALS	NN	<unknown>
</span>
in	IN	in
professional	JJ	professional
soccer	NN	soccer
and	CC	and
American	JJ	American
football	NN	football
players	NNS	player
,	,	,
and	CC	and
a	DT	a
slightly	RB	slightly
increased	VBN	increase
risk	NN	risk
of	IN	of
<span class='disease'>
ALS	NN	<unknown>
</span>
in	IN	in
varsity	NN	varsity
athletes	NNS	athlete
.	SENT	.
<td class='article_title' rowspan='2'>
Heat	NN	heat
shock	NN	shock
proteins	NNS	protein
as	IN	as
potential	JJ	potential
targets	NNS	target
for	IN	for
protective	JJ	protective
strategies	NNS	strategy
in	IN	in
neurodegeneration	NN	<unknown>
.	SENT	.
</td>
Protein	NN	protein
aggregates	NNS	aggregate
are	VBP	be
hallmarks	NNS	hallmark
of	IN	of
nearly	RB	nearly
all	DT	all
age-related	JJ	age-related
neurodegenerative	JJ	<unknown>
diseases	NNS	disease
,	,	,
including	VBG	include
Alzheimer	NP	Alzheimer
's	POS	's
disease	NN	disease
,	,	,
Parkinson	NP	Parkinson
's	POS	's
disease	NN	disease
,	,	,
<span class='disease'>
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
,	,	,
and	CC	and
several	JJ	several
polyglutamine	NN	<unknown>
diseases	NNS	disease
such	JJ	such
as	IN	as
Huntington	NP	Huntington
's	POS	's
disease	NN	disease
and	CC	and
different	JJ	different
forms	NNS	form
of	IN	of
spinocerebellar	JJ	<unknown>
ataxias	NNS	ataxia
(	(	(
SCA	NP	SCA
;	:	;
SCA1-3	NP	<unknown>
,	,	,
<span class='disease'>
SCA6	NP	<unknown>
</span>
,	,	,
and	CC	and
<span class='disease'>
SCA7	JJ	<unknown>
</span>
)	)	)
.	SENT	.
The	DT	the
collapse	NN	collapse
of	IN	of
cellular	JJ	cellular
protein	NN	protein
homoeostasis	NN	homoeostasis
can	MD	can
be	VB	be
both	CC	both
a	DT	a
cause	NN	cause
and	CC	and
a	DT	a
consequence	NN	consequence
of	IN	of
this	DT	this
protein	NN	protein
aggregation	NN	aggregation
.	SENT	.
Boosting	VBG	boost
components	NNS	component
of	IN	of
the	DT	the
cellular	JJ	cellular
protein	NN	protein
quality	NN	quality
control	NN	control
system	NN	system
has	VBZ	have
been	VBN	be
widely	RB	widely
investigated	VBN	investigate
as	IN	as
a	DT	a
strategy	NN	strategy
to	TO	to
counteract	VB	counteract
protein	NN	protein
aggregates	NNS	aggregate
or	CC	or
their	PP$	their
toxic	JJ	toxic
consequences	NNS	consequence
.	SENT	.
Heat	NN	heat
shock	NN	shock
proteins	NNS	protein
(	(	(
HSPs	NP	<unknown>
)	)	)
play	VBP	play
a	DT	a
central	JJ	central
part	NN	part
in	IN	in
regulating	VBG	regulate
protein	NN	protein
quality	NN	quality
control	NN	control
and	CC	and
contribute	VB	contribute
to	TO	to
protein	NN	protein
aggregation	NN	aggregation
and	CC	and
disaggregation	NN	<unknown>
.	SENT	.
Therefore	RB	therefore
,	,	,
HSPs	NNS	<unknown>
are	VBP	be
viable	JJ	viable
targets	NNS	target
for	IN	for
the	DT	the
development	NN	development
of	IN	of
drugs	NNS	drug
aimed	VBN	aim
at	IN	at
reducing	VBG	reduce
pathogenic	JJ	pathogenic
protein	NN	protein
aggregates	NNS	aggregate
that	WDT	that
are	VBP	be
thought	VBN	think
to	TO	to
contribute	VB	contribute
to	TO	to
the	DT	the
development	NN	development
of	IN	of
so	RB	so
many	JJ	many
neurodegenerative	JJ	<unknown>
disorders	NNS	disorder
.	SENT	.
<td class='article_title' rowspan='2'>
p53	NN	p53
isoforms	NNS	<unknown>
regulate	VB	regulate
astrocyte-mediated	JJ	<unknown>
neuroprotection	NN	<unknown>
and	CC	and
neurodegeneration	NN	<unknown>
.	SENT	.
</td>
Bidirectional	JJ	<unknown>
interactions	NNS	interaction
between	IN	between
astrocytes	NNS	astrocyte
and	CC	and
neurons	NNS	neuron
have	VBP	have
physiological	JJ	physiological
roles	NNS	role
in	IN	in
the	DT	the
central	JJ	central
nervous	JJ	nervous
system	NN	system
and	CC	and
an	DT	an
altered	JJ	altered
state	NN	state
or	CC	or
dysfunction	NN	dysfunction
of	IN	of
such	JJ	such
interactions	NNS	interaction
may	MD	may
be	VB	be
associated	VBN	associate
with	IN	with
neurodegenerative	JJ	<unknown>
diseases	NNS	disease
,	,	,
such	JJ	such
as	IN	as
Alzheimer	NP	Alzheimer
's	POS	's
disease	NN	disease
(	(	(
AD	NN	ad
)	)	)
and	CC	and
<span class='disease'>
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
(	(	(
<span class='disease'>
ALS	NN	<unknown>
</span>
)	)	)
.	SENT	.
Astrocytes	NNS	astrocyte
exert	VBP	exert
structural	JJ	structural
,	,	,
metabolic	JJ	metabolic
and	CC	and
functional	JJ	functional
effects	NNS	effect
on	IN	on
neurons	NNS	neuron
,	,	,
which	WDT	which
can	MD	can
be	VB	be
either	RB	either
neurotoxic	JJ	neurotoxic
or	CC	or
neuroprotective	JJ	<unknown>
.	SENT	.
Their	PP$	their
neurotoxic	JJ	neurotoxic
effect	NN	effect
is	VBZ	be
mediated	VBN	mediate
via	IN	via
the	DT	the
senescence-associated	JJ	<unknown>
secretory	JJ	secretory
phenotype	NN	phenotype
(	(	(
SASP	NP	<unknown>
)	)	)
involving	VBG	involve
pro-inflammatory	JJ	<unknown>
cytokines	NNS	<unknown>
(	(	(
e.g.	FW	e.g.
,	,	,
IL-6	NP	<unknown>
)	)	)
,	,	,
while	IN	while
their	PP$	their
neuroprotective	JJ	<unknown>
effect	NN	effect
is	VBZ	be
attributed	VBN	attribute
to	TO	to
neurotrophic	JJ	<unknown>
growth	NN	growth
factors	NNS	factor
(	(	(
e.g.	FW	e.g.
,	,	,
<span class='gene'>
NGF	NP	<unknown>
</span>
)	)	)
.	SENT	.
We	PP	we
here	RB	here
demonstrate	VBP	demonstrate
that	IN	that
the	DT	the
p53	NN	p53
isoforms	VBZ	<unknown>
Δ133p53	NN	<unknown>
and	CC	and
p53β	NN	<unknown>
are	VBP	be
expressed	VBN	express
in	IN	in
astrocytes	NNS	astrocyte
and	CC	and
regulate	VB	regulate
their	PP$	their
toxic	JJ	toxic
and	CC	and
protective	JJ	protective
effects	NNS	effect
on	IN	on
neurons	NNS	neuron
.	SENT	.
Primary	JJ	primary
human	JJ	human
astrocytes	NNS	astrocyte
undergoing	VBG	undergo
cellular	JJ	cellular
senescence	NN	senescence
upon	IN	upon
serial	NN	serial
passaging	VBG	passage
in	IN	in
vitro	NN	<unknown>
showed	VBD	show
diminished	JJ	diminished
expression	NN	expression
of	IN	of
Δ133p53	NN	<unknown>
and	CC	and
increased	VBN	increase
p53β	NN	<unknown>
,	,	,
which	WDT	which
were	VBD	be
attributed	VBN	attribute
to	TO	to
the	DT	the
autophagic	JJ	<unknown>
degradation	NN	degradation
and	CC	and
the	DT	the
SRSF3-mediated	NP	<unknown>
alternative	NN	alternative
RNA	NP	RNA
splicing	VBG	splice
,	,	,
respectively	RB	respectively
.	SENT	.
Early-passage	NN	<unknown>
astrocytes	NNS	astrocyte
with	IN	with
Δ133p53	JJ	<unknown>
knockdown	NN	knockdown
or	CC	or
p53β	NN	<unknown>
overexpression	NN	<unknown>
were	VBD	be
induced	VBN	induce
to	TO	to
show	VB	show
SASP	NP	<unknown>
and	CC	and
to	TO	to
exert	VB	exert
neurotoxicity	NN	<unknown>
in	IN	in
co-culture	NN	<unknown>
with	IN	with
neurons	NNS	neuron
.	SENT	.
Restored	VBN	restore
expression	NN	expression
of	IN	of
Δ133p53	NN	<unknown>
in	IN	in
near-senescent	JJ	<unknown>
,	,	,
otherwise	RB	otherwise
neurotoxic	JJ	neurotoxic
astrocytes	NNS	astrocyte
conferred	VBD	confer
them	PP	them
with	IN	with
neuroprotective	JJ	<unknown>
activity	NN	activity
through	IN	through
repression	NN	repression
of	IN	of
SASP	NP	<unknown>
and	CC	and
induction	NN	induction
of	IN	of
neurotrophic	JJ	<unknown>
growth	NN	growth
factors	NNS	factor
.	SENT	.
Brain	NN	brain
tissues	NNS	tissue
from	IN	from
AD	NN	ad
and	CC	and
<span class='disease'>
ALS	NN	<unknown>
</span>
patients	NNS	patient
possessed	VBD	possess
increased	VBN	increase
numbers	NNS	number
of	IN	of
senescent	JJ	senescent
astrocytes	NNS	astrocyte
and	CC	and
,	,	,
like	IN	like
senescent	JJ	senescent
astrocytes	NNS	astrocyte
in	IN	in
vitro	NN	<unknown>
,	,	,
showed	VBD	show
decreased	VBN	decrease
Δ133p53	NN	<unknown>
and	CC	and
increased	VBD	increase
p53β	JJ	<unknown>
expression	NN	expression
,	,	,
supporting	VBG	support
that	IN	that
our	PP$	our
in	IN	in
vitro	NN	<unknown>
findings	NNS	finding
recapitulate	VBP	recapitulate
in	IN	in
vivo	JJ	vivo
pathology	NN	pathology
of	IN	of
these	DT	these
neurodegenerative	JJ	<unknown>
diseases	NNS	disease
.	SENT	.
Our	PP$	our
finding	NN	finding
that	IN	that
Δ133p53	NN	<unknown>
enhances	VBZ	enhance
the	DT	the
neuroprotective	JJ	<unknown>
function	NN	function
of	IN	of
aged	JJ	aged
and	CC	and
senescent	JJ	senescent
astrocytes	NNS	astrocyte
suggests	VBZ	suggest
that	IN	that
the	DT	the
p53	NN	p53
isoforms	NNS	<unknown>
and	CC	and
their	PP$	their
regulatory	JJ	regulatory
mechanisms	NNS	mechanism
are	VBP	be
potential	JJ	potential
targets	NNS	target
for	IN	for
therapeutic	JJ	therapeutic
intervention	NN	intervention
in	IN	in
neurodegenerative	JJ	<unknown>
diseases.Cell	NN	<unknown>
Death	NN	death
and	CC	and
Differentiation	NN	differentiation
advance	NN	advance
online	JJ	online
publication	NN	publication
,	,	,
22	CD	@card@
April	NP	April
2016	CD	@card@
;	:	;
doi:10.1038/cdd.2016.37	JJ	<unknown>
.	SENT	.
<td class='article_title' rowspan='2'>
Involvement	NN	involvement
of	IN	of
distal	JJ	distal
sensory	JJ	sensory
nerves	NNS	nerve
in	IN	in
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
.	SENT	.
</td>
The	DT	the
diagnostic	JJ	diagnostic
criteria	NNS	criterion
for	IN	for
<span class='disease'>
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
(	(	(
<span class='disease'>
ALS	NN	<unknown>
</span>
)	)	)
require	VBP	require
normal	JJ	normal
sensory	JJ	sensory
nerve	NN	nerve
conduction	NN	conduction
studies	NNS	study
(	(	(
NCS	NP	<unknown>
)	)	)
or	CC	or
abnormal	JJ	abnormal
NCS	NNS	<unknown>
only	RB	only
in	IN	in
the	DT	the
presence	NN	presence
of	IN	of
<span class='symptom'>
neuropathy	NN	neuropathy
</span>
of	IN	of
identified	VBN	identify
etiology	NN	etiology
.	SENT	.
In	IN	in
this	DT	this
study	NN	study
,	,	,
we	PP	we
investigated	VBD	investigate
the	DT	the
presence	NN	presence
and	CC	and
extent	NN	extent
of	IN	of
involvement	NN	involvement
of	IN	of
A-beta	NP	<unknown>
sensory	JJ	sensory
fibers	NNS	fiber
in	IN	in
<span class='disease'>
ALS	JJ	<unknown>
</span>
.Distal	JJ	<unknown>
sensory	JJ	sensory
NCS	NP	<unknown>
(	(	(
antidromic	JJ	antidromic
dorsal	JJ	dorsal
sural	JJ	sural
(	(	(
<span class='disease'>
DS	NP	DS
</span>
)	)	)
and	CC	and
orthodromic	JJ	<unknown>
medial	JJ	medial
plantar	JJ	plantar
(	(	(
MP	NN	MP
)	)	)
]	SYM	]
,	,	,
and	CC	and
conventional	JJ	conventional
sensory	JJ	sensory
NCS	NNS	<unknown>
[	SYM	[
unilateral	JJ	unilateral
median	JJ	median
sensory	JJ	sensory
and	CC	and
bilateral	JJ	bilateral
sural	JJ	sural
nerves	NNS	nerve
)	)	)
were	VBD	be
performed	VBN	perform
in	IN	in
16	CD	@card@
definite	JJ	definite
and	CC	and
2	CD	2
probable	JJ	probable
<span class='disease'>
ALS	NN	<unknown>
</span>
patients	NNS	patient
based	VBN	base
on	IN	on
Awaji	NP	<unknown>
criteria	NNS	criterion
and	CC	and
31	CD	@card@
controls.Abnormal	JJ	<unknown>
conventional	JJ	conventional
sensory	JJ	sensory
NCS	NP	<unknown>
were	VBD	be
found	VBN	find
in	IN	in
8	CD	8
(	(	(
44.4	CD	@card@
%	NN	%
)	)	)
<span class='disease'>
ALS	NN	<unknown>
</span>
patients	NNS	patient
and	CC	and
one	CD	one
(	(	(
3.2	CD	@card@
%	NN	%
)	)	)
control	NN	control
(	(	(
P	NN	P
=	SYM	=
0.002	CD	@card@
)	)	)
,	,	,
while	IN	while
abnormal	JJ	abnormal
distal	JJ	distal
sensory	JJ	sensory
NCS	NP	<unknown>
were	VBD	be
found	VBN	find
in	IN	in
12	CD	@card@
(	(	(
66.7	CD	@card@
%	NN	%
)	)	)
<span class='disease'>
ALS	NN	<unknown>
</span>
patients	NNS	patient
and	CC	and
3	CD	3
(	(	(
9.6	CD	@card@
%	NN	%
)	)	)
controls	VBZ	control
(	(	(
P	NN	P
<	SYM	<
0.0001).Distal	JJ	<unknown>
sensory	JJ	sensory
NCS	NNS	<unknown>
were	VBD	be
more	JJR	more
often	RB	often
abnormal	JJ	abnormal
than	IN	than
conventional	JJ	conventional
NCS	NP	<unknown>
in	IN	in
<span class='disease'>
ALS	NP	<unknown>
</span>
.	SENT	.
This	DT	this
article	NN	article
is	VBZ	be
protected	VBN	protect
by	IN	by
copyright	NN	copyright
.	SENT	.
All	DT	all
rights	NNS	right
reserved	VBD	reserve
.	SENT	.
<td class='article_title' rowspan='2'>
Structural	JJ	structural
and	CC	and
diffusion	NN	diffusion
imaging	NN	imaging
versus	CC	versus
clinical	JJ	clinical
assessment	NN	assessment
to	TO	to
monitor	VB	monitor
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
.	SENT	.
</td>
<span class='disease'>
Amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
is	VBZ	be
a	DT	a
progressive	JJ	progressive
<span class='symptom'>
neurodegenerative	JJ	<unknown>
disease	NN	disease
</span>
that	WDT	that
affects	VBZ	affect
upper	JJ	upper
and	CC	and
lower	JJR	low
motor	NN	motor
neurons	NNS	neuron
.	SENT	.
Observational	JJ	observational
and	CC	and
intervention	NN	intervention
studies	NNS	study
can	MD	can
be	VB	be
tracked	VBN	track
using	VBG	use
clinical	JJ	clinical
measures	NNS	measure
such	JJ	such
as	IN	as
the	DT	the
revised	VBN	revise
<span class='disease'>
Amyotrophic	NP	<unknown>
Lateral	NP	<unknown>
Sclerosis	NP	<unknown>
</span>
Functional	NP	<unknown>
Rating	NP	<unknown>
Scale	NP	Scale
(	(	(
ALSFRS-R	NP	<unknown>
)	)	)
but	CC	but
for	IN	for
a	DT	a
complete	JJ	complete
understanding	NN	understanding
of	IN	of
disease	NN	disease
progression	NN	progression
,	,	,
objective	NN	objective
in	IN	in
vivo	JJ	vivo
biomarkers	NNS	<unknown>
of	IN	of
both	DT	both
central	JJ	central
and	CC	and
peripheral	JJ	peripheral
motor	NN	motor
pathway	NN	pathway
pathology	NN	pathology
are	VBP	be
highly	RB	highly
desirable	JJ	desirable
.	SENT	.
The	DT	the
aim	NN	aim
of	IN	of
this	DT	this
study	NN	study
was	VBD	be
to	TO	to
determine	VB	determine
the	DT	the
utility	NN	utility
of	IN	of
structural	JJ	structural
and	CC	and
diffusion	NN	diffusion
imaging	NN	imaging
as	IN	as
central	JJ	central
nervous	JJ	nervous
system	NN	system
biomarkers	NNS	<unknown>
compared	VBN	compare
to	TO	to
the	DT	the
standard	JJ	standard
clinical	JJ	clinical
measure	NN	measure
,	,	,
ALSFRS-R	NP	<unknown>
,	,	,
to	TO	to
track	VB	track
longitudinal	JJ	longitudinal
evolution	NN	evolution
using	VBG	use
three	CD	three
time-point	NN	<unknown>
measurements	NNS	measurement
.	SENT	.
N	NN	N
=	SYM	=
34	CD	@card@
patients	NNS	patient
with	IN	with
<span class='disease'>
ALS	NN	<unknown>
</span>
were	VBD	be
scanned	VBN	scan
and	CC	and
clinically	RB	clinically
assessed	VBD	assess
three	CD	three
times	NNS	time
at	IN	at
a	DT	a
mean	NN	mean
of	IN	of
three	CD	three
month	NN	month
time	NN	time
intervals	NNS	interval
.	SENT	.
The	DT	the
MRI	NP	MRI
biomarkers	NNS	<unknown>
were	VBD	be
structural	JJ	structural
T1-weighted	JJ	<unknown>
volumes	NNS	volume
for	IN	for
cortical	JJ	cortical
thickness	NN	thickness
measurement	NN	measurement
as	RB	as
well	RB	well
as	IN	as
deep	JJ	deep
grey	JJ	grey
matter	NN	matter
volumetry	NN	volumetry
,	,	,
voxel-based	JJ	<unknown>
morphometry	NN	<unknown>
and	CC	and
diffusion	NN	diffusion
tensor	NN	tensor
imaging	NN	imaging
(DTI)	NN	<unknown>
.	SENT	.
Cortical	JJ	cortical
thickness	NN	thickness
focused	VBD	focus
specifically	RB	specifically
on	IN	on
the	DT	the
precentral	JJ	<unknown>
gyrus	NN	gyrus
while	IN	while
quantitative	JJ	quantitative
DTI	NP	DTI
biomarkers	NNS	<unknown>
focused	VBN	focus
on	IN	on
the	DT	the
corticospinal	JJ	<unknown>
tracts	NNS	tract
.	SENT	.
The	DT	the
evolution	NN	evolution
of	IN	of
imaging	NN	imaging
biomarkers	NNS	<unknown>
and	CC	and
ALSFRS-R	NN	<unknown>
scores	NNS	score
over	IN	over
time	NN	time
were	VBD	be
analysed	VBN	analyse
using	VBG	use
a	DT	a
mixed	JJ	mixed
effects	NNS	effect
model	NN	model
that	WDT	that
accounted	VBD	account
for	IN	for
the	DT	the
scanning	VBG	scan
interval	NN	interval
as	IN	as
a	DT	a
fixed	VBN	fix
effect	NN	effect
variable	NN	variable
,	,	,
and	CC	and
,	,	,
the	DT	the
initial	JJ	initial
measurements	NNS	measurement
and	CC	and
time	NN	time
from	IN	from
onset	NN	onset
as	IN	as
random	JJ	random
variables	NNS	variable
.	SENT	.
The	DT	the
mixed	JJ	mixed
effects	NNS	effect
model	NN	model
showed	VBD	show
a	DT	a
significant	JJ	significant
decrease	NN	decrease
in	IN	in
the	DT	the
ALSFRS-R	NP	<unknown>
score	NN	score
,	,	,
(	(	(
p	NN	p
< 0.0001, and an annual rate of change (AROC) of - 7.3 points). Similarly, fractional anisotropy of the corticospinal tract showed a significant decrease (p = 0.009, AROC = - 0.0066) that, in turn, was driven by a significant increase in radial diffusivity combined with a trend to decrease in axial diffusivity. No significant change in cortical thickness of the precentral gyrus was found (p >
0.5)	NN	<unknown>
.	SENT	.
In	IN	in
addition	NN	addition
,	,	,
deep	JJ	deep
grey	JJ	grey
matter	NN	matter
volumetry	NN	volumetry
and	CC	and
voxel-based	JJ	<unknown>
morphometry	NN	<unknown>
also	RB	also
identified	VBD	identify
no	DT	no
significant	JJ	significant
changes	NNS	change
.	SENT	.
Furthermore	RB	furthermore
,	,	,
the	DT	the
availability	NN	availability
of	IN	of
three	CD	three
time	NN	time
points	NNS	point
was	VBD	be
able	JJ	able
to	TO	to
indicate	VB	indicate
that	IN	that
there	EX	there
was	VBD	be
a	DT	a
linear	JJ	linear
progression	NN	progression
in	IN	in
both	DT	both
clinical	JJ	clinical
and	CC	and
fractional	JJ	fractional
anisotropy	NN	anisotropy
measures	NNS	measure
adding	VBG	add
to	TO	to
the	DT	the
validity	NN	validity
of	IN	of
these	DT	these
results	NNS	result
.	SENT	.
The	DT	the
results	NNS	result
indicate	VBP	indicate
that	IN	that
DTI	NP	DTI
is	VBZ	be
clearly	RB	clearly
a	DT	a
superior	JJ	superior
imaging	NN	imaging
marker	NN	marker
compared	VBN	compare
to	TO	to
atrophy	VB	atrophy
for	IN	for
tracking	VBG	track
the	DT	the
evolution	NN	evolution
of	IN	of
the	DT	the
disease	NN	disease
and	CC	and
can	MD	can
act	VB	act
as	IN	as
a	DT	a
central	JJ	central
nervous	JJ	nervous
biomarker	NN	<unknown>
in	IN	in
longitudinal	JJ	longitudinal
studies	NNS	study
.	SENT	.
It	PP	it
remains	VBZ	remain
,	,	,
however	RB	however
,	,	,
less	RBR	less
sensitive	JJ	sensitive
than	IN	than
the	DT	the
ALSFRS-R	NP	<unknown>
score	NN	score
for	IN	for
monitoring	VBG	monitor
decline	NN	decline
over	IN	over
time	NN	time
.	SENT	.
<td class='article_title' rowspan='2'>
Association	NN	association
between	IN	between
alcohol	NN	alcohol
consumption	NN	consumption
and	CC	and
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
:	:	:
a	DT	a
meta-analysis	NN	<unknown>
of	IN	of
five	CD	five
observational	JJ	observational
studies	NNS	study
.	SENT	.
</td>
The	DT	the
purpose	NN	purpose
of	IN	of
this	DT	this
study	NN	study
is	VBZ	be
to	TO	to
examine	VB	examine
the	DT	the
association	NN	association
between	IN	between
alcohol	NN	alcohol
consumption	NN	consumption
and	CC	and
<span class='disease'>
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
.	SENT	.
Published	VBN	publish
literature	NN	literature
on	IN	on
the	DT	the
association	NN	association
between	IN	between
alcohol	NN	alcohol
consumption	NN	consumption
and	CC	and
<span class='disease'>
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
was	VBD	be
retrieved	VBN	retrieve
from	IN	from
the	DT	the
PubMed	NP	<unknown>
and	CC	and
Embase	NP	<unknown>
databases	NNS	database
.	SENT	.
Two	CD	Two
authors	NNS	author
independently	RB	independently
extracted	VBD	extract
the	DT	the
data	NNS	datum
.	SENT	.
The	DT	the
quality	NN	quality
of	IN	of
the	DT	the
identified	VBN	identify
studies	NNS	study
was	VBD	be
evaluated	VBN	evaluate
according	VBG	accord
to	TO	to
the	DT	the
Newcastle-Ottawa	NP	<unknown>
scale	NN	scale
.	SENT	.
Subgroup	NN	subgroup
and	CC	and
sensitivity	NN	sensitivity
analyses	NNS	analysis
were	VBD	be
performed	VBN	perform
and	CC	and
publication	NN	publication
bias	NN	bias
was	VBD	be
assessed	VBN	assess
.	SENT	.
Five	CD	Five
articles	NNS	article
,	,	,
including	VBG	include
one	CD	one
cohort	NN	cohort
study	NN	study
and	CC	and
seven	CD	seven
case-control	NN	<unknown>
studies	NNS	study
,	,	,
and	CC	and
a	DT	a
total	NN	total
of	IN	of
431,943	CD	@card@
participants	NNS	participant
,	,	,
were	VBD	be
identified	VBN	identify
.	SENT	.
The	DT	the
odds	NNS	odd
ratio	NN	ratio
for	IN	for
the	DT	the
association	NN	association
between	IN	between
alcohol	NN	alcohol
consumption	NN	consumption
and	CC	and
<span class='disease'>
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
was	VBD	be
0.57	CD	@card@
(	(	(
95	CD	@card@
%	NN	%
confidence	NN	confidence
interval	NN	interval
0.51-0.64)	NN	<unknown>
.	SENT	.
Subgroup	NN	subgroup
and	CC	and
sensitivity	NN	sensitivity
analyses	NNS	analysis
confirmed	VBD	confirm
the	DT	the
result	NN	result
.	SENT	.
Evidence	NN	evidence
for	IN	for
publication	NN	publication
bias	NN	bias
was	VBD	be
detected	VBN	detect
.	SENT	.
Alcohol	NN	alcohol
consumption	NN	consumption
reduced	VBD	reduce
the	DT	the
risk	NN	risk
of	IN	of
developing	VBG	develop
<span class='disease'>
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
compared	VBN	compare
with	IN	with
non-drinking	NN	<unknown>
.	SENT	.
Alcohol	NN	alcohol
,	,	,
therefore	RB	therefore
,	,	,
has	VBZ	have
a	DT	a
potentially	RB	potentially
neuroprotective	JJ	<unknown>
effect	NN	effect
on	IN	on
the	DT	the
development	NN	development
of	IN	of
<span class='disease'>
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
.	SENT	.
<td class='article_title' rowspan='2'>
Syntactic	JJ	syntactic
comprehension	NN	comprehension
deficits	NNS	deficit
across	IN	across
the	DT	the
FTD-ALS	NP	<unknown>
continuum	NN	continuum
.	SENT	.
</td>
To	TO	To
establish	VB	establish
the	DT	the
frequency	NN	frequency
,	,	,
severity	NN	severity
,	,	,
relationship	NN	relationship
to	TO	to
bulbar	JJ	bulbar
symptoms	NNS	symptom
,	,	,
and	CC	and
neural	JJ	neural
correlates	NNS	correlate
of	IN	of
syntactic	JJ	syntactic
comprehension	NN	comprehension
deficits	NNS	deficit
across	IN	across
the	DT	the
frontotemporal	JJ	<unknown>
dementia-amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
(	(	(
<span class='disease'>
FTD-ALS	NP	<unknown>
</span>
)	)	)
disease	NN	disease
spectrum	NN	spectrum
.	SENT	.
In	IN	in
total	NN	total
,	,	,
85	CD	@card@
participants	NNS	participant
were	VBD	be
included	VBN	include
in	IN	in
the	DT	the
study	NN	study
;	:	;
20	CD	@card@
<span class='disease'>
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
(	(	(
<span class='disease'>
ALS	NP	<unknown>
</span>
)	)	)
,	,	,
15	NP	@card@
<span class='disease'>
FTD-ALS	NP	<unknown>
</span>
,	,	,
27	CD	@card@
progressive	JJ	progressive
nonfluent	JJ	<unknown>
<span class='symptom'>
aphasia	NN	aphasia
</span>
(	(	(
PNFA	NP	<unknown>
)	)	)
,	,	,
and	CC	and
23	CD	@card@
controls	NNS	control
.	SENT	.
Syntactic	JJ	syntactic
comprehension	NN	comprehension
was	VBD	be
evaluated	VBN	evaluate
in	IN	in
<span class='disease'>
ALS	NP	<unknown>
</span>
,	,	,
<span class='disease'>
FTD-ALS	NP	<unknown>
</span>
,	,	,
PNFA	NP	<unknown>
,	,	,
and	CC	and
controls	NNS	control
using	VBG	use
the	DT	the
Test	NN	test
for	IN	for
Reception	NP	<unknown>
of	IN	of
Grammar	NP	<unknown>
.	SENT	.
Voxel-based	JJ	<unknown>
morphometry	NN	<unknown>
examined	VBD	examine
neuroanatomical	JJ	<unknown>
correlates	NNS	correlate
of	IN	of
performance	NN	performance
.	SENT	.
Syntactic	JJ	syntactic
comprehension	NN	comprehension
deficits	NNS	deficit
were	VBD	be
detected	VBN	detect
in	IN	in
25	CD	@card@
%	NN	%
of	IN	of
<span class='disease'>
ALS	NP	<unknown>
</span>
(	(	(
p	NN	p
=	SYM	=
0.011	CD	@card@
)	)	)
,	,	,
92.9	CD	@card@
%	NN	%
of	IN	of
<span class='disease'>
FTD-ALS	NP	<unknown>
</span>
(	(	(
p	NN	p
<	SYM	<
0.001	CD	@card@
)	)	)
,	,	,
and	CC	and
81.5	CD	@card@
%	NN	%
of	IN	of
PNFA	NP	<unknown>
(	(	(
p	NN	p
<	SYM	<
0.001	CD	@card@
)	)	)
patients	NNS	patient
.	SENT	.
<span class='disease'>
FTD-ALS	NNS	<unknown>
</span>
was	VBD	be
disproportionately	RB	disproportionately
impaired	VBN	impair
compared	VBN	compare
to	TO	to
PNFA	NP	<unknown>
.	SENT	.
Impaired	JJ	impaired
Test	NN	test
for	IN	for
Reception	NP	<unknown>
of	IN	of
Grammar	NP	<unknown>
performance	NN	performance
was	VBD	be
frequent	JJ	frequent
in	IN	in
<span class='disease'>
ALS	NN	<unknown>
</span>
with	IN	with
early	JJ	early
bulbar	JJ	bulbar
involvement	NN	involvement
but	CC	but
did	VBD	do
not	RB	not
correlate	VB	correlate
with	IN	with
bulbar	JJ	bulbar
impairment	NN	impairment
overall	NN	overall
.	SENT	.
Left	VBN	leave
peri-insular	JJ	<unknown>
atrophy	NN	atrophy
correlated	VBN	correlate
with	IN	with
syntactic	JJ	syntactic
comprehension	NN	comprehension
deficits	NNS	deficit
.	SENT	.
Syntactic	JJ	syntactic
comprehension	NN	comprehension
deficits	NNS	deficit
are	VBP	be
frequent	JJ	frequent
in	IN	in
<span class='disease'>
FTD-ALS	NP	<unknown>
</span>
,	,	,
more	RBR	more
severe	JJ	severe
than	IN	than
in	IN	in
PNFA	NP	<unknown>
,	,	,
and	CC	and
related	VBN	relate
to	TO	to
left	VBN	leave
peri-insular	JJ	<unknown>
atrophy	NN	atrophy
.	SENT	.
A	DT	a
significant	JJ	significant
minority	NN	minority
of	IN	of
<span class='disease'>
ALS	JJ	<unknown>
</span>
patients	NNS	patient
are	VBP	be
impaired	VBN	impair
,	,	,
but	CC	but
the	DT	the
relationship	NN	relationship
between	IN	between
bulbar	JJ	bulbar
symptoms	NNS	symptom
and	CC	and
syntactic	JJ	syntactic
impairment	NN	impairment
is	VBZ	be
not	RB	not
understood	VBN	understand
.	SENT	.
<td class='article_title' rowspan='2'>
Loss	NN	loss
of	IN	of
C9ORF72	NP	<unknown>
impairs	VBZ	impair
autophagy	NN	<unknown>
and	CC	and
synergizes	NNS	<unknown>
with	IN	with
polyQ	NP	<unknown>
Ataxin-2	NP	<unknown>
to	TO	to
induce	VB	induce
motor	NN	motor
neuron	NN	neuron
dysfunction	NN	dysfunction
and	CC	and
cell	NN	cell
death	NN	death
.	SENT	.
</td>
An	DT	an
intronic	JJ	<unknown>
expansion	NN	expansion
ofGGGGCCrepeats	NNS	<unknown>
within	IN	within
the	DT	the
<span class='gene'>
C9ORF72	NP	<unknown>
</span>
gene	NN	gene
is	VBZ	be
the	DT	the
most	RBS	most
common	JJ	common
genetic	JJ	genetic
cause	NN	cause
of	IN	of
<span class='disease'>
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
and	CC	and
<span class='disease'>
frontotemporal	JJ	<unknown>
dementia	NN	dementia
</span>
(ALS-FTD)	NN	<unknown>
.	SENT	.
Ataxin-2	NN	<unknown>
with	IN	with
intermediate	JJ	intermediate
length	NN	length
of	IN	of
polyglutamine	JJ	<unknown>
expansions	NNS	expansion
(	(	(
Ataxin-2	NP	<unknown>
Q30x	NP	<unknown>
)	)	)
is	VBZ	be
a	DT	a
genetic	JJ	genetic
modifier	NN	modifier
of	IN	of
the	DT	the
disease	NN	disease
.	SENT	.
Here	RB	here
,	,	,
we	PP	we
found	VBD	find
that	IN	that
<span class='gene'>
C9ORF72	NP	<unknown>
</span>
forms	VBZ	form
a	DT	a
complex	NN	complex
with	IN	with
theWDR41	JJ	<unknown>
andSMCR8	NN	<unknown>
proteins	NNS	protein
to	TO	to
act	VB	act
as	IN	as
aGDP/GTPexchange	NN	<unknown>
factor	NN	factor
forRAB8a	NN	<unknown>
andRAB39b	NN	<unknown>
and	CC	and
to	TO	to
thereby	RB	thereby
control	VB	control
autophagic	JJ	<unknown>
flux	NN	flux
.	SENT	.
Depletion	NN	depletion
of	IN	of
<span class='gene'>
C9orf72	NP	<unknown>
</span>
in	IN	in
neurons	NNS	neuron
partly	RB	partly
impairs	VBZ	impair
autophagy	NN	<unknown>
and	CC	and
leads	VBZ	lead
to	TO	to
accumulation	NN	accumulation
of	IN	of
aggregates	NNS	aggregate
ofTDP-43	JJ	<unknown>
and	CC	and
P62	JJ	<unknown>
proteins	NNS	protein
,	,	,
which	WDT	which
are	VBP	be
histopathological	JJ	histopathological
hallmarks	NNS	hallmark
ofALS-FTDSMCR8	NN	<unknown>
is	VBZ	be
phosphorylated	JJ	<unknown>
byTBK1	NN	<unknown>
and	CC	and
depletion	NN	depletion
ofTBK1	NN	<unknown>
can	MD	can
be	VB	be
rescued	VBN	rescue
by	IN	by
phosphomimetic	JJ	<unknown>
mutants	NNS	mutant
ofSMCR8	NN	<unknown>
or	CC	or
by	IN	by
constitutively	RB	constitutively
activeRAB39b	NN	<unknown>
,	,	,
suggesting	VBG	suggest
thatTBK1,SMCR8	NN	<unknown>
,	,	,
<span class='gene'>
C9ORF72	NP	<unknown>
</span>
,	,	,
andRAB39b	NN	<unknown>
belong	VBP	belong
to	TO	to
a	DT	a
common	JJ	common
pathway	NN	pathway
regulating	VBG	regulate
autophagy	NN	<unknown>
.	SENT	.
While	IN	while
depletion	NN	depletion
of	IN	of
<span class='gene'>
C9ORF72	NP	<unknown>
</span>
only	RB	only
has	VBZ	have
a	DT	a
partial	JJ	partial
deleterious	JJ	deleterious
effect	NN	effect
on	IN	on
neuron	NN	neuron
survival	NN	survival
,	,	,
it	PP	it
synergizes	VBZ	<unknown>
with	IN	with
Ataxin-2	NP	<unknown>
Q30x	NP	<unknown>
toxicity	NN	toxicity
to	TO	to
induce	VB	induce
motor	NN	motor
neuron	NN	neuron
dysfunction	NN	dysfunction
and	CC	and
neuronal	JJ	<unknown>
cell	NN	cell
death	NN	death
.	SENT	.
These	DT	these
results	NNS	result
indicate	VBP	indicate
that	IN	that
partial	JJ	partial
loss	NN	loss
of	IN	of
function	NN	function
of	IN	of
<span class='gene'>
C9ORF72	NP	<unknown>
</span>
is	VBZ	be
not	RB	not
deleterious	JJ	deleterious
by	IN	by
itself	PP	itself
but	CC	but
synergizes	NNS	<unknown>
with	IN	with
Ataxin-2	JJ	<unknown>
toxicity	NN	toxicity
,	,	,
suggesting	VBG	suggest
a	DT	a
double-hit	JJ	<unknown>
pathological	JJ	pathological
mechanism	NN	mechanism
inALS-FTD	NNS	<unknown>
.	SENT	.
<td class='article_title' rowspan='2'>
Unusual	JJ	unusual
association	NN	association
of	IN	of
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
and	CC	and
myasthenia	NN	myasthenia
gravis	NNS	<unknown>
:	:	:
A	DT	a
dysregulation	NN	<unknown>
of	IN	of
the	DT	the
adaptive	JJ	adaptive
immune	JJ	immune
system	NN	system
?	SENT	?
</td>
<span class='disease'>
Myasthenia	NN	myasthenia
gravis	NN	<unknown>
</span>
is	VBZ	be
an	DT	an
autoimmune	JJ	autoimmune
disorder	NN	disorder
affecting	VBG	affect
neuromuscular	JJ	neuromuscular
junctions	NNS	junction
that	WDT	that
has	VBZ	have
been	VBN	be
associated	VBN	associate
with	IN	with
a	DT	a
small	JJ	small
increased	VBN	increase
risk	NN	risk
of	IN	of
<span class='disease'>
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
(	(	(
<span class='disease'>
ALS	NN	<unknown>
</span>
)	)	)
.	SENT	.
Here	RB	here
,	,	,
we	PP	we
describe	VBP	describe
a	DT	a
retrospective	JJ	retrospective
series	NN	series
of	IN	of
seven	CD	seven
cases	NNS	case
with	IN	with
a	DT	a
concomitant	JJ	concomitant
diagnosis	NN	diagnosis
of	IN	of
<span class='disease'>
ALS	NN	<unknown>
</span>
and	CC	and
<span class='disease'>
myasthenia	NN	myasthenia
gravis	NNS	<unknown>
</span>
,	,	,
collected	VBN	collect
among	IN	among
the	DT	the
18	CD	@card@
French	JJ	French
reference	NN	reference
centers	NNS	center
for	IN	for
<span class='disease'>
ALS	NN	<unknown>
</span>
in	IN	in
a	DT	a
twelve	NN	twelve
year	NN	year
period	NN	period
.	SENT	.
After	IN	after
careful	JJ	careful
review	NN	review
,	,	,
only	RB	only
six	CD	six
patients	NNS	patient
strictly	RB	strictly
met	VBD	meet
the	DT	the
diagnostic	JJ	diagnostic
criteria	NNS	criterion
for	IN	for
both	DT	both
<span class='disease'>
ALS	NN	<unknown>
</span>
and	CC	and
<span class='disease'>
myasthenia	NN	myasthenia
gravis	NNS	<unknown>
</span>
.	SENT	.
In	IN	in
these	DT	these
patients	NNS	patient
,	,	,
limb	NN	limb
onset	NN	onset
of	IN	of
<span class='disease'>
ALS	NP	<unknown>
</span>
was	VBD	be
reported	VBN	report
in	IN	in
five	CD	five
(	(	(
83	CD	@card@
%	NN	%
)	)	)
cases	NNS	case
.	SENT	.
Localization	NN	localization
of	IN	of
<span class='disease'>
myasthenia	NN	myasthenia
gravis	NNS	<unknown>
</span>
initial	JJ	initial
symptoms	NNS	symptom
was	VBD	be
ocular	JJ	ocular
in	IN	in
three	CD	three
(	(	(
50	CD	@card@
%	NN	%
)	)	)
cases	NNS	case
,	,	,
generalized	VBN	generalize
in	IN	in
two	CD	two
(	(	(
33	CD	@card@
%	NN	%
)	)	)
and	CC	and
bulbar	JJ	bulbar
in	IN	in
one	CD	one
(17%)	NN	<unknown>
.	SENT	.
Median	JJ	Median
delay	NN	delay
between	IN	between
onset	NN	onset
of	IN	of
the	DT	the
two	CD	two
conditions	NNS	condition
was	VBD	be
19	CD	@card@
months	NNS	month
(	(	(
6-319	CD	@card@
months)	NN	<unknown>
.	SENT	.
Anti-acetylcholine	JJ	<unknown>
receptor	NN	receptor
antibodies	NNS	antibody
testing	NN	testing
was	VBD	be
positive	JJ	positive
in	IN	in
all	DT	all
cases	NNS	case
.	SENT	.
All	DT	all
patients	NNS	patient
were	VBD	be
treated	VBN	treat
with	IN	with
riluzole	NN	<unknown>
and	CC	and
one	PP	one
had	VBD	have
an	DT	an
associated	JJ	associated
immune-mediated	JJ	<unknown>
disease	NN	disease
.	SENT	.
In	IN	in
the	DT	the
one	CD	one
last	JJ	last
<span class='disease'>
ALS	NN	<unknown>
</span>
case	NN	case
,	,	,
the	DT	the
final	JJ	final
diagnosis	NN	diagnosis
was	VBD	be
false-positivity	NN	<unknown>
for	IN	for
anti-acetylcholine	JJ	<unknown>
receptor	NN	receptor
antibodies	NNS	antibody
.	SENT	.
The	DT	the
co-occurrence	NN	<unknown>
of	IN	of
<span class='disease'>
ALS	NN	<unknown>
</span>
and	CC	and
<span class='disease'>
myasthenia	NN	myasthenia
gravis	NN	<unknown>
</span>
is	VBZ	be
rare	JJ	rare
and	CC	and
requires	VBZ	require
strict	JJ	strict
diagnostic	JJ	diagnostic
criteria	NNS	criterion
.	SENT	.
Its	PP$	its
demonstration	NN	demonstration
needs	VBZ	need
thoughtful	JJ	thoughtful
interpretation	NN	interpretation
of	IN	of
electrophysiological	JJ	electrophysiological
results	NNS	result
and	CC	and
exclusion	NN	exclusion
of	IN	of
false	JJ	false
positivity	NN	<unknown>
for	IN	for
<span class='disease'>
myasthenia	NN	myasthenia
gravis	NN	<unknown>
</span>
antibody	NN	antibody
testing	NN	testing
in	IN	in
some	DT	some
<span class='disease'>
ALS	JJ	<unknown>
</span>
cases	NNS	case
.	SENT	.
This	DT	this
association	NN	association
may	MD	may
be	VB	be
triggered	VBN	trigger
by	IN	by
a	DT	a
dysfunction	NN	dysfunction
of	IN	of
adaptive	JJ	adaptive
immunity	NN	immunity
.	SENT	.
<td class='article_title' rowspan='2'>
Myasthenia	NN	myasthenia
gravis	NNS	<unknown>
and	CC	and
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
:	:	:
A	DT	a
pathogenic	JJ	pathogenic
overlap	VB	overlap
.	SENT	.
</td>
The	DT	the
aim	NN	aim
was	VBD	be
to	TO	to
examine	VB	examine
potential	JJ	potential
<span class='symptom'>
joint	JJ	joint
disease	NN	disease
</span>
mechanisms	NNS	mechanism
for	IN	for
<span class='disease'>
myasthenia	NN	myasthenia
gravis	NNS	<unknown>
</span>
(	(	(
MG	NP	MG
)	)	)
and	CC	and
<span class='disease'>
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
(	(	(
<span class='disease'>
ALS	NN	<unknown>
</span>
)	)	)
through	IN	through
the	DT	the
examination	NN	examination
of	IN	of
long-term	JJ	long-term
patient	JJ	patient
cohorts	NNS	cohort
for	IN	for
comorbidity	NN	<unknown>
.	SENT	.
Recent	JJ	Recent
studies	NNS	study
support	VBP	support
early	JJ	early
involvement	NN	involvement
of	IN	of
the	DT	the
neuromuscular	JJ	neuromuscular
junction	NN	junction
in	IN	in
<span class='disease'>
ALS	JJ	<unknown>
</span>
patients	NNS	patient
with	IN	with
subsequent	JJ	subsequent
degeneration	NN	degeneration
of	IN	of
motor	NN	motor
neurons	NNS	neuron
.	SENT	.
Medical	JJ	medical
records	NNS	record
at	IN	at
Haukeland	NP	<unknown>
University	NP	University
Hospital	NP	Hospital
from	IN	from
1987	CD	@card@
to	TO	to
2012	CD	@card@
were	VBD	be
examined	VBN	examine
for	IN	for
International	NP	International
Classification	NP	Classification
of	IN	of
Diseases	NPS	<unknown>
diagnostic	JJ	diagnostic
codes	NNS	code
for	IN	for
MG	NP	MG
and	CC	and
<span class='disease'>
ALS	NP	<unknown>
</span>
.	SENT	.
Sera	NP	Sera
were	VBD	be
re-tested	VBN	<unknown>
for	IN	for
antibodies	NNS	antibody
to	TO	to
acetylcholine	NN	acetylcholine
receptor	NN	receptor
,	,	,
<span class='gene'>
titin	NP	<unknown>
</span>
,	,	,
MuSK	NP	<unknown>
and	CC	and
GM1	NP	<unknown>
.	SENT	.
We	PP	we
report	VBP	report
one	CD	one
patient	NN	patient
with	IN	with
both	DT	both
MG	NP	MG
and	CC	and
<span class='disease'>
ALS	NP	<unknown>
</span>
,	,	,
and	CC	and
another	DT	another
3	CD	3
patients	NNS	patient
with	IN	with
suggestive	JJ	suggestive
evidence	NN	evidence
of	IN	of
both	DT	both
conditions	NNS	condition
.	SENT	.
This	DT	this
is	VBZ	be
far	RB	far
more	RBR	more
than	IN	than
expected	VBN	expect
from	IN	from
prevalence	NN	prevalence
and	CC	and
incidence	NN	incidence
figures	NNS	figure
in	IN	in
this	DT	this
area	NN	area
if	IN	if
the	DT	the
disorders	NNS	disorder
were	VBD	be
unrelated	JJ	unrelated
.	SENT	.
Our	PP$	our
data	NNS	datum
suggest	VBP	suggest
that	IN	that
immunological	JJ	immunological
mechanisms	NNS	mechanism
in	IN	in
the	DT	the
neuromuscular	JJ	neuromuscular
junction	NN	junction
are	VBP	be
relevant	JJ	relevant
in	IN	in
<span class='disease'>
ALS	JJ	<unknown>
</span>
pathogenesis	NN	pathogenesis
.	SENT	.
Attention	NN	attention
should	MD	should
be	VB	be
given	VBN	give
to	TO	to
possible	JJ	possible
therapeutic	JJ	therapeutic
targets	NNS	target
in	IN	in
the	DT	the
neuromuscular	JJ	neuromuscular
junction	NN	junction
and	CC	and
muscle	NN	muscle
in	IN	in
<span class='disease'>
ALS	JJ	<unknown>
</span>
patients	NNS	patient
.	SENT	.
<td class='article_title' rowspan='2'>
A	DT	a
novel	JJ	novel
fly	NN	fly
model	NN	model
of	IN	of
TDP-43	NP	<unknown>
proteinopathies	NNS	<unknown>
:	:	:
N-terminus	JJ	<unknown>
sequences	NNS	sequence
combined	VBN	combine
with	IN	with
the	DT	the
Q/N	NP	<unknown>
domain	NN	domain
induce	VB	induce
protein	NN	protein
functional	JJ	functional
loss	NN	loss
and	CC	and
locomotion	NN	locomotion
defects	NNS	defect
.	SENT	.
</td>
Transactive	JJ	<unknown>
response	NN	response
DNA	NN	DNA
binding	VBG	bind
protein	NN	protein
43	CD	@card@
kDa	NNS	<unknown>
(	(	(
TDP-43	NP	<unknown>
)	)	)
is	VBZ	be
the	DT	the
main	JJ	main
protein	NN	protein
component	NN	component
of	IN	of
the	DT	the
pathological	JJ	pathological
inclusions	NNS	inclusion
observed	VBN	observe
in	IN	in
neurons	NNS	neuron
of	IN	of
patients	NNS	patient
affected	VBN	affect
by	IN	by
different	JJ	different
neurodegenerative	JJ	<unknown>
disorders	NNS	disorder
,	,	,
including	VBG	include
<span class='disease'>
Amyotrophic	NP	<unknown>
Lateral	NP	<unknown>
Sclerosis	NP	<unknown>
</span>
(	(	(
<span class='disease'>
ALS	NP	<unknown>
</span>
)	)	)
and	CC	and
Fronto-Temporal	NP	<unknown>
Lobar	NP	<unknown>
Degeneration	NP	<unknown>
(FTLD)	NN	<unknown>
.	SENT	.
The	DT	the
number	NN	number
of	IN	of
studies	NNS	study
investigating	VBG	investigate
the	DT	the
molecular	JJ	molecular
mechanisms	NNS	mechanism
underlying	VBG	underlie
<span class='symptom'>
neurodegeneration	NN	<unknown>
</span>
are	VBP	be
constantly	RB	constantly
growing	VBG	grow
however	RB	however
,	,	,
the	DT	the
role	NN	role
played	VBN	play
by	IN	by
TDP-43	NP	<unknown>
in	IN	in
disease	NN	disease
onset	NN	onset
and	CC	and
progression	NN	progression
is	VBZ	be
still	RB	still
unclear	JJ	unclear
.	SENT	.
A	DT	a
fundamental	JJ	fundamental
shortcoming	NN	shortcoming
that	WDT	that
hampers	VBZ	hamper
progress	NN	progress
is	VBZ	be
the	DT	the
lack	NN	lack
of	IN	of
animal	JJ	animal
models	NNS	model
of	IN	of
aggregation	NN	aggregation
without	IN	without
TDP-43	NP	<unknown>
overexpression	NN	<unknown>
.	SENT	.
In	IN	in
this	DT	this
manuscript	NN	manuscript
,	,	,
we	PP	we
have	VBP	have
extended	VBN	extend
our	PP$	our
cellular	JJ	cellular
model	NN	model
of	IN	of
aggregation	NN	aggregation
to	TO	to
a	DT	a
transgenic	JJ	transgenic
ITALIC	NN	italic
!	SENT	!
Drosophilaline	NP	<unknown>
.	SENT	.
Our	PP$	our
fly	NN	fly
model	NN	model
is	VBZ	be
not	RB	not
based	VBN	base
on	IN	on
the	DT	the
overexpression	NN	<unknown>
of	IN	of
a	DT	a
wild-type	JJ	<unknown>
TDP-43	NP	<unknown>
transgene	NN	<unknown>
.	SENT	.
On	IN	on
the	DT	the
contrary	NN	contrary
,	,	,
we	PP	we
engineered	VBD	engineer
a	DT	a
construct	NN	construct
that	WDT	that
includes	VBZ	include
only	RB	only
the	DT	the
specific	JJ	specific
TDP-43	NP	<unknown>
amino	NN	amino
acid	NN	acid
sequences	NNS	sequence
necessary	JJ	necessary
to	TO	to
trigger	VB	trigger
aggregate	JJ	aggregate
formation	NN	formation
and	CC	and
trapping	VBG	trap
of	IN	of
endogenous	JJ	endogenous
dTDP-43	NN	<unknown>
into	IN	into
a	DT	a
non-functional	JJ	<unknown>
insoluble	JJ	insoluble
form	NN	form
.	SENT	.
Importantly	RB	importantly
,	,	,
the	DT	the
resulting	VBG	result
recombinant	JJ	recombinant
product	NN	product
lacks	VBZ	lack
of	IN	of
functional	JJ	functional
RNA	NP	RNA
recognition	NN	recognition
motifs	NNS	motif
(	(	(
RRMs	NP	<unknown>
)	)	)
thus	RB	thus
resulting	VBG	result
devoid	JJ	devoid
of	IN	of
specific	JJ	specific
TDP-43-physiological	JJ	<unknown>
functions	NNS	function
(	(	(
i.e.	FW	i.e.
splicing	VBG	splice
regulation	NN	regulation
ability	NN	ability
)	)	)
that	WDT	that
might	MD	might
affect	VB	affect
the	DT	the
animal	JJ	animal
phenotype	NN	phenotype
ITALIC	NN	italic
!	SENT	!
per	FW	per
se	FW	se
This	DT	this
novel	NN	novel
ITALIC	NN	italic
!	SENT	!
Drosophilamodel	NP	<unknown>
exhibits	VBZ	exhibit
an	DT	an
evident	JJ	evident
degenerative	JJ	degenerative
phenotype	NN	phenotype
with	IN	with
reduced	VBN	reduce
life-span	NN	life-span
and	CC	and
early	JJ	early
locomotion	NN	locomotion
defects	NNS	defect
.	SENT	.
Additionally	RB	additionally
,	,	,
we	PP	we
show	VBP	show
that	IN	that
important	JJ	important
proteins	NNS	protein
involved	VBN	involve
in	IN	in
neuromuscular	JJ	neuromuscular
junction	NN	junction
function	NN	function
,	,	,
such	JJ	such
as	IN	as
syntaxin	NP	<unknown>
(	(	(
SYX	NP	<unknown>
)	)	)
,	,	,
decrease	VB	decrease
their	PP$	their
levels	NNS	level
as	IN	as
a	DT	a
consequence	NN	consequence
of	IN	of
TDP-43/TBPH	NP	<unknown>
loss	NN	loss
of	IN	of
function	NN	function
implying	VBG	imply
that	IN	that
the	DT	the
degenerative	JJ	degenerative
phenotype	NN	phenotype
is	VBZ	be
a	DT	a
consequence	NN	consequence
of	IN	of
TDP-43/TBPH	NP	<unknown>
sequestration	NN	sequestration
into	IN	into
the	DT	the
aggregates	NNS	aggregate
.	SENT	.
Our	PP$	our
data	NNS	datum
lend	VBP	lend
further	JJR	further
support	NN	support
to	TO	to
the	DT	the
role	NN	role
of	IN	of
TDP-43	NP	<unknown>
loss-of-function	NN	<unknown>
in	IN	in
the	DT	the
pathogenesis	NN	pathogenesis
of	IN	of
neurodegenerative	JJ	<unknown>
disorders	NNS	disorder
.	SENT	.
The	DT	the
novel	NN	novel
transgenic	JJ	transgenic
ITALIC	NP	<unknown>
!	SENT	!
Drosophilamodel	NP	<unknown>
presented	VBD	present
in	IN	in
this	DT	this
study	NN	study
will	MD	will
help	VB	help
to	TO	to
gain	VB	gain
further	JJR	further
insight	NN	insight
into	IN	into
the	DT	the
molecular	JJ	molecular
mechanisms	NNS	mechanism
underlying	VBG	underlie
<span class='symptom'>
neurodegeneration	NN	<unknown>
</span>
and	CC	and
will	MD	will
provide	VB	provide
a	DT	a
valuable	JJ	valuable
system	NN	system
to	TO	to
test	VB	test
potential	JJ	potential
therapeutic	JJ	therapeutic
agents	NNS	agent
to	TO	to
counteract	VB	counteract
disease	NN	disease
.	SENT	.
<td class='article_title' rowspan='2'>
The	DT	the
impact	NN	impact
of	IN	of
autophagy	NN	<unknown>
on	IN	on
peripheral	JJ	peripheral
synapses	NNS	synapse
in	IN	in
health	NN	health
and	CC	and
disease	NN	disease
.	SENT	.
</td>
Alterations	NNS	alteration
of	IN	of
autophagy	NN	<unknown>
have	VBP	have
been	VBN	be
linked	VBN	link
to	TO	to
several	JJ	several
peripheral	JJ	peripheral
nervous	JJ	nervous
system	NN	system
diseases	NNS	disease
,	,	,
such	JJ	such
as	IN	as
<span class='disease'>
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
and	CC	and
Charcot-Marie-Tooth	JJ	<unknown>
disease	NN	disease
.	SENT	.
Modulation	NN	modulation
of	IN	of
autophagy	NN	<unknown>
by	IN	by
metabolic	JJ	metabolic
or	CC	or
pharmacological	JJ	pharmacological
interventions	NNS	intervention
has	VBZ	have
been	VBN	be
increasingly	RB	increasingly
recognized	VBN	recognize
as	IN	as
a	DT	a
strategy	NN	strategy
to	TO	to
fight	VB	fight
many	JJ	many
of	IN	of
these	DT	these
disorders	NNS	disorder
.	SENT	.
Cellular	JJ	cellular
processes	NNS	process
that	WDT	that
are	VBP	be
aberrant	JJ	aberrant
in	IN	in
case	NN	case
of	IN	of
impaired	JJ	impaired
autophagy	NN	<unknown>
and	CC	and
that	WDT	that
might	MD	might
lead	VB	lead
to	TO	to
these	DT	these
diseases	NNS	disease
belong	VBP	belong
to	TO	to
three	CD	three
different	JJ	different
categories	NNS	category
:	:	:
(	(	(
1	LS	1
)	)	)
clearing	NN	clearing
of	IN	of
protein	NN	protein
aggregates	NNS	aggregate
,	,	,
(	(	(
2	LS	2
)	)	)
regulation	NN	regulation
of	IN	of
vesicle	NN	vesicle
and	CC	and
cargo	NN	cargo
turnover	NN	turnover
,	,	,
and	CC	and
(	(	(
3	LS	3
)	)	)
disposal	NN	disposal
of	IN	of
damaged	JJ	damaged
mitochondria	NNS	mitochondrion
.	SENT	.
This	DT	this
review	NN	review
summarizes	VBZ	summarize
the	DT	the
present	JJ	present
literature	NN	literature
that	WDT	that
addresses	VBZ	address
both	CC	both
,	,	,
the	DT	the
<span class='gene'>
impact	NN	impact
</span>
and	CC	and
mechanisms	NNS	mechanism
of	IN	of
autophagy	NN	<unknown>
on	IN	on
the	DT	the
health	NN	health
of	IN	of
the	DT	the
peripheral	JJ	peripheral
nervous	JJ	nervous
system	NN	system
and	CC	and
treatment	NN	treatment
proposals	NNS	proposal
for	IN	for
human	JJ	human
disorders	NNS	disorder
associated	VBN	associate
with	IN	with
impaired	JJ	impaired
autophagy	NN	<unknown>
.	SENT	.
<td class='article_title' rowspan='2'>
Biophysical	JJ	biophysical
analysis	NN	analysis
of	IN	of
three	CD	three
novel	NN	novel
Profilin-1	JJ	<unknown>
variants	NNS	variant
associated	VBN	associate
with	IN	with
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
indicates	VBZ	indicate
a	DT	a
correlation	NN	correlation
between	IN	between
their	PP$	their
aggregation	NN	aggregation
propensity	NN	propensity
and	CC	and
the	DT	the
structural	JJ	structural
features	NNS	feature
of	IN	of
their	PP$	their
globular	JJ	globular
state	NN	state
.	SENT	.
</td>
Profilin-1	NP	<unknown>
is	VBZ	be
a	DT	a
small	JJ	small
protein	NN	protein
involved	VBN	involve
in	IN	in
actin-mediated	JJ	<unknown>
cytoskeleton	NN	<unknown>
rearrangement	NN	rearrangement
.	SENT	.
Recently	RB	recently
,	,	,
mutations	NNS	mutation
of	IN	of
profilin-1	JJ	<unknown>
have	VBP	have
been	VBN	be
associated	VBN	associate
with	IN	with
familial	JJ	familial
<span class='disease'>
Amyotrophic	NP	<unknown>
Lateral	NP	<unknown>
Sclerosis	NP	<unknown>
</span>
.	SENT	.
It	PP	it
was	VBD	be
previously	RB	previously
reported	VBN	report
that	IN	that
pathogenic	JJ	pathogenic
mutations	NNS	mutation
of	IN	of
profilin-1	JJ	<unknown>
increase	NN	increase
the	DT	the
aggregation	NN	aggregation
propensity	NN	propensity
of	IN	of
this	DT	this
protein	NN	protein
,	,	,
leaving	VBG	leave
its	PP$	its
function	NN	function
unaffected	JJ	unaffected
.	SENT	.
However	RB	however
,	,	,
it	PP	it
is	VBZ	be
not	RB	not
clear	JJ	clear
if	IN	if
the	DT	the
mutations	NNS	mutation
act	NN	act
by	IN	by
decreasing	VBG	decrease
the	DT	the
conformational	JJ	<unknown>
stability	NN	stability
or	CC	or
by	IN	by
promoting	VBG	promote
structural	JJ	structural
perturbations	NNS	perturbation
of	IN	of
the	DT	the
folded	VBN	fold
state	NN	state
of	IN	of
this	DT	this
protein	NN	protein
.	SENT	.
In	IN	in
this	DT	this
work	NN	work
we	PP	we
have	VBP	have
purified	VBN	purify
three	CD	three
novel	NN	novel
profilin-1	JJ	<unknown>
mutants	NNS	mutant
that	WDT	that
were	VBD	be
recently	RB	recently
discovered	VBN	discover
and	CC	and
have	VBP	have
investigated	VBN	investigate
their	PP$	their
conformational	JJ	<unknown>
stability	NN	stability
,	,	,
structural	JJ	structural
features	NNS	feature
and	CC	and
aggregation	NN	aggregation
behaviour	NN	behaviour
in	IN	in
vitro	NN	<unknown>
.	SENT	.
Analysis	NN	analysis
of	IN	of
the	DT	the
data	NNS	datum
obtained	VBN	obtain
with	IN	with
the	DT	the
three	CD	three
novel	NN	novel
variants	NNS	variant
and	CC	and
a	DT	a
global	JJ	global
statistical	JJ	statistical
analysis	NN	analysis
with	IN	with
all	DT	all
profilin-1	JJ	<unknown>
mutants	NNS	mutant
so	RB	so
far	RB	far
characterised	VBN	characterise
indicate	VBP	indicate
significant	JJ	significant
correlations	NNS	correlation
between	IN	between
aggregation	NN	aggregation
propensity	NN	propensity
and	CC	and
structural	JJ	structural
perturbations	NNS	perturbation
of	IN	of
the	DT	the
folded	VBN	fold
state	NN	state
,	,	,
rather	RB	rather
than	IN	than
its	PP$	its
conformational	JJ	<unknown>
stability	NN	stability
,	,	,
in	IN	in
this	DT	this
group	NN	group
of	IN	of
mutants	NNS	mutant
.	SENT	.
<td class='article_title' rowspan='2'>
Tract-specific	JJ	<unknown>
and	CC	and
age-related	JJ	age-related
variations	NNS	variation
of	IN	of
the	DT	the
spinal	JJ	spinal
cord	NN	cord
microstructure	NN	microstructure
:	:	:
a	DT	a
multi-parametric	JJ	<unknown>
MRI	NP	MRI
study	NN	study
using	VBG	use
diffusion	NN	diffusion
tensor	NN	tensor
imaging	NN	imaging
(	(	(
DTI	NP	DTI
)	)	)
and	CC	and
inhomogeneous	JJ	inhomogeneous
magnetization	NN	magnetization
transfer	NN	transfer
(ihMT)	NN	<unknown>
.	SENT	.
</td>
Being	VBG	be
able	JJ	able
to	TO	to
finely	RB	finely
characterize	VB	characterize
the	DT	the
spinal	JJ	spinal
cord	NN	cord
(	(	(
SC	NP	SC
)	)	)
microstructure	NN	microstructure
and	CC	and
its	PP$	its
alterations	NNS	alteration
is	VBZ	be
a	DT	a
key	JJ	key
point	NN	point
when	WRB	when
investigating	VBG	investigate
neural	JJ	neural
damage	NN	damage
mechanisms	NNS	mechanism
encountered	VBN	encounter
in	IN	in
different	JJ	different
central	JJ	central
nervous	JJ	nervous
system	NN	system
(	(	(
CNS	NP	<unknown>
)	)	)
pathologies	NNS	pathology
,	,	,
such	JJ	such
as	IN	as
multiple	JJ	multiple
sclerosis	NN	sclerosis
,	,	,
<span class='disease'>
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
or	CC	or
<span class='symptom'>
myelopathy	NN	<unknown>
</span>
.	SENT	.
Based	VBN	base
on	IN	on
novel	NN	novel
methods	NNS	method
,	,	,
including	VBG	include
inhomogeneous	JJ	inhomogeneous
magnetization	NN	magnetization
transfer	NN	transfer
(	(	(
ihMT	NN	<unknown>
)	)	)
and	CC	and
dedicated	JJ	dedicated
SC	NP	SC
probabilistic	JJ	probabilistic
atlas	NN	atlas
post-processing	NN	post-processing
,	,	,
the	DT	the
present	JJ	present
study	NN	study
focuses	VBZ	focus
on	IN	on
the	DT	the
in	IN	in
vivo	JJ	vivo
characterization	NN	characterization
of	IN	of
the	DT	the
healthy	JJ	healthy
SC	NP	SC
tissue	NN	tissue
in	IN	in
terms	NNS	term
of	IN	of
regional	JJ	regional
microstructure	NN	microstructure
differences	NNS	difference
between	IN	between
(	(	(
i	NP	i
)	)	)
upper	JJ	upper
and	CC	and
lower	JJR	low
cervical	JJ	cervical
vertebral	JJ	vertebral
levels	NNS	level
and	CC	and
(	(	(
ii	NNS	<unknown>
)	)	)
sensory	JJ	sensory
and	CC	and
motor	NN	motor
tracts	NNS	tract
,	,	,
as	RB	as
well	RB	well
as	IN	as
differences	NNS	difference
attributed	VBN	attribute
to	TO	to
normal	JJ	normal
aging	NN	aging
.	SENT	.
Forty-eight	NP	<unknown>
healthy	JJ	healthy
volunteers	NNS	volunteer
aged	VBN	age
from	IN	from
20	CD	@card@
to	TO	to
70	CD	@card@
years	NNS	year
old	JJ	old
were	VBD	be
included	VBN	include
in	IN	in
the	DT	the
study	NN	study
and	CC	and
scanned	VBN	scan
at	IN	at
3	CD	3
T	NN	T
using	VBG	use
axial	JJ	axial
high-resolution	NN	high-resolution
T2	NP	<unknown>
*-w	NN	<unknown>
imaging	NN	imaging
,	,	,
diffusion	NN	diffusion
tensor	NN	tensor
imaging	NN	imaging
(	(	(
DTI	NP	DTI
)	)	)
and	CC	and
ihMT	NN	<unknown>
,	,	,
at	IN	at
two	CD	two
vertebral	JJ	vertebral
levels	NNS	level
(	(	(
<span class='gene'>
C2	NP	<unknown>
</span>
and	CC	and
<span class='gene'>
C5	NP	<unknown>
</span>
)	)	)
.	SENT	.
A	DT	a
processing	NN	processing
pipeline	NN	pipeline
with	IN	with
minimal	JJ	minimal
user	NN	user
intervention	NN	intervention
,	,	,
SC	NP	SC
segmentation	NN	segmentation
and	CC	and
spatial	JJ	spatial
normalization	NN	normalization
into	IN	into
a	DT	a
reference	NN	reference
space	NN	space
was	VBD	be
implemented	VBN	implement
in	IN	in
order	NN	order
to	TO	to
assess	VB	assess
quantitative	JJ	quantitative
morphological	JJ	morphological
and	CC	and
structural	JJ	structural
parameters	NNS	parameter
(	(	(
cross-sectional	JJ	cross-sectional
areas	NNS	area
,	,	,
scalar	JJ	scalar
DTI	NP	DTI
and	CC	and
MT/ihMT	NP	<unknown>
metrics	NNS	metric
)	)	)
in	IN	in
specific	JJ	specific
white	JJ	white
and	CC	and
gray	JJ	gray
matter	NN	matter
regions	NNS	region
of	IN	of
interest	NN	interest
.	SENT	.
The	DT	the
multi-parametric	JJ	<unknown>
MRI	NP	MRI
metrics	NNS	metric
collected	VBD	collect
allowed	VBN	allow
upper	JJ	upper
and	CC	and
lower	JJR	low
cervical	JJ	cervical
levels	NNS	level
to	TO	to
be	VB	be
distinguished	VBN	distinguish
,	,	,
with	IN	with
higher	JJR	high
ihMT	NN	<unknown>
ratio	NN	ratio
(	(	(
ihMTR	NN	<unknown>
)	)	)
,	,	,
higher	JJR	high
axial	JJ	axial
diffusivity	NN	diffusivity
(	(	(
λ∥	NN	<unknown>
)	)	)
and	CC	and
lower	JJR	low
radial	JJ	radial
diffusivity	NN	diffusivity
(	(	(
λ⊥	NN	<unknown>
)	)	)
at	IN	at
<span class='gene'>
C2	NP	<unknown>
</span>
compared	VBN	compare
with	IN	with
<span class='gene'>
C5	NP	<unknown>
</span>
.	SENT	.
Significant	JJ	significant
differences	NNS	difference
were	VBD	be
also	RB	also
observed	VBN	observe
between	IN	between
white	JJ	white
matter	NN	matter
fascicles	NNS	fascicle
,	,	,
with	IN	with
higher	JJR	high
ihMTR	NN	<unknown>
and	CC	and
lower	JJR	low
λ∥	NN	<unknown>
in	IN	in
motor	NN	motor
tracts	NNS	tract
compared	VBN	compare
with	IN	with
posterior	JJ	posterior
sensory	JJ	sensory
tracts	NNS	tract
.	SENT	.
Finally	RB	finally
,	,	,
aging	NN	aging
was	VBD	be
found	VBN	find
to	TO	to
be	VB	be
associated	VBN	associate
with	IN	with
significant	JJ	significant
metric	JJ	metric
alterations	NNS	alteration
(	(	(
decreased	VBN	decrease
ihMTR	NN	<unknown>
and	CC	and
λ∥	NN	<unknown>
)	)	)
.	SENT	.
The	DT	the
methodology	NN	methodology
proposed	VBN	propose
here	RB	here
,	,	,
which	WDT	which
can	MD	can
be	VB	be
easily	RB	easily
transferred	VBN	transfer
to	TO	to
the	DT	the
clinic	NN	clinic
,	,	,
provides	VBZ	provide
new	JJ	new
insights	NNS	insight
for	IN	for
SC	NP	SC
characterization	NN	characterization
.	SENT	.
It	PP	it
bears	VBZ	bear
great	JJ	great
potential	NN	potential
to	TO	to
study	VB	study
focal	JJ	focal
and	CC	and
diffuse	JJ	diffuse
SC	NP	SC
damage	NN	damage
in	IN	in
neurodegenerative	JJ	<unknown>
and	CC	and
demyelinating	JJ	<unknown>
diseases	NNS	disease
.	SENT	.
Copyright	NN	copyright
©	SYM	©
2016	CD	@card@
John	NP	John
Wiley	NP	Wiley
&	CC	&
Sons	NP	Sons
,	,	,
Ltd.	NP	Ltd.
<td class='article_title' rowspan='2'>
Quantitating	NP	<unknown>
Changes	NP	Changes
in	IN	in
Jitter	NP	<unknown>
and	CC	and
Spike	NP	Spike
Number	NP	Number
Using	VBG	use
Concentric	NP	<unknown>
Needle	NP	Needle
Electrodes	NP	<unknown>
in	IN	in
Amyotrophic	NP	<unknown>
Lateral	NP	<unknown>
Sclerosis	NP	<unknown>
Patients	NPS	Patients
.	SENT	.
</td>
Single-fiber	NP	<unknown>
electromyography	NP	<unknown>
(	(	(
SFEMG	NP	<unknown>
)	)	)
has	VBZ	have
been	VBN	be
suggested	VBN	suggest
as	IN	as
a	DT	a
quantitative	JJ	quantitative
method	NN	method
for	IN	for
supporting	VBG	support
chronic	JJ	chronic
partial	JJ	partial
denervation	NN	<unknown>
in	IN	in
<span class='disease'>
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
(	(	(
<span class='disease'>
ALS	NN	<unknown>
</span>
)	)	)
by	IN	by
the	DT	the
revised	VBN	revise
<span class='disease'>
EI	NP	EI
</span>
Escorial	NP	<unknown>
criteria	NNS	criterion
.	SENT	.
Although	IN	although
concentric	JJ	concentric
needle	NN	needle
(	(	(
CN	NP	CN
)	)	)
electrodes	NNS	electrode
have	VBP	have
been	VBN	be
used	VBN	use
to	TO	to
assess	VB	assess
jitter	NN	jitter
in	IN	in
<span class='disease'>
myasthenia	NN	myasthenia
gravis	NN	<unknown>
</span>
patients	NNS	patient
and	CC	and
healthy	JJ	healthy
controls	NNS	control
,	,	,
there	EX	there
are	VBP	be
few	JJ	few
reports	NNS	report
using	VBG	use
CN	NP	CN
electrodes	NNS	electrode
to	TO	to
assess	VB	assess
motor	NN	motor
unit	NN	unit
instability	NN	instability
and	CC	and
denervation	NN	<unknown>
in	IN	in
neurogenic	JJ	neurogenic
diseases	NNS	disease
.	SENT	.
The	DT	the
aim	NN	aim
of	IN	of
this	DT	this
study	NN	study
was	VBD	be
to	TO	to
determine	VB	determine
whether	IN	whether
quantitative	JJ	quantitative
changes	NNS	change
in	IN	in
jitter	NN	jitter
and	CC	and
spike	NN	spike
number	NN	number
using	VBG	use
CN	NP	CN
electrodes	NNS	electrode
could	MD	could
be	VB	be
used	VBN	use
for	IN	for
<span class='disease'>
ALS	JJ	<unknown>
</span>
studies.Twenty-seven	JJ	<unknown>
healthy	JJ	healthy
controls	NNS	control
and	CC	and
23	CD	@card@
<span class='disease'>
ALS	JJ	<unknown>
</span>
patients	NNS	patient
were	VBD	be
studied	VBN	study
using	VBG	use
both	DT	both
CN	NP	CN
and	CC	and
single-fiber	NN	<unknown>
needle	NN	needle
(	(	(
<span class='gene'>
SFN	NP	SFN
</span>
)	)	)
electrodes	NNS	electrode
on	IN	on
the	DT	the
extensor	NN	extensor
digitorum	NN	<unknown>
communis	NN	<unknown>
muscle	NN	muscle
with	IN	with
an	DT	an
SFEMG	NP	<unknown>
program	NN	program
.	SENT	.
The	DT	the
SFN-jitter	NP	<unknown>
and	CC	and
SFN-fiber	NP	<unknown>
density	NN	density
data	NNS	datum
were	VBD	be
measured	VBN	measure
using	VBG	use
<span class='gene'>
SFN	NN	SFN
</span>
electrodes	NNS	electrode
.	SENT	.
The	DT	the
CN-jitter	NN	<unknown>
and	CC	and
spike	NN	spike
number	NN	number
were	VBD	be
measured	VBN	measure
using	VBG	use
CN	NP	CN
electrodes.The	NNS	<unknown>
mean	VBP	mean
CN-jitter	NP	<unknown>
was	VBD	be
significantly	RB	significantly
increased	VBN	increase
in	IN	in
<span class='disease'>
ALS	JJ	<unknown>
</span>
patients	NNS	patient
(	(	(
47.3	CD	@card@
±	SYM	±
17.0	CD	@card@
μs	NNS	<unknown>
)	)	)
than	IN	than
in	IN	in
healthy	JJ	healthy
controls	NNS	control
(	(	(
27.4	CD	@card@
±	SYM	±
3.3	CD	@card@
μs	NNS	<unknown>
)	)	)
(	(	(
P	NN	P
<	SYM	<
0.001)	JJ	<unknown>
.	SENT	.
Besides	RB	besides
,	,	,
the	DT	the
mean	JJ	mean
spike	NN	spike
number	NN	number
was	VBD	be
significantly	RB	significantly
increased	VBN	increase
in	IN	in
<span class='disease'>
ALS	JJ	<unknown>
</span>
patients	NNS	patient
(	(	(
2.5	CD	@card@
±	SYM	±
0.5	CD	@card@
)	)	)
than	IN	than
in	IN	in
healthy	JJ	healthy
controls	NNS	control
(	(	(
1.7	CD	@card@
±	SYM	±
0.3	CD	@card@
)	)	)
(	(	(
P	NN	P
<	SYM	<
0.001)	JJ	<unknown>
.	SENT	.
The	DT	the
sensitivity	NN	sensitivity
and	CC	and
specificity	NN	specificity
in	IN	in
the	DT	the
diagnosis	NN	diagnosis
of	IN	of
<span class='disease'>
ALS	NN	<unknown>
</span>
were	VBD	be
82.6	CD	@card@
%	NN	%
and	CC	and
92.6	CD	@card@
%	NN	%
for	IN	for
CN-jitter	NP	<unknown>
(	(	(
cut-off	NN	cut-off
value	NN	value
:	:	:
32	CD	@card@
μs	NNS	<unknown>
)	)	)
,	,	,
and	CC	and
91.3	CD	@card@
%	NN	%
and	CC	and
96.3	CD	@card@
%	NN	%
for	IN	for
the	DT	the
spike	NN	spike
number	NN	number
(	(	(
cut-off	NN	cut-off
value	NN	value
:	:	:
2.0	LS	@card@
)	)	)
,	,	,
respectively	RB	respectively
.	SENT	.
There	EX	there
was	VBD	be
no	DT	no
significant	JJ	significant
difference	NN	difference
between	IN	between
the	DT	the
SFN-jitter	NP	<unknown>
and	CC	and
CN-jitter	NP	<unknown>
in	IN	in
<span class='disease'>
ALS	JJ	<unknown>
</span>
patients	NNS	patient
;	:	;
meanwhile	RB	meanwhile
,	,	,
there	EX	there
was	VBD	be
no	DT	no
significant	JJ	significant
difference	NN	difference
between	IN	between
the	DT	the
SFN-jitter	NP	<unknown>
and	CC	and
CN-jitter	NP	<unknown>
in	IN	in
healthy	JJ	healthy
controls.CN-jitter	NN	<unknown>
and	CC	and
spike	NN	spike
number	NN	number
could	MD	could
be	VB	be
used	VBN	use
to	TO	to
quantitatively	RB	quantitatively
evaluate	VB	evaluate
changes	NNS	change
due	JJ	due
to	TO	to
denervation-reinnervation	NN	<unknown>
in	IN	in
<span class='disease'>
ALS	NN	<unknown>
</span>
.	SENT	.
<td class='article_title' rowspan='2'>
Altered	JJ	altered
development	NN	development
in	IN	in
GABA	NP	Gaba
co-release	NN	<unknown>
shapes	VBZ	shape
glycinergic	JJ	<unknown>
synaptic	JJ	synaptic
currents	NNS	current
in	IN	in
cultured	JJ	cultured
spinal	JJ	spinal
slices	NNS	slice
of	IN	of
the	DT	the
SOD1(G93A)	NP	<unknown>
mouse	NN	mouse
model	NN	model
of	IN	of
ALS	NN	<unknown>
.	SENT	.
</td>
<span class='disease'>
Amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
(	(	(
<span class='disease'>
ALS	NN	<unknown>
</span>
)	)	)
is	VBZ	be
a	DT	a
fatal	JJ	fatal
,	,	,
adult-onset	NN	<unknown>
neurological	JJ	neurological
disease	NN	disease
characterized	VBN	characterize
by	IN	by
progressive	JJ	progressive
degeneration	NN	degeneration
of	IN	of
motoneurons	NNS	motoneuron
(MNs)	JJ	<unknown>
.	SENT	.
In	IN	in
our	PP$	our
previous	JJ	previous
study	NN	study
we	PP	we
developed	VBD	develop
organotypic	JJ	<unknown>
spinal	JJ	spinal
cultures	NNS	culture
from	IN	from
an	DT	an
<span class='disease'>
ALS	JJ	<unknown>
</span>
mouse	NN	mouse
model	NN	model
expressing	VBG	express
a	DT	a
mutant	JJ	mutant
form	NN	form
of	IN	of
human	JJ	human
superoxide	NN	superoxide
dismutase	NN	dismutase
1	CD	1
(	(	(
SOD1(G93A)	NP	<unknown>
)	)	)
.	SENT	.
We	PP	we
reported	VBD	report
the	DT	the
presence	NN	presence
of	IN	of
a	DT	a
significant	JJ	significant
synaptic	JJ	synaptic
rearrangement	NN	rearrangement
expressed	VBN	express
by	IN	by
these	DT	these
embryonic	JJ	embryonic
cultured	JJ	cultured
networks	NNS	network
,	,	,
which	WDT	which
may	MD	may
lead	VB	lead
to	TO	to
altered	JJ	altered
development	NN	development
of	IN	of
spinal	JJ	spinal
synaptic	JJ	synaptic
signalling	VBG	signal
,	,	,
potentially	RB	potentially
linked	VBN	link
to	TO	to
the	DT	the
adult	JJ	adult
disease	NN	disease
phenotype	NN	phenotype
.	SENT	.
Recent	JJ	Recent
studies	NNS	study
on	IN	on
the	DT	the
same	JJ	same
<span class='disease'>
ALS	NN	<unknown>
</span>
mouse	NN	mouse
model	NN	model
,	,	,
reported	VBD	report
a	DT	a
selective	JJ	selective
loss	NN	loss
of	IN	of
glycinergic	JJ	<unknown>
innervation	NN	innervation
in	IN	in
cultured	JJ	cultured
MNs	NNS	<unknown>
,	,	,
suggestive	JJ	suggestive
of	IN	of
a	DT	a
contribution	NN	contribution
of	IN	of
synaptic	JJ	synaptic
inhibition	NN	inhibition
to	TO	to
MNs	NP	<unknown>
dysfunction	NN	dysfunction
and	CC	and
degeneration	NN	degeneration
.	SENT	.
Here	RB	here
we	PP	we
further	RBR	further
exploit	VB	exploit
organotypic	JJ	<unknown>
cultures	NNS	culture
from	IN	from
wild	JJ	wild
type	NN	type
and	CC	and
SOD1(G93A)	NN	<unknown>
mice	NNS	mouse
to	TO	to
investigate	VB	investigate
the	DT	the
development	NN	development
of	IN	of
glycine-receptor	NN	<unknown>
mediated	VBD	mediate
synaptic	JJ	synaptic
currents	NNS	current
recorded	VBN	record
from	IN	from
interneurons	NNS	interneuron
of	IN	of
the	DT	the
premotor	JJ	<unknown>
ventral	JJ	ventral
circuits	NNS	circuit
.	SENT	.
We	PP	we
perform	VBP	perform
single	JJ	single
cell	NN	cell
electrophysiology	NN	electrophysiology
,	,	,
immunocytochemistry	NN	<unknown>
and	CC	and
confocal	JJ	confocal
microscopy	NN	microscopy
and	CC	and
we	PP	we
suggest	VBP	suggest
that	IN	that
GABA	NP	Gaba
co-release	NN	<unknown>
may	MD	may
speed	VB	speed
the	DT	the
decay	NN	decay
of	IN	of
glycine	NN	glycine
responses	NNS	response
altering	VBG	alter
,	,	,
in	IN	in
SOD1(G93A)	NP	<unknown>
developing	VBG	develop
networks	NNS	network
,	,	,
temporal	JJ	temporal
precision	NN	precision
and	CC	and
signal	NN	signal
integration	NN	integration
at	IN	at
the	DT	the
postsynaptic	JJ	<unknown>
site	NN	site
.	SENT	.
Our	PP$	our
hypothesis	NN	hypothesis
is	VBZ	be
supported	VBN	support
by	IN	by
the	DT	the
finding	NN	finding
of	IN	of
an	DT	an
increased	VBN	increase
MN	NN	<unknown>
bursting	VBG	burst
activity	NN	activity
in	IN	in
immature	JJ	immature
SOD1(G93A)	NP	<unknown>
spinal	NN	spinal
cords	NNS	cord
and	CC	and
by	IN	by
immunofluorescence	NN	<unknown>
microscopy	NN	microscopy
detection	NN	detection
of	IN	of
longer	JJR	long
persistence	NN	persistence
of	IN	of
GABA	NP	Gaba
in	IN	in
SOD1(G93A)	NP	<unknown>
glycinergic	JJ	<unknown>
terminals	NNS	terminal
in	IN	in
cultured	JJ	cultured
and	CC	and
ex-vivo	NP	<unknown>
spinal	JJ	spinal
slices	NNS	slice
.	SENT	.
This	DT	this
article	NN	article
is	VBZ	be
protected	VBN	protect
by	IN	by
copyright	NN	copyright
.	SENT	.
All	DT	all
rights	NNS	right
reserved	VBD	reserve
.	SENT	.
<td class='article_title' rowspan='2'>
Trends	NNS	trend
in	IN	in
motor	NN	motor
neuron	NN	neuron
disease	NN	disease
:	:	:
association	NN	association
with	IN	with
latitude	NN	latitude
and	CC	and
air	NN	air
lead	NN	lead
levels	NNS	level
in	IN	in
Spain	NP	Spain
.	SENT	.
</td>
Motor	NP	Motor
neuron	NN	neuron
diseases	NNS	disease
(	(	(
MND	NP	<unknown>
)	)	)
are	VBP	be
a	DT	a
group	NN	group
of	IN	of
disorders	NNS	disorder
characterized	VBN	characterize
by	IN	by
motor	NN	motor
neuron	NN	neuron
degeneration	NN	degeneration
.	SENT	.
Among	IN	among
them	PP	them
,	,	,
<span class='disease'>
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
(	(	(
<span class='disease'>
ALS	NN	<unknown>
</span>
)	)	)
is	VBZ	be
by	IN	by
far	RB	far
the	DT	the
most	RBS	most
common	JJ	common
in	IN	in
adulthood	NN	adulthood
.	SENT	.
This	DT	this
paper	NN	paper
assesses	VBZ	assess
the	DT	the
trend	NN	trend
and	CC	and
geographical	JJ	geographical
pattern	NN	pattern
in	IN	in
MND	NP	<unknown>
incidence	NN	incidence
in	IN	in
Spain	NP	Spain
and	CC	and
the	DT	the
possible	JJ	possible
air	NN	air
lead	NN	lead
levels	NNS	level
effect	NN	effect
on	IN	on
this	DT	this
pathology	NN	pathology
.	SENT	.
To	TO	To
confirm	VB	confirm
this	DT	this
concept	NN	concept
,	,	,
we	PP	we
performed	VBD	perform
a	DT	a
retrospective	JJ	retrospective
analysis	NN	analysis
of	IN	of
the	DT	the
deaths	NNS	death
due	JJ	due
to	TO	to
MND	NP	<unknown>
in	IN	in
Spain	NP	Spain
during	IN	during
2000	CD	@card@
and	CC	and
2013	CD	@card@
,	,	,
determined	VBN	determine
the	DT	the
geographical	JJ	geographical
differences	NNS	difference
,	,	,
and	CC	and
explored	VBD	explore
the	DT	the
relationship	NN	relationship
between	IN	between
MND	NP	<unknown>
and	CC	and
the	DT	the
air	NN	air
levels	NNS	level
of	IN	of
lead	NN	lead
.	SENT	.
Overall	RB	overall
,	,	,
between	IN	between
2000	CD	@card@
and	CC	and
2013	CD	@card@
,	,	,
11,355	CD	@card@
people	NNS	people
died	VBN	die
in	IN	in
Spain	NP	Spain
because	IN	because
of	IN	of
MND	NP	<unknown>
.	SENT	.
Disease	NN	disease
mortality	NN	mortality
significantly	RB	significantly
increased	VBN	increase
in	IN	in
recent	JJ	recent
years	NNS	year
(	(	(
2007-2013	CD	@card@
)	)	)
when	WRB	when
compared	VBN	compare
with	IN	with
the	DT	the
first	JJ	first
time	NN	time
of	IN	of
the	DT	the
period	NN	period
.	SENT	.
Spearman	NP	Spearman
's	POS	's
rank	JJ	rank
correlation	NN	correlation
coefficient	NN	coefficient
also	RB	also
showed	VBD	show
a	DT	a
statistically	RB	statistically
significant	JJ	significant
positive	JJ	positive
trend	NN	trend
(	(	(
CC	NP	CC
=	SYM	=
0.824	CD	@card@
,	,	,
p	NN	p
=	SYM	=
0.0002)	JJ	<unknown>
.	SENT	.
Among	IN	among
people	NNS	people
over	IN	over
65	CD	@card@
years	NNS	year
,	,	,
mortality	NN	mortality
rates	NNS	rate
were	VBD	be
higher	JJR	high
in	IN	in
Northern	JJ	northern
provinces	NNS	province
.	SENT	.
Moreover	RB	moreover
,	,	,
we	PP	we
found	VBD	find
a	DT	a
significant	JJ	significant
association	NN	association
of	IN	of
MND	NP	<unknown>
mortality	NN	mortality
with	IN	with
higher	JJR	high
air	NN	air
lead	NN	lead
levels	NNS	level
(	(	(
CC	NP	CC
=	SYM	=
0.457	CD	@card@
,	,	,
p	NN	p
=	SYM	=
0.01)	JJ	<unknown>
.	SENT	.
Our	PP$	our
study	NN	study
confirms	VBZ	confirm
that	IN	that
MND	NP	<unknown>
mortality	NN	mortality
is	VBZ	be
increasing	VBG	increase
in	IN	in
Spain	NP	Spain
,	,	,
with	IN	with
a	DT	a
significant	JJ	significant
latitude	NN	latitude
gradient	NN	gradient
,	,	,
which	WDT	which
suggests	VBZ	suggest
an	DT	an
important	JJ	important
role	NN	role
of	IN	of
environmental	JJ	environmental
exposures	NNS	exposure
.	SENT	.
This	DT	this
ecological	JJ	ecological
study	NN	study
suggests	VBZ	suggest
that	IN	that
air	NN	air
lead	NN	lead
levels	NNS	level
may	MD	may
be	VB	be
implicated	VBN	implicate
in	IN	in
<span class='disease'>
ALS	JJ	<unknown>
</span>
pathogenesis	NN	pathogenesis
.	SENT	.
<td class='article_title' rowspan='2'>
C9orf72	NP	<unknown>
Hexanucleotide	NP	<unknown>
Expansions	NNS	expansion
are	VBP	be
Associated	NP	Associated
with	IN	with
Altered	NP	<unknown>
ER	NP	<unknown>
Calcium	NP	<unknown>
Homeostasis	NP	<unknown>
and	CC	and
Stress	NP	<unknown>
Granule	NN	granule
Formation	NN	formation
in	IN	in
iPSC-Derived	JJ	<unknown>
Neurons	NP	<unknown>
from	IN	from
Patients	NPS	Patients
with	IN	with
Amyotrophic	NP	<unknown>
Lateral	NP	<unknown>
Sclerosis	NP	<unknown>
and	CC	and
Frontotemporal	NP	<unknown>
Dementia	NP	<unknown>
.	SENT	.
</td>
An	DT	an
expanded	JJ	expanded
hexanucleotide	NN	<unknown>
repeat	NN	repeat
in	IN	in
a	DT	a
noncoding	JJ	<unknown>
region	NN	region
of	IN	of
the	DT	the
<span class='gene'>
C9orf72	NP	<unknown>
</span>
gene	NN	gene
is	VBZ	be
a	DT	a
major	JJ	major
cause	NN	cause
of	IN	of
<span class='disease'>
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
(	(	(
<span class='disease'>
ALS	NP	<unknown>
</span>
)	)	)
,	,	,
accounting	VBG	account
for	IN	for
up	IN	up
to	TO	to
40	CD	@card@
%	NN	%
of	IN	of
familial	JJ	familial
cases	NNS	case
and	CC	and
7	CD	7
%	NN	%
of	IN	of
sporadic	JJ	sporadic
<span class='disease'>
ALS	NN	<unknown>
</span>
in	IN	in
European	JJ	European
populations	NNS	population
.	SENT	.
We	PP	we
have	VBP	have
generated	VBN	generate
induced	VBN	induce
pluripotent	JJ	<unknown>
stem	NN	stem
cells	NNS	cell
(	(	(
iPSCs	NNS	<unknown>
)	)	)
from	IN	from
fibroblasts	NNS	fibroblast
of	IN	of
patients	NNS	patient
carrying	VBG	carry
<span class='gene'>
C9orf72	JJ	<unknown>
</span>
hexanucleotide	NN	<unknown>
expansions	NNS	expansion
,	,	,
differentiated	VBD	differentiate
these	DT	these
to	TO	to
functional	JJ	functional
motor	NN	motor
and	CC	and
cortical	JJ	cortical
neurons	NNS	neuron
and	CC	and
performed	VBD	perform
an	DT	an
extensive	JJ	extensive
phenotypic	JJ	phenotypic
characterization	NN	characterization
.	SENT	.
In	IN	in
<span class='gene'>
C9orf72	NP	<unknown>
</span>
iPSC-derived	JJ	<unknown>
motor	NN	motor
neurons	NNS	neuron
,	,	,
decreased	VBD	decrease
cell	NN	cell
survival	NN	survival
is	VBZ	be
correlated	VBN	correlate
with	IN	with
dysfunction	NN	dysfunction
in	IN	in
Ca(2+)	NP	<unknown>
homeostasis	NN	homeostasis
,	,	,
reduced	VBD	reduce
levels	NNS	level
of	IN	of
the	DT	the
anti-apoptotic	JJ	<unknown>
protein	NN	protein
Bcl-2	NP	<unknown>
,	,	,
increased	VBD	increase
endoplasmic	JJ	endoplasmic
reticulum	NN	reticulum
(	(	(
ER	NN	<unknown>
)	)	)
stress	NN	stress
and	CC	and
reduced	VBD	reduce
mitochondrial	JJ	mitochondrial
membrane	NN	membrane
potential	NN	potential
.	SENT	.
Furthermore	RB	furthermore
,	,	,
<span class='gene'>
C9orf72	JJ	<unknown>
</span>
motor	NN	motor
neurons	NNS	neuron
,	,	,
and	CC	and
also	RB	also
cortical	JJ	cortical
neurons	NNS	neuron
,	,	,
show	NN	show
evidence	NN	evidence
of	IN	of
abnormal	JJ	abnormal
protein	NN	protein
aggregation	NN	aggregation
and	CC	and
stress	NN	stress
granule	NN	granule
formation	NN	formation
.	SENT	.
This	DT	this
study	NN	study
is	VBZ	be
an	DT	an
extensive	JJ	extensive
characterization	NN	characterization
of	IN	of
iPSC-derived	JJ	<unknown>
motor	NN	motor
neurons	NNS	neuron
as	IN	as
cellular	JJ	cellular
models	NNS	model
of	IN	of
<span class='disease'>
ALS	NNS	<unknown>
</span>
carrying	VBG	carry
<span class='gene'>
C9orf72	JJ	<unknown>
</span>
hexanucleotide	NN	<unknown>
repeats	NNS	repeat
,	,	,
which	WDT	which
describes	VBZ	describe
a	DT	a
novel	JJ	novel
pathogenic	JJ	pathogenic
link	NN	link
between	IN	between
<span class='gene'>
C9orf72	JJ	<unknown>
</span>
mutations	NNS	mutation
,	,	,
dysregulation	NN	<unknown>
of	IN	of
calcium	NN	calcium
signalling	VBG	signal
and	CC	and
altered	JJ	altered
proteostasis	NN	<unknown>
and	CC	and
provides	VBZ	provide
a	DT	a
potential	JJ	potential
pharmacological	JJ	pharmacological
target	NN	target
for	IN	for
the	DT	the
treatment	NN	treatment
of	IN	of
<span class='disease'>
ALS	NN	<unknown>
</span>
and	CC	and
the	DT	the
related	JJ	related
<span class='symptom'>
neurodegenerative	JJ	<unknown>
disease	NN	disease
</span>
<span class='disease'>
frontotemporal	NN	<unknown>
dementia	NN	dementia
</span>
(	(	(
<span class='disease'>
FTD	NP	<unknown>
</span>
)	)	)
.	SENT	.
This	DT	this
article	NN	article
is	VBZ	be
protected	VBN	protect
by	IN	by
copyright	NN	copyright
.	SENT	.
All	DT	all
rights	NNS	right
reserved	VBD	reserve
.	SENT	.
<td class='article_title' rowspan='2'>
Ketamine	NP	<unknown>
Metabolites	NP	<unknown>
Enantioselectively	NP	<unknown>
Decrease	NP	<unknown>
Intracellular	NP	<unknown>
D-Serine	NP	<unknown>
Concentrations	NNS	concentration
in	IN	in
PC-12	NP	<unknown>
Cells	NP	<unknown>
.	SENT	.
</td>
D-Serine	NP	<unknown>
is	VBZ	be
an	DT	an
endogenous	JJ	endogenous
NMDA	NP	<unknown>
receptor	NN	receptor
co-agonist	NN	<unknown>
that	WDT	that
activates	VBZ	activate
synaptic	JJ	synaptic
NMDA	NP	<unknown>
receptors	NNS	receptor
modulating	VBG	modulate
neuronal	JJ	<unknown>
networks	NNS	network
in	IN	in
the	DT	the
cerebral	JJ	cerebral
cortex	NN	cortex
and	CC	and
plays	VBZ	play
a	DT	a
key	JJ	key
role	NN	role
in	IN	in
long-term	JJ	long-term
potentiation	NN	<unknown>
of	IN	of
synaptic	JJ	synaptic
transmission	NN	transmission
.	SENT	.
D-serine	NP	<unknown>
is	VBZ	be
associated	VBN	associate
with	IN	with
NMDA	NP	<unknown>
receptor	NN	receptor
neurotoxicity	NN	<unknown>
and	CC	and
<span class='symptom'>
neurodegeneration	NN	<unknown>
</span>
and	CC	and
elevated	JJ	elevated
D-serine	NP	<unknown>
concentrations	NNS	concentration
have	VBP	have
been	VBN	be
associated	VBN	associate
with	IN	with
Alzheimer	NP	Alzheimer
's	POS	's
and	CC	and
Parkinsons	NP	<unknown>
'	POS	'
diseases	NNS	disease
and	CC	and
<span class='disease'>
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
.	SENT	.
Previous	JJ	previous
studies	NNS	study
have	VBP	have
demonstrated	VBN	demonstrate
that	IN	that
the	DT	the
ketamine	NN	<unknown>
metabolites	NNS	metabolite
(rac)-dehydronorketamine	NN	<unknown>
and	CC	and
(2S,6S)-hydroxynorketamine	NN	<unknown>
decrease	NN	decrease
intracellular	JJ	intracellular
D-serine	NP	<unknown>
concentrations	NNS	concentration
in	IN	in
a	DT	a
concentration	NN	concentration
dependent	JJ	dependent
manner	NN	manner
in	IN	in
PC-12	JJ	<unknown>
cells	NNS	cell
.	SENT	.
In	IN	in
the	DT	the
current	JJ	current
study	NN	study
,	,	,
PC-12	NP	<unknown>
cells	NNS	cell
were	VBD	be
incubated	VBN	incubate
with	IN	with
a	DT	a
series	NN	series
of	IN	of
ketamine	NN	<unknown>
metabolites	NNS	metabolite
and	CC	and
the	DT	the
IC50	NP	<unknown>
values	NNS	value
associated	VBN	associate
with	IN	with
attenuated	JJ	attenuated
intracellular	JJ	intracellular
D-serine	NP	<unknown>
concentrations	NNS	concentration
were	VBD	be
determined	VBN	determine
.	SENT	.
The	DT	the
results	NNS	result
demonstrate	VBP	demonstrate
that	IN	that
structural	JJ	structural
and	CC	and
stereochemical	JJ	<unknown>
features	NNS	feature
of	IN	of
the	DT	the
studied	VBN	study
compounds	NNS	compound
contribute	VBP	contribute
to	TO	to
the	DT	the
magnitude	NN	magnitude
of	IN	of
the	DT	the
inhibitory	JJ	inhibitory
effect	NN	effect
with	IN	with
(2S,6S)-hydroxynorketamine	NN	<unknown>
and	CC	and
(2R,6R)-hydroxynorketamine	NN	<unknown>
displaying	VBG	display
the	DT	the
most	RBS	most
potent	JJ	potent
inhibition	NN	inhibition
with	IN	with
IC50	JJ	<unknown>
values	NNS	value
of	IN	of
0.18	CD	@card@
±	SYM	±
0.04	CD	@card@
nM	NN	<unknown>
and	CC	and
0.68	CD	@card@
±	SYM	±
0.09	CD	@card@
nM	NN	<unknown>
.	SENT	.
The	DT	the
data	NNS	datum
was	VBD	be
utilized	VBN	utilize
to	TO	to
construct	VB	construct
a	DT	a
preliminary	JJ	preliminary
3D-QSAR/pharmacophore	JJ	<unknown>
model	NN	model
for	IN	for
use	NN	use
in	IN	in
the	DT	the
design	NN	design
of	IN	of
new	JJ	new
and	CC	and
more	RBR	more
efficient	JJ	efficient
modulators	NNS	modulator
of	IN	of
D-serine	NP	<unknown>
.	SENT	.
TDP-43	NP	<unknown>
is	VBZ	be
a	DT	a
protein	NN	protein
that	WDT	that
forms	VBZ	form
aggregates	NNS	aggregate
implicated	VBN	implicate
in	IN	in
<span class='disease'>
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
.	SENT	.
In	IN	in
response	NN	response
to	TO	to
a	DT	a
recent	JJ	recent
study	NN	study
,	,	,
this	DT	this
Formal	NP	<unknown>
Comment	NP	Comment
argues	VBZ	argue
that	IN	that
the	DT	the
pH-dependent	JJ	<unknown>
solubility	NN	solubility
of	IN	of
this	DT	this
protein	NN	protein
is	VBZ	be
better	RBR	well
explained	VBN	explain
by	IN	by
the	DT	the
mutual	JJ	mutual
repulsion	NN	repulsion
of	IN	of
charged	VBN	charge
groups	NNS	group
than	IN	than
by	IN	by
the	DT	the
formation	NN	formation
of	IN	of
hydrogen	NN	hydrogen
bonds	NNS	bond
.	SENT	.
<td class='article_title' rowspan='2'>
Genetic	JJ	genetic
analysis	NN	analysis
of	IN	of
CHCHD10	NP	<unknown>
in	IN	in
French	JJ	French
familial	JJ	familial
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
patients	NNS	patient
.	SENT	.
</td>
Mutations	NNS	mutation
in	IN	in
<span class='gene'>
CHCHD10	NP	<unknown>
</span>
have	VBP	have
been	VBN	be
reported	VBN	report
as	IN	as
the	DT	the
cause	NN	cause
of	IN	of
a	DT	a
large	JJ	large
panel	NN	panel
of	IN	of
neurologic	JJ	neurologic
disorders	NNS	disorder
.	SENT	.
To	TO	To
confirm	VB	confirm
the	DT	the
contribution	NN	contribution
of	IN	of
this	DT	this
gene	NN	gene
to	TO	to
<span class='disease'>
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
(	(	(
<span class='disease'>
ALS	NN	<unknown>
</span>
)	)	)
disease	NN	disease
,	,	,
we	PP	we
analyzed	VBD	analyze
the	DT	the
4	CD	4
coding	VBG	code
exons	NNS	exon
of	IN	of
<span class='gene'>
CHCHD10	NP	<unknown>
</span>
by	IN	by
Sanger	NP	Sanger
sequencing	NP	sequencing
in	IN	in
a	DT	a
cohort	NN	cohort
of	IN	of
118	CD	@card@
French	JJ	French
familial	JJ	familial
<span class='disease'>
ALS	NN	<unknown>
</span>
already	RB	already
excluded	VBN	exclude
for	IN	for
all	DT	all
known	VBN	know
ALS-related	JJ	<unknown>
genes	NNS	gene
.	SENT	.
We	PP	we
did	VBD	do
not	RB	not
find	VB	find
any	DT	any
pathogenic	JJ	pathogenic
mutation	NN	mutation
suggesting	VBG	suggest
that	IN	that
<span class='gene'>
CHCHD10	NP	<unknown>
</span>
is	VBZ	be
not	RB	not
a	DT	a
major	JJ	major
genetic	JJ	genetic
cause	NN	cause
of	IN	of
familial	JJ	familial
<span class='disease'>
ALS	NN	<unknown>
</span>
,	,	,
in	IN	in
France	NP	France
.	SENT	.
<td class='article_title' rowspan='2'>
Impaired	JJ	impaired
Perception	NN	perception
of	IN	of
Emotional	NP	<unknown>
Expression	NP	<unknown>
in	IN	in
Amyotrophic	NP	<unknown>
Lateral	NP	<unknown>
Sclerosis	NP	<unknown>
.	SENT	.
</td>
The	DT	the
increasing	VBG	increase
recognition	NN	recognition
that	IN	that
deficits	NNS	deficit
in	IN	in
social	JJ	social
emotions	NNS	emotion
occur	VBP	occur
in	IN	in
<span class='disease'>
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
(	(	(
<span class='disease'>
ALS	NN	<unknown>
</span>
)	)	)
is	VBZ	be
helping	VBG	help
to	TO	to
explain	VB	explain
the	DT	the
spectrum	NN	spectrum
of	IN	of
neuropsychological	JJ	<unknown>
dysfunctions	NNS	dysfunction
,	,	,
thus	RB	thus
supporting	VBG	support
the	DT	the
view	NN	view
of	IN	of
<span class='disease'>
ALS	NN	<unknown>
</span>
as	IN	as
a	DT	a
multisystem	NN	<unknown>
disorder	NN	disorder
involving	VBG	involve
neuropsychological	JJ	<unknown>
deficits	NNS	deficit
as	RB	as
well	RB	well
as	IN	as
motor	NN	motor
deficits	NNS	deficit
.	SENT	.
The	DT	the
aim	NN	aim
of	IN	of
this	DT	this
study	NN	study
was	VBD	be
to	TO	to
characterize	VB	characterize
the	DT	the
emotion	NN	emotion
perception	NN	perception
abilities	NNS	ability
of	IN	of
Korean	JJ	Korean
patients	NNS	patient
with	IN	with
<span class='disease'>
ALS	NNS	<unknown>
</span>
based	VBN	base
on	IN	on
the	DT	the
recognition	NN	recognition
of	IN	of
facial	JJ	facial
expressions.Twenty-four	NN	<unknown>
patients	NNS	patient
with	IN	with
<span class='disease'>
ALS	NN	<unknown>
</span>
and	CC	and
24	CD	@card@
age-	NN	<unknown>
and	CC	and
sex-matched	JJ	<unknown>
healthy	JJ	healthy
controls	NNS	control
completed	VBD	complete
neuropsychological	JJ	<unknown>
tests	NNS	test
and	CC	and
facial	JJ	facial
emotion	NN	emotion
recognition	NN	recognition
tasks	NNS	task
[	SYM	[
ChaeLee	NP	<unknown>
Korean	NP	Korean
Facial	NP	<unknown>
Expressions	NNS	expression
of	IN	of
Emotions	NNS	emotion
(	(	(
ChaeLee-E	NP	<unknown>
)	)	)
]	SYM	]
.	SENT	.
The	DT	the
ChaeLee-E	JJ	<unknown>
test	NN	test
includes	VBZ	include
facial	JJ	facial
expressions	NNS	expression
for	IN	for
seven	CD	seven
emotions	NNS	emotion
:	:	:
happiness	NN	happiness
,	,	,
sadness	NN	sadness
,	,	,
anger	NN	anger
,	,	,
disgust	NN	disgust
,	,	,
fear	NN	fear
,	,	,
surprise	NN	surprise
,	,	,
and	CC	and
neutral.The	JJ	<unknown>
ability	NN	ability
to	TO	to
perceive	VB	perceive
facial	JJ	facial
emotions	NNS	emotion
was	VBD	be
significantly	RB	significantly
worse	JJR	bad
among	IN	among
<span class='disease'>
ALS	JJ	<unknown>
</span>
patients	NNS	patient
performed	VBN	perform
than	IN	than
among	IN	among
healthy	JJ	healthy
controls	NNS	control
[	SYM	[
65.2±18.0	JJ	<unknown>
%	NN	%
vs.	IN	vs.
77.1±6.6	JJ	<unknown>
%	NN	%
(	(	(
mean±SD	NN	<unknown>
)	)	)
,	,	,
p=0.009	NN	<unknown>
]	SYM	]
.	SENT	.
Eight	CD	Eight
of	IN	of
the	DT	the
24	CD	@card@
patients	NNS	patient
(	(	(
33	CD	@card@
%	NN	%
)	)	)
scored	VBN	score
below	IN	below
the	DT	the
5th	JJ	5th
percentile	NN	percentile
score	NN	score
of	IN	of
controls	NNS	control
for	IN	for
recognizing	VBG	recognize
facial	JJ	facial
emotions.Emotion	NN	<unknown>
perception	NN	perception
deficits	NNS	deficit
occur	VBP	occur
in	IN	in
Korean	JJ	Korean
<span class='disease'>
ALS	NN	<unknown>
</span>
patients	NNS	patient
,	,	,
particularly	RB	particularly
regarding	VBG	regard
facial	JJ	facial
expressions	NNS	expression
of	IN	of
emotion	NN	emotion
.	SENT	.
These	DT	these
findings	NNS	finding
expand	VBP	expand
the	DT	the
spectrum	NN	spectrum
of	IN	of
cognitive	JJ	cognitive
and	CC	and
behavioral	JJ	behavioral
dysfunction	NN	dysfunction
associated	VBN	associate
with	IN	with
<span class='disease'>
ALS	NN	<unknown>
</span>
into	IN	into
emotion	NN	emotion
processing	NN	processing
dysfunction	NN	dysfunction
.	SENT	.
<td class='article_title' rowspan='2'>
The	DT	the
cytoskeleton	NN	<unknown>
as	IN	as
a	DT	a
novel	JJ	novel
therapeutic	JJ	therapeutic
target	NN	target
for	IN	for
old	JJ	old
neurodegenerative	JJ	<unknown>
disorders	NNS	disorder
.	SENT	.
</td>
Cytoskeleton	NN	<unknown>
defects	NNS	defect
,	,	,
including	VBG	include
alterations	NNS	alteration
in	IN	in
microtubule	NN	<unknown>
stability	NN	stability
,	,	,
in	IN	in
axonal	JJ	axonal
transport	NN	transport
as	IN	as
well	RB	well
as	RB	as
in	IN	in
actin	NN	actin
dynamics	NNS	dynamics
,	,	,
have	VBP	have
been	VBN	be
characterized	VBN	characterize
in	IN	in
several	JJ	several
unrelated	JJ	unrelated
neurodegenerative	JJ	<unknown>
conditions	NNS	condition
.	SENT	.
These	DT	these
observations	NNS	observation
suggest	VBP	suggest
that	IN	that
defects	NNS	defect
of	IN	of
cytoskeleton	NN	<unknown>
organization	NN	organization
may	MD	may
be	VB	be
a	DT	a
common	JJ	common
feature	NN	feature
contributing	VBG	contribute
to	TO	to
<span class='symptom'>
neurodegeneration	NN	<unknown>
</span>
.	SENT	.
In	IN	in
line	NN	line
with	IN	with
this	DT	this
hypothesis	NN	hypothesis
,	,	,
drugs	NNS	drug
targeting	VBG	target
the	DT	the
cytoskeleton	NN	<unknown>
are	VBP	be
currently	RB	currently
being	VBG	be
tested	VBN	test
in	IN	in
animal	JJ	animal
models	NNS	model
and	CC	and
in	IN	in
human	JJ	human
clinical	JJ	clinical
trials	NNS	trial
,	,	,
showing	VBG	show
promising	JJ	promising
effects	NNS	effect
.	SENT	.
Drugs	NNS	drug
that	WDT	that
modulate	VBP	modulate
microtubule	NN	<unknown>
stability	NN	stability
,	,	,
inhibitors	NNS	inhibitor
of	IN	of
posttranslational	JJ	<unknown>
modifications	NNS	modification
of	IN	of
cytoskeletal	JJ	<unknown>
components	NNS	component
,	,	,
specifically	RB	specifically
compounds	NNS	compound
affecting	VBG	affect
the	DT	the
levels	NNS	level
of	IN	of
tubulin	NN	<unknown>
acetylation	NN	acetylation
,	,	,
and	CC	and
compounds	NNS	compound
targeting	VBG	target
signaling	VBG	signal
molecules	NNS	molecule
which	WDT	which
regulate	VBP	regulate
cytoskeleton	NN	<unknown>
dynamics	NNS	dynamics
,	,	,
constitute	VBP	constitute
the	DT	the
mostly	RB	mostly
addressed	VBN	address
therapeutic	JJ	therapeutic
interventions	NNS	intervention
aiming	VBG	aim
at	IN	at
preventing	VBG	prevent
cytoskeleton	NN	<unknown>
damage	NN	damage
in	IN	in
neurodegenerative	JJ	<unknown>
disorders	NNS	disorder
.	SENT	.
In	IN	in
this	DT	this
review	NN	review
,	,	,
we	PP	we
will	MD	will
discuss	VB	discuss
in	IN	in
a	DT	a
critical	JJ	critical
perspective	NN	perspective
the	DT	the
current	JJ	current
knowledge	NN	knowledge
on	IN	on
cytoskeleton	NN	<unknown>
damage	NN	damage
pathways	NNS	pathway
as	RB	as
well	RB	well
as	IN	as
therapeutic	JJ	therapeutic
strategies	NNS	strategy
designed	VBN	design
to	TO	to
revert	VB	revert
cytoskeleton-related	JJ	<unknown>
defects	NNS	defect
mainly	RB	mainly
focusing	VBG	focus
on	IN	on
the	DT	the
following	VBG	follow
neurodegenerative	JJ	<unknown>
disorders	NNS	disorder
:	:	:
Alzheimer	NP	Alzheimer
's	POS	's
Disease	NP	Disease
,	,	,
Parkinson	NP	Parkinson
's	POS	's
Disease	NP	Disease
,	,	,
Huntington	NP	Huntington
's	POS	's
Disease	NP	Disease
,	,	,
<span class='disease'>
Amyotrophic	NP	<unknown>
Lateral	NP	<unknown>
Sclerosis	NP	<unknown>
</span>
and	CC	and
Charcot-Marie-Tooth	NP	<unknown>
Disease	NP	Disease
.	SENT	.
The	DT	the
increasing	VBG	increase
recognition	NN	recognition
that	IN	that
deficits	NNS	deficit
in	IN	in
social	JJ	social
emotions	NNS	emotion
occur	VBP	occur
in	IN	in
<span class='disease'>
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
(	(	(
<span class='disease'>
ALS	NN	<unknown>
</span>
)	)	)
is	VBZ	be
helping	VBG	help
to	TO	to
explain	VB	explain
the	DT	the
spectrum	NN	spectrum
of	IN	of
neuropsychological	JJ	<unknown>
dysfunctions	NNS	dysfunction
,	,	,
thus	RB	thus
supporting	VBG	support
the	DT	the
view	NN	view
of	IN	of
<span class='disease'>
ALS	NN	<unknown>
</span>
as	IN	as
a	DT	a
multisystem	NN	<unknown>
disorder	NN	disorder
involving	VBG	involve
neuropsychological	JJ	<unknown>
deficits	NNS	deficit
as	RB	as
well	RB	well
as	IN	as
motor	NN	motor
deficits	NNS	deficit
.	SENT	.
The	DT	the
aim	NN	aim
of	IN	of
this	DT	this
study	NN	study
was	VBD	be
to	TO	to
characterize	VB	characterize
the	DT	the
emotion	NN	emotion
perception	NN	perception
abilities	NNS	ability
of	IN	of
Korean	JJ	Korean
patients	NNS	patient
with	IN	with
<span class='disease'>
ALS	NNS	<unknown>
</span>
based	VBN	base
on	IN	on
the	DT	the
recognition	NN	recognition
of	IN	of
facial	JJ	facial
expressions.Twenty-four	NN	<unknown>
patients	NNS	patient
with	IN	with
<span class='disease'>
ALS	NN	<unknown>
</span>
and	CC	and
24	CD	@card@
age-	NN	<unknown>
and	CC	and
sex-matched	JJ	<unknown>
healthy	JJ	healthy
controls	NNS	control
completed	VBD	complete
neuropsychological	JJ	<unknown>
tests	NNS	test
and	CC	and
facial	JJ	facial
emotion	NN	emotion
recognition	NN	recognition
tasks	NNS	task
[	SYM	[
ChaeLee	NP	<unknown>
Korean	NP	Korean
Facial	NP	<unknown>
Expressions	NNS	expression
of	IN	of
Emotions	NNS	emotion
(	(	(
ChaeLee-E	NP	<unknown>
)	)	)
]	SYM	]
.	SENT	.
The	DT	the
ChaeLee-E	JJ	<unknown>
test	NN	test
includes	VBZ	include
facial	JJ	facial
expressions	NNS	expression
for	IN	for
seven	CD	seven
emotions	NNS	emotion
:	:	:
happiness	NN	happiness
,	,	,
sadness	NN	sadness
,	,	,
anger	NN	anger
,	,	,
disgust	NN	disgust
,	,	,
fear	NN	fear
,	,	,
surprise	NN	surprise
,	,	,
and	CC	and
neutral.The	JJ	<unknown>
ability	NN	ability
to	TO	to
perceive	VB	perceive
facial	JJ	facial
emotions	NNS	emotion
was	VBD	be
significantly	RB	significantly
worse	JJR	bad
among	IN	among
<span class='disease'>
ALS	JJ	<unknown>
</span>
patients	NNS	patient
performed	VBN	perform
than	IN	than
among	IN	among
healthy	JJ	healthy
controls	NNS	control
[	SYM	[
65.2±18.0	JJ	<unknown>
%	NN	%
vs.	IN	vs.
77.1±6.6	JJ	<unknown>
%	NN	%
(	(	(
mean±SD	NN	<unknown>
)	)	)
,	,	,
p=0.009	NN	<unknown>
]	SYM	]
.	SENT	.
Eight	CD	Eight
of	IN	of
the	DT	the
24	CD	@card@
patients	NNS	patient
(	(	(
33	CD	@card@
%	NN	%
)	)	)
scored	VBN	score
below	IN	below
the	DT	the
5th	JJ	5th
percentile	NN	percentile
score	NN	score
of	IN	of
controls	NNS	control
for	IN	for
recognizing	VBG	recognize
facial	JJ	facial
emotions.Emotion	NN	<unknown>
perception	NN	perception
deficits	NNS	deficit
occur	VBP	occur
in	IN	in
Korean	JJ	Korean
<span class='disease'>
ALS	NN	<unknown>
</span>
patients	NNS	patient
,	,	,
particularly	RB	particularly
regarding	VBG	regard
facial	JJ	facial
expressions	NNS	expression
of	IN	of
emotion	NN	emotion
.	SENT	.
These	DT	these
findings	NNS	finding
expand	VBP	expand
the	DT	the
spectrum	NN	spectrum
of	IN	of
cognitive	JJ	cognitive
and	CC	and
behavioral	JJ	behavioral
dysfunction	NN	dysfunction
associated	VBN	associate
with	IN	with
<span class='disease'>
ALS	NN	<unknown>
</span>
into	IN	into
emotion	NN	emotion
processing	NN	processing
dysfunction	NN	dysfunction
.	SENT	.
<td class='article_title' rowspan='2'>
The	DT	the
cytoskeleton	NN	<unknown>
as	IN	as
a	DT	a
novel	JJ	novel
therapeutic	JJ	therapeutic
target	NN	target
for	IN	for
old	JJ	old
neurodegenerative	JJ	<unknown>
disorders	NNS	disorder
.	SENT	.
</td>
Cytoskeleton	NN	<unknown>
defects	NNS	defect
,	,	,
including	VBG	include
alterations	NNS	alteration
in	IN	in
microtubule	NN	<unknown>
stability	NN	stability
,	,	,
in	IN	in
axonal	JJ	axonal
transport	NN	transport
as	IN	as
well	RB	well
as	RB	as
in	IN	in
actin	NN	actin
dynamics	NNS	dynamics
,	,	,
have	VBP	have
been	VBN	be
characterized	VBN	characterize
in	IN	in
several	JJ	several
unrelated	JJ	unrelated
neurodegenerative	JJ	<unknown>
conditions	NNS	condition
.	SENT	.
These	DT	these
observations	NNS	observation
suggest	VBP	suggest
that	IN	that
defects	NNS	defect
of	IN	of
cytoskeleton	NN	<unknown>
organization	NN	organization
may	MD	may
be	VB	be
a	DT	a
common	JJ	common
feature	NN	feature
contributing	VBG	contribute
to	TO	to
<span class='symptom'>
neurodegeneration	NN	<unknown>
</span>
.	SENT	.
In	IN	in
line	NN	line
with	IN	with
this	DT	this
hypothesis	NN	hypothesis
,	,	,
drugs	NNS	drug
targeting	VBG	target
the	DT	the
cytoskeleton	NN	<unknown>
are	VBP	be
currently	RB	currently
being	VBG	be
tested	VBN	test
in	IN	in
animal	JJ	animal
models	NNS	model
and	CC	and
in	IN	in
human	JJ	human
clinical	JJ	clinical
trials	NNS	trial
,	,	,
showing	VBG	show
promising	JJ	promising
effects	NNS	effect
.	SENT	.
Drugs	NNS	drug
that	WDT	that
modulate	VBP	modulate
microtubule	NN	<unknown>
stability	NN	stability
,	,	,
inhibitors	NNS	inhibitor
of	IN	of
posttranslational	JJ	<unknown>
modifications	NNS	modification
of	IN	of
cytoskeletal	JJ	<unknown>
components	NNS	component
,	,	,
specifically	RB	specifically
compounds	NNS	compound
affecting	VBG	affect
the	DT	the
levels	NNS	level
of	IN	of
tubulin	NN	<unknown>
acetylation	NN	acetylation
,	,	,
and	CC	and
compounds	NNS	compound
targeting	VBG	target
signaling	VBG	signal
molecules	NNS	molecule
which	WDT	which
regulate	VBP	regulate
cytoskeleton	NN	<unknown>
dynamics	NNS	dynamics
,	,	,
constitute	VBP	constitute
the	DT	the
mostly	RB	mostly
addressed	VBN	address
therapeutic	JJ	therapeutic
interventions	NNS	intervention
aiming	VBG	aim
at	IN	at
preventing	VBG	prevent
cytoskeleton	NN	<unknown>
damage	NN	damage
in	IN	in
neurodegenerative	JJ	<unknown>
disorders	NNS	disorder
.	SENT	.
In	IN	in
this	DT	this
review	NN	review
,	,	,
we	PP	we
will	MD	will
discuss	VB	discuss
in	IN	in
a	DT	a
critical	JJ	critical
perspective	NN	perspective
the	DT	the
current	JJ	current
knowledge	NN	knowledge
on	IN	on
cytoskeleton	NN	<unknown>
damage	NN	damage
pathways	NNS	pathway
as	RB	as
well	RB	well
as	IN	as
therapeutic	JJ	therapeutic
strategies	NNS	strategy
designed	VBN	design
to	TO	to
revert	VB	revert
cytoskeleton-related	JJ	<unknown>
defects	NNS	defect
mainly	RB	mainly
focusing	VBG	focus
on	IN	on
the	DT	the
following	VBG	follow
neurodegenerative	JJ	<unknown>
disorders	NNS	disorder
:	:	:
Alzheimer	NP	Alzheimer
's	POS	's
Disease	NP	Disease
,	,	,
Parkinson	NP	Parkinson
's	POS	's
Disease	NP	Disease
,	,	,
Huntington	NP	Huntington
's	POS	's
Disease	NP	Disease
,	,	,
<span class='disease'>
Amyotrophic	NP	<unknown>
Lateral	NP	<unknown>
Sclerosis	NP	<unknown>
</span>
and	CC	and
Charcot-Marie-Tooth	NP	<unknown>
Disease	NP	Disease
.	SENT	.
<td class='article_title' rowspan='2'>
Glyco-redox	NP	<unknown>
,	,	,
a	DT	a
link	NN	link
between	IN	between
oxidative	JJ	oxidative
stress	NN	stress
and	CC	and
changes	NNS	change
of	IN	of
glycans	NNS	<unknown>
:	:	:
Lessons	NNS	lesson
from	IN	from
research	NN	research
on	IN	on
glutathione	NN	glutathione
,	,	,
reactive	JJ	reactive
oxygen	NN	oxygen
and	CC	and
nitrogen	NN	nitrogen
species	NNS	specie
to	TO	to
glycobiology	NN	<unknown>
.	SENT	.
</td>
Reduction-oxidation	NP	<unknown>
(	(	(
redox	NN	redox
)	)	)
response	NN	response
is	VBZ	be
one	CD	one
of	IN	of
the	DT	the
most	RBS	most
important	JJ	important
biological	JJ	biological
phenomena	NNS	phenomenon
.	SENT	.
The	DT	the
concept	NN	concept
introduced	VBN	introduce
by	IN	by
Helmut	NP	Helmut
Sies	NP	<unknown>
encouraged	VBD	encourage
many	JJ	many
researchers	NNS	researcher
to	TO	to
examine	VB	examine
oxidative	JJ	oxidative
stress	NN	stress
under	IN	under
pathophysiological	JJ	<unknown>
conditions	NNS	condition
.	SENT	.
Our	PP$	our
group	NN	group
has	VBZ	have
been	VBN	be
interested	JJ	interested
in	IN	in
redox	NN	redox
regulation	NN	regulation
under	IN	under
oxidative	JJ	oxidative
stress	NN	stress
as	RB	as
well	RB	well
as	IN	as
glycobiology	NN	<unknown>
in	IN	in
relation	NN	relation
to	TO	to
disease	NN	disease
.	SENT	.
Current	JJ	current
studies	NNS	study
by	IN	by
our	PP$	our
group	NN	group
and	CC	and
other	JJ	other
groups	NNS	group
indicate	VBP	indicate
that	IN	that
functional	JJ	functional
and	CC	and
structural	JJ	structural
changes	NNS	change
of	IN	of
glycans	NNS	<unknown>
are	VBP	be
regulated	VBN	regulate
by	IN	by
redox	NN	redox
responses	NNS	response
resulting	VBG	result
from	IN	from
the	DT	the
generation	NN	generation
of	IN	of
reactive	JJ	reactive
oxygen	NN	oxygen
species	NNS	specie
(	(	(
ROS	NP	Ros
)	)	)
or	CC	or
reactive	JJ	reactive
nitrogen	NN	nitrogen
species	NNS	specie
(	(	(
<span class='disease'>
RNS	NP	<unknown>
</span>
)	)	)
in	IN	in
various	JJ	various
diseases	NNS	disease
including	VBG	include
<span class='symptom'>
cancer	NN	cancer
</span>
,	,	,
diabetes	NN	diabetes
,	,	,
<span class='symptom'>
neurodegenerative	JJ	<unknown>
disease	NN	disease
</span>
such	JJ	such
as	IN	as
Parkinson	NP	Parkinson
disease	NN	disease
,	,	,
Alzheimer	NP	Alzheimer
's	POS	's
disease	NN	disease
and	CC	and
<span class='disease'>
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
(	(	(
<span class='disease'>
ALS	NP	<unknown>
</span>
)	)	)
,	,	,
and	CC	and
<span class='symptom'>
chronic	JJ	chronic
obstructive	JJ	obstructive
pulmonary	JJ	pulmonary
disease	NN	disease
</span>
(	(	(
COPD	NP	<unknown>
)	)	)
,	,	,
even	RB	even
though	IN	though
very	RB	very
few	JJ	few
investigators	NNS	investigator
appear	VBP	appear
to	TO	to
be	VB	be
aware	JJ	aware
of	IN	of
these	DT	these
facts	NNS	fact
.	SENT	.
Here	RB	here
we	PP	we
propose	VBP	propose
that	IN	that
the	DT	the
field	NN	field
"	``	"
glyco-redox	NN	<unknown>
"	''	"
will	MD	will
open	VB	open
the	DT	the
door	NN	door
to	TO	to
a	DT	a
more	RBR	more
comprehensive	JJ	comprehensive
understanding	NN	understanding
of	IN	of
the	DT	the
mechanism	NN	mechanism
associated	VBN	associate
with	IN	with
diseases	NNS	disease
in	IN	in
relation	NN	relation
to	TO	to
glycan	JJ	<unknown>
changes	NNS	change
under	IN	under
oxidative	JJ	oxidative
stress	NN	stress
.	SENT	.
A	DT	a
tight	JJ	tight
link	NN	link
between	IN	between
structural	JJ	structural
and	CC	and
functional	JJ	functional
changes	NNS	change
of	IN	of
glycans	NNS	<unknown>
and	CC	and
redox	NN	redox
system	NN	system
under	IN	under
oxidative	JJ	oxidative
stress	NN	stress
will	MD	will
lead	VB	lead
to	TO	to
the	DT	the
recognition	NN	recognition
and	CC	and
interest	NN	interest
of	IN	of
these	DT	these
aspects	NNS	aspect
by	IN	by
many	JJ	many
scientists	NNS	scientist
.	SENT	.
Helmut	NP	Helmut
's	POS	's
contribution	NN	contribution
in	IN	in
this	DT	this
field	NN	field
facilitated	VBD	facilitate
our	PP$	our
future	JJ	future
perspectives	NNS	perspective
in	IN	in
glycobiology	NN	<unknown>
.	SENT	.
<td class='article_title' rowspan='2'>
Glyco-redox	NP	<unknown>
,	,	,
a	DT	a
link	NN	link
between	IN	between
oxidative	JJ	oxidative
stress	NN	stress
and	CC	and
changes	NNS	change
of	IN	of
glycans	NNS	<unknown>
:	:	:
Lessons	NNS	lesson
from	IN	from
research	NN	research
on	IN	on
glutathione	NN	glutathione
,	,	,
reactive	JJ	reactive
oxygen	NN	oxygen
and	CC	and
nitrogen	NN	nitrogen
species	NNS	specie
to	TO	to
glycobiology	NN	<unknown>
.	SENT	.
</td>
Reduction-oxidation	NP	<unknown>
(	(	(
redox	NN	redox
)	)	)
response	NN	response
is	VBZ	be
one	CD	one
of	IN	of
the	DT	the
most	RBS	most
important	JJ	important
biological	JJ	biological
phenomena	NNS	phenomenon
.	SENT	.
The	DT	the
concept	NN	concept
introduced	VBN	introduce
by	IN	by
Helmut	NP	Helmut
Sies	NP	<unknown>
encouraged	VBD	encourage
many	JJ	many
researchers	NNS	researcher
to	TO	to
examine	VB	examine
oxidative	JJ	oxidative
stress	NN	stress
under	IN	under
pathophysiological	JJ	<unknown>
conditions	NNS	condition
.	SENT	.
Our	PP$	our
group	NN	group
has	VBZ	have
been	VBN	be
interested	JJ	interested
in	IN	in
redox	NN	redox
regulation	NN	regulation
under	IN	under
oxidative	JJ	oxidative
stress	NN	stress
as	RB	as
well	RB	well
as	IN	as
glycobiology	NN	<unknown>
in	IN	in
relation	NN	relation
to	TO	to
disease	NN	disease
.	SENT	.
Current	JJ	current
studies	NNS	study
by	IN	by
our	PP$	our
group	NN	group
and	CC	and
other	JJ	other
groups	NNS	group
indicate	VBP	indicate
that	IN	that
functional	JJ	functional
and	CC	and
structural	JJ	structural
changes	NNS	change
of	IN	of
glycans	NNS	<unknown>
are	VBP	be
regulated	VBN	regulate
by	IN	by
redox	NN	redox
responses	NNS	response
resulting	VBG	result
from	IN	from
the	DT	the
generation	NN	generation
of	IN	of
reactive	JJ	reactive
oxygen	NN	oxygen
species	NNS	specie
(	(	(
ROS	NP	Ros
)	)	)
or	CC	or
reactive	JJ	reactive
nitrogen	NN	nitrogen
species	NNS	specie
(	(	(
<span class='disease'>
RNS	NP	<unknown>
</span>
)	)	)
in	IN	in
various	JJ	various
diseases	NNS	disease
including	VBG	include
<span class='symptom'>
cancer	NN	cancer
</span>
,	,	,
diabetes	NN	diabetes
,	,	,
<span class='symptom'>
neurodegenerative	JJ	<unknown>
disease	NN	disease
</span>
such	JJ	such
as	IN	as
Parkinson	NP	Parkinson
disease	NN	disease
,	,	,
Alzheimer	NP	Alzheimer
's	POS	's
disease	NN	disease
and	CC	and
<span class='disease'>
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
(	(	(
<span class='disease'>
ALS	NP	<unknown>
</span>
)	)	)
,	,	,
and	CC	and
<span class='symptom'>
chronic	JJ	chronic
obstructive	JJ	obstructive
pulmonary	JJ	pulmonary
disease	NN	disease
</span>
(	(	(
COPD	NP	<unknown>
)	)	)
,	,	,
even	RB	even
though	IN	though
very	RB	very
few	JJ	few
investigators	NNS	investigator
appear	VBP	appear
to	TO	to
be	VB	be
aware	JJ	aware
of	IN	of
these	DT	these
facts	NNS	fact
.	SENT	.
Here	RB	here
we	PP	we
propose	VBP	propose
that	IN	that
the	DT	the
field	NN	field
"	``	"
glyco-redox	NN	<unknown>
"	''	"
will	MD	will
open	VB	open
the	DT	the
door	NN	door
to	TO	to
a	DT	a
more	RBR	more
comprehensive	JJ	comprehensive
understanding	NN	understanding
of	IN	of
the	DT	the
mechanism	NN	mechanism
associated	VBN	associate
with	IN	with
diseases	NNS	disease
in	IN	in
relation	NN	relation
to	TO	to
glycan	JJ	<unknown>
changes	NNS	change
under	IN	under
oxidative	JJ	oxidative
stress	NN	stress
.	SENT	.
A	DT	a
tight	JJ	tight
link	NN	link
between	IN	between
structural	JJ	structural
and	CC	and
functional	JJ	functional
changes	NNS	change
of	IN	of
glycans	NNS	<unknown>
and	CC	and
redox	NN	redox
system	NN	system
under	IN	under
oxidative	JJ	oxidative
stress	NN	stress
will	MD	will
lead	VB	lead
to	TO	to
the	DT	the
recognition	NN	recognition
and	CC	and
interest	NN	interest
of	IN	of
these	DT	these
aspects	NNS	aspect
by	IN	by
many	JJ	many
scientists	NNS	scientist
.	SENT	.
Helmut	NP	Helmut
's	POS	's
contribution	NN	contribution
in	IN	in
this	DT	this
field	NN	field
facilitated	VBD	facilitate
our	PP$	our
future	JJ	future
perspectives	NNS	perspective
in	IN	in
glycobiology	NN	<unknown>
.	SENT	.
<td class='article_title' rowspan='2'>
Can	MD	Can
pharmacotherapy	NN	<unknown>
improve	VB	improve
depressive	JJ	depressive
symptoms	NNS	symptom
in	IN	in
patients	NNS	patient
with	IN	with
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
?	SENT	?
A	DT	a
systematic	JJ	systematic
review	NN	review
of	IN	of
the	DT	the
literature	NN	literature
.	SENT	.
</td>
<td class='article_title' rowspan='2'>
Verbal	JJ	verbal
communication	NN	communication
impacts	NNS	impact
quality	NN	quality
of	IN	of
life	NN	life
in	IN	in
patients	NNS	patient
with	IN	with
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
.	SENT	.
</td>
Global	JJ	global
quality	NN	quality
of	IN	of
life	NN	life
(	(	(
QoL	NP	<unknown>
)	)	)
in	IN	in
patients	NNS	patient
with	IN	with
<span class='disease'>
ALS	NN	<unknown>
</span>
has	VBZ	have
been	VBN	be
found	VBN	find
to	TO	to
be	VB	be
independent	JJ	independent
of	IN	of
overall	JJ	overall
physical	JJ	physical
function	NN	function
.	SENT	.
However	RB	however
,	,	,
the	DT	the
relationship	NN	relationship
between	IN	between
verbal	JJ	verbal
communication	NN	communication
ability	NN	ability
and	CC	and
QoL	NP	<unknown>
has	VBZ	have
not	RB	not
been	VBN	be
explored	VBN	explore
.	SENT	.
This	DT	this
was	VBD	be
a	DT	a
retrospective	JJ	retrospective
study	NN	study
using	VBG	use
data	NNS	datum
from	IN	from
a	DT	a
study	NN	study
validating	VBG	validate
the	DT	the
ALS-Specific	NP	<unknown>
QoL	NP	<unknown>
Questionnaire	NP	<unknown>
(ALSSQoL)	NN	<unknown>
.	SENT	.
Speech	NN	speech
function	NN	function
was	VBD	be
assessed	VBN	assess
using	VBG	use
the	DT	the
first	JJ	first
question	NN	question
on	IN	on
the	DT	the
<span class='disease'>
ALS	NP	<unknown>
</span>
Functional	NP	<unknown>
Rating	NP	<unknown>
Scale	NP	Scale
(	(	(
ALSFRS	NP	<unknown>
)	)	)
,	,	,
ranging	VBG	range
from	IN	from
4	CD	4
(	(	(
normal	JJ	normal
speech	NN	speech
)	)	)
to	TO	to
0	CD	0
(	(	(
loss	NN	loss
of	IN	of
useful	JJ	useful
speech)	NN	<unknown>
.	SENT	.
There	EX	there
were	VBD	be
338	CD	@card@
participants	NNS	participant
for	IN	for
whom	WP	whom
data	NNS	datum
were	VBD	be
available	JJ	available
for	IN	for
speech	NN	speech
function	NN	function
and	CC	and
for	IN	for
all	DT	all
ALSSQoL	NP	<unknown>
subscales	NNS	<unknown>
.	SENT	.
Analysis	NN	analysis
of	IN	of
variance	NN	variance
revealed	VBD	reveal
that	IN	that
QoL	NP	<unknown>
varied	VBD	vary
among	IN	among
individuals	NNS	individual
with	IN	with
different	JJ	different
functional	JJ	functional
abilities	NNS	ability
for	IN	for
speech	NN	speech
(	(	(
F	NN	F
(	(	(
4,333	CD	@card@
)	)	)
=	SYM	=
5.13	CD	@card@
,	,	,
p	NN	p
=	SYM	=
0.001)	JJ	<unknown>
.	SENT	.
Specifically	RB	specifically
,	,	,
poorer	JJR	poor
QoL	NN	<unknown>
was	VBD	be
related	VBN	relate
to	TO	to
initial	JJ	initial
impairments	NNS	impairment
in	IN	in
verbal	JJ	verbal
communication	NN	communication
ability	NN	ability
(	(	(
p	NN	p
=	SYM	=
0.005)	JJ	<unknown>
.	SENT	.
QoL	NP	<unknown>
also	RB	also
was	VBD	be
poorer	JJR	poor
in	IN	in
those	DT	those
with	IN	with
no	DT	no
speech	NN	speech
ability	NN	ability
compared	VBN	compare
to	TO	to
those	DT	those
with	IN	with
normal	JJ	normal
speech	NN	speech
(	(	(
p	NN	p
=	SYM	=
0.008)	JJ	<unknown>
.	SENT	.
In	IN	in
conclusion	NN	conclusion
,	,	,
the	DT	the
ability	NN	ability
to	TO	to
communicate	VB	communicate
verbally	RB	verbally
,	,	,
unlike	IN	unlike
overall	JJ	overall
physical	JJ	physical
function	NN	function
,	,	,
is	VBZ	be
directly	RB	directly
related	VBN	relate
to	TO	to
overall	JJ	overall
QoL	NN	<unknown>
in	IN	in
patients	NNS	patient
with	IN	with
<span class='disease'>
ALS	NN	<unknown>
</span>
.	SENT	.
The	DT	the
initial	JJ	initial
period	NN	period
of	IN	of
<span class='symptom'>
speech	NN	speech
impairment	NN	impairment
</span>
appears	VBZ	appear
to	TO	to
have	VB	have
a	DT	a
particularly	RB	particularly
strong	JJ	strong
<span class='gene'>
impact	NN	impact
</span>
on	IN	on
QoL	NP	<unknown>
,	,	,
and	CC	and
may	MD	may
be	VB	be
an	DT	an
important	JJ	important
time	NN	time
for	IN	for
intervention	NN	intervention
.	SENT	.
<td class='article_title' rowspan='2'>
Case	NN	case
report	NN	report
of	IN	of
concurrent	JJ	concurrent
Fabry	NP	Fabry
disease	NN	disease
and	CC	and
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
supports	VBZ	support
a	DT	a
common	JJ	common
pathway	NN	pathway
of	IN	of
pathogenesis	NN	pathogenesis
.	SENT	.
</td>
<td class='article_title' rowspan='2'>
Meta-analysis	NN	<unknown>
of	IN	of
the	DT	the
relationship	NN	relationship
between	IN	between
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
and	CC	and
susceptibility	NN	susceptibility
to	TO	to
serum	NN	serum
ferritin	NN	ferritin
level	NN	level
elevation	NN	elevation
.	SENT	.
</td>
<td class='article_title' rowspan='2'>
Amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
and	CC	and
motor	NN	motor
neuron	NN	neuron
syndromes	NNS	syndrome
in	IN	in
Asia	NP	Asia
.	SENT	.
</td>
While	IN	while
the	DT	the
past	JJ	past
2	CD	2
decades	NNS	decade
have	VBP	have
witnessed	VBN	witness
an	DT	an
increasing	VBG	increase
understanding	NN	understanding
of	IN	of
<span class='disease'>
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
(	(	(
<span class='disease'>
ALS	NN	<unknown>
</span>
)	)	)
arising	VBG	arise
from	IN	from
East	NP	East
Asia	NP	Asia
,	,	,
particularly	RB	particularly
Japan	NP	Japan
,	,	,
South	NP	South
Korea	NP	Korea
,	,	,
Taiwan	NP	Taiwan
and	CC	and
China	NP	China
,	,	,
knowledge	NN	knowledge
of	IN	of
<span class='disease'>
ALS	NN	<unknown>
</span>
throughout	IN	throughout
the	DT	the
whole	NN	whole
of	IN	of
Asia	NP	Asia
remains	VBZ	remain
limited	JJ	limited
.	SENT	.
Asia	NP	Asia
represents	VBZ	represent
>50	JJ	<unknown>
%	NN	%
of	IN	of
the	DT	the
world	NN	world
population	NN	population
,	,	,
making	VBG	make
it	PP	it
host	NN	host
to	TO	to
the	DT	the
largest	JJS	large
patient	NN	patient
cohort	NN	cohort
of	IN	of
<span class='disease'>
ALS	NN	<unknown>
</span>
.	SENT	.
Furthermore	RB	furthermore
,	,	,
Asia	NP	Asia
represents	VBZ	represent
a	DT	a
diverse	JJ	diverse
population	NN	population
in	IN	in
terms	NNS	term
of	IN	of
ethnic	JJ	ethnic
,	,	,
social	JJ	social
and	CC	and
cultural	JJ	cultural
backgrounds	NNS	background
.	SENT	.
In	IN	in
this	DT	this
review	NN	review
,	,	,
an	DT	an
overview	NN	overview
is	VBZ	be
presented	VBN	present
that	IN	that
covers	NNS	cover
what	WP	what
is	VBZ	be
currently	RB	currently
known	VBN	know
of	IN	of
<span class='disease'>
ALS	NN	<unknown>
</span>
in	IN	in
Asia	NP	Asia
from	IN	from
basic	JJ	basic
epidemiology	NN	epidemiology
and	CC	and
genetic	JJ	genetic
influences	NNS	influence
,	,	,
through	IN	through
to	TO	to
disease	NN	disease
characteristics	NNS	characteristic
including	VBG	include
atypical	JJ	atypical
phenotypes	NNS	phenotype
which	WDT	which
manifest	VBP	manifest
a	DT	a
predilection	NN	predilection
for	IN	for
Asians	NPS	Asians
.	SENT	.
With	IN	with
the	DT	the
recent	JJ	recent
establishment	NN	establishment
of	IN	of
the	DT	the
Pan-Asian	NP	<unknown>
Consortium	NP	Consortium
for	IN	for
Treatment	NP	Treatment
and	CC	and
Research	NP	Research
in	IN	in
<span class='disease'>
ALS	NP	<unknown>
</span>
to	TO	to
facilitate	VB	facilitate
collaborations	NNS	collaboration
between	IN	between
clinicians	NNS	clinician
and	CC	and
researchers	NNS	researcher
across	IN	across
the	DT	the
region	NN	region
,	,	,
it	PP	it
is	VBZ	be
anticipated	VBN	anticipate
that	IN	that
Asia	NP	Asia
and	CC	and
the	DT	the
Pacific	NP	Pacific
will	MD	will
contribute	VB	contribute
to	TO	to
unravelling	VBG	unravel
the	DT	the
uncertainties	NNS	uncertainty
in	IN	in
<span class='disease'>
ALS	NN	<unknown>
</span>
.	SENT	.
<td class='article_title' rowspan='2'>
A	DT	a
Japanese	JJ	Japanese
familial	JJ	familial
ALS	NN	<unknown>
patient	NN	patient
with	IN	with
autonomic	JJ	autonomic
failure	NN	failure
and	CC	and
a	DT	a
p.Cys146Arg	NP	<unknown>
mutation	NN	mutation
in	IN	in
the	DT	the
gene	NN	gene
for	IN	for
SOD1	JJ	<unknown>
(SOD1)	NN	<unknown>
.	SENT	.
</td>
We	PP	we
describe	VBP	describe
a	DT	a
Japanese	JJ	Japanese
man	NN	man
with	IN	with
familial	JJ	familial
<span class='disease'>
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
(	(	(
<span class='disease'>
ALS	NN	<unknown>
</span>
)	)	)
associated	VBN	associate
with	IN	with
a	DT	a
p.Cys146Arg	NP	<unknown>
mutation	NN	mutation
in	IN	in
the	DT	the
copper/zinc	NN	<unknown>
superoxide	NN	superoxide
dismutase	NN	dismutase
gene	NN	gene
(	(	(
<span class='gene'>
SOD1	NP	<unknown>
</span>
)	)	)
.	SENT	.
The	DT	the
patient	NN	patient
developed	VBD	develop
<span class='symptom'>
bulbar	JJ	bulbar
signs	NNS	sign
</span>
followed	VBN	follow
by	IN	by
rapidly	RB	rapidly
progressive	JJ	progressive
<span class='symptom'>
limb	NN	limb
muscle	NN	muscle
weakness	NN	weakness
</span>
.	SENT	.
The	DT	the
prominent	JJ	prominent
clinical	JJ	clinical
feature	NN	feature
was	VBD	be
<span class='symptom'>
orthostatic	JJ	<unknown>
hypotension	NN	hypotension
</span>
due	JJ	due
to	TO	to
autonomic	JJ	autonomic
failure	NN	failure
,	,	,
which	WDT	which
occurred	VBD	occur
after	IN	after
he	PP	he
underwent	VBD	undergo
tracheostomy	NN	tracheostomy
1	CD	1
year	NN	year
and	CC	and
3	CD	3
months	NNS	month
after	IN	after
the	DT	the
onset	NN	onset
.	SENT	.
Thereafter	RB	thereafter
,	,	,
he	PP	he
required	VBD	require
mechanical	JJ	mechanical
ventilation	NN	ventilation
and	CC	and
progressed	VBD	progress
to	TO	to
communication	NN	communication
stage	NN	stage
V	NN	V
(	(	(
totally	RB	totally
locked-in	JJ	locked-in
state	NN	state
)	)	)
7	CD	7
years	NNS	year
after	IN	after
the	DT	the
onset	NN	onset
.	SENT	.
Neuropathology	NN	neuropathology
showed	VBD	show
<span class='disease'>
ALS	NN	<unknown>
</span>
with	IN	with
posterior	JJ	posterior
column	NN	column
degeneration	NN	degeneration
and	CC	and
multiple	JJ	multiple
system	NN	system
degeneration	NN	degeneration
.	SENT	.
Severe	JJ	severe
<span class='symptom'>
neuronal	JJ	<unknown>
loss	NN	loss
</span>
in	IN	in
the	DT	the
intermediolateral	JJ	<unknown>
nucleus	NN	nucleus
was	VBD	be
also	RB	also
observed	VBN	observe
.	SENT	.
Two	CD	Two
previously	RB	previously
reported	VBD	report
cases	NNS	case
of	IN	of
<span class='disease'>
ALS	JJ	<unknown>
</span>
patients	NNS	patient
with	IN	with
autonomic	JJ	autonomic
failure	NN	failure
showed	VBD	show
severe	JJ	severe
<span class='symptom'>
neuronal	JJ	<unknown>
loss	NN	loss
</span>
in	IN	in
the	DT	the
intermediolateral	JJ	<unknown>
nucleus	NN	nucleus
in	IN	in
addition	NN	addition
to	TO	to
degeneration	NN	degeneration
of	IN	of
the	DT	the
motor	NN	motor
neurons	NNS	neuron
.	SENT	.
Thus	RB	thus
,	,	,
autonomic	JJ	autonomic
failure	NN	failure
due	JJ	due
to	TO	to
<span class='symptom'>
neuronal	JJ	<unknown>
loss	NN	loss
</span>
in	IN	in
the	DT	the
intermediolateral	JJ	<unknown>
nucleus	NN	nucleus
could	MD	could
present	VB	present
in	IN	in
patients	NNS	patient
with	IN	with
<span class='disease'>
ALS	NNS	<unknown>
</span>
associated	VBN	associate
with	IN	with
certain	JJ	certain
mutations	NNS	mutation
in	IN	in
<span class='gene'>
SOD1	NP	<unknown>
</span>
.	SENT	.
<td class='article_title' rowspan='2'>
Mitochondrial	JJ	mitochondrial
dysfunction	NN	dysfunction
during	IN	during
the	DT	the
early	JJ	early
stages	NNS	stage
of	IN	of
excitotoxic	JJ	<unknown>
spinal	JJ	spinal
motor	NN	motor
neuron	NN	neuron
degeneration	NN	degeneration
in	IN	in
vivo	RB	vivo
.	SENT	.
</td>
Glutamate	NN	glutamate
excitotoxicity	NN	<unknown>
and	CC	and
<span class='symptom'>
mitochondrial	JJ	mitochondrial
dysfunction	NN	dysfunction
</span>
are	VBP	be
involved	VBN	involve
in	IN	in
motor	NN	motor
neuron	NN	neuron
degeneration	NN	degeneration
process	NN	process
during	IN	during
<span class='disease'>
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
(	(	(
<span class='disease'>
ALS	NN	<unknown>
</span>
)	)	)
.	SENT	.
We	PP	we
have	VBP	have
previously	RB	previously
shown	VBN	show
that	IN	that
microdialysis	NN	<unknown>
perfusion	NN	perfusion
of	IN	of
α-amino-3-hydroxy-5-methyl-4-isoxazole	NN	<unknown>
propionate	NN	propionate
(	(	(
AMPA	NP	<unknown>
)	)	)
in	IN	in
the	DT	the
lumbar	JJ	lumbar
region	NN	region
of	IN	of
the	DT	the
rat	NN	rat
spinal	JJ	spinal
cord	NN	cord
produces	VBZ	produce
permanent	JJ	permanent
<span class='symptom'>
paralysis	NN	paralysis
</span>
of	IN	of
the	DT	the
ipsilateral	JJ	ipsilateral
hindlimb	NN	<unknown>
and	CC	and
death	NN	death
of	IN	of
motor	NN	motor
neurons	NNS	neuron
by	IN	by
a	DT	a
Ca2+-dependent	NP	<unknown>
mechanism	NN	mechanism
,	,	,
in	IN	in
a	DT	a
process	NN	process
that	WDT	that
starts	VBZ	start
2-3	CD	@card@
h	NN	h
after	IN	after
AMPA	NP	<unknown>
perfusion	NN	perfusion
.	SENT	.
Co-perfusion	NN	<unknown>
with	IN	with
different	JJ	different
energy	NN	energy
metabolic	JJ	metabolic
substrates	NNS	substrate
,	,	,
mainly	RB	mainly
pyruvate	NNS	<unknown>
,	,	,
prevented	VBD	prevent
the	DT	the
<span class='symptom'>
paralysis	NN	paralysis
</span>
and	CC	and
motor	NN	motor
neuron	NN	neuron
degeneration	NN	degeneration
induced	VBN	induce
by	IN	by
AMPA	NP	<unknown>
,	,	,
suggesting	VBG	suggest
that	IN	that
mitochondrial	JJ	mitochondrial
energetic	JJ	energetic
deficiencies	NNS	deficiency
are	VBP	be
involved	VBN	involve
in	IN	in
this	DT	this
excitotoxic	JJ	<unknown>
motor	NN	motor
neuron	NN	neuron
death	NN	death
.	SENT	.
To	TO	To
test	VB	test
this	DT	this
,	,	,
in	IN	in
the	DT	the
present	JJ	present
work	NN	work
we	PP	we
studied	VBD	study
the	DT	the
functional	JJ	functional
and	CC	and
ultrastructural	JJ	ultrastructural
characteristics	NNS	characteristic
of	IN	of
mitochondria	NNS	mitochondrion
isolated	VBN	isolate
from	IN	from
the	DT	the
ventral	JJ	ventral
horns	NNS	horn
of	IN	of
lumbar	JJ	lumbar
spinal	JJ	spinal
cords	NNS	cord
of	IN	of
rats	NNS	rat
,	,	,
at	IN	at
the	DT	the
beginning	NN	beginning
of	IN	of
the	DT	the
AMPA-induced	JJ	<unknown>
degeneration	NN	degeneration
process	NN	process
,	,	,
when	WRB	when
motor	NN	motor
neurons	NNS	neuron
are	VBP	be
still	RB	still
alive	JJ	alive
.	SENT	.
Animals	NNS	animal
were	VBD	be
divided	VBN	divide
in	IN	in
four	CD	four
groups	NNS	group
:	:	:
perfused	VBN	perfuse
with	IN	with
AMPA	NP	<unknown>
,	,	,
AMPA	NP	<unknown>
+	SYM	+
pyruvate	NN	<unknown>
,	,	,
pyruvate	NNS	<unknown>
alone	RB	alone
,	,	,
and	CC	and
Krebs-Ringer	NP	<unknown>
medium	NN	medium
as	IN	as
controls	NNS	control
.	SENT	.
Mitochondria	NNS	mitochondrion
from	IN	from
the	DT	the
AMPA-treated	JJ	<unknown>
group	NN	group
showed	VBD	show
decreased	VBN	decrease
oxygen	NN	oxygen
consumption	NN	consumption
rates	NNS	rate
,	,	,
respiratory	JJ	respiratory
controls	NNS	control
and	CC	and
transmembrane	NN	<unknown>
potentials	NNS	potential
.	SENT	.
Additionally	RB	additionally
,	,	,
activities	NNS	activity
of	IN	of
the	DT	the
respiratory	JJ	respiratory
chain	NN	chain
complexes	NNS	complex
I	PP	I
and	CC	and
IV	NP	IV
were	VBD	be
significantly	RB	significantly
decreased	VBN	decrease
.	SENT	.
Electron	NP	Electron
microscopy	NN	microscopy
showed	VBD	show
that	IN	that
mitochondria	NNS	mitochondrion
from	IN	from
AMPA-treated	JJ	<unknown>
rats	NNS	rat
presented	VBD	present
swelling	VBG	swell
,	,	,
disorganized	VBN	disorganize
cristae	NNS	crista
and	CC	and
disrupted	VBN	disrupt
membranes	NNS	membrane
.	SENT	.
Remarkably	RB	remarkably
,	,	,
in	IN	in
the	DT	the
animals	NNS	animal
co-perfused	VBN	<unknown>
with	IN	with
AMPA	NP	<unknown>
and	CC	and
pyruvate	RB	<unknown>
all	PDT	all
these	DT	these
abnormalities	NNS	abnormality
were	VBD	be
prevented	VBN	prevent
.	SENT	.
We	PP	we
conclude	VBP	conclude
that	IN	that
<span class='symptom'>
mitochondrial	JJ	mitochondrial
dysfunction	NN	dysfunction
</span>
plays	VBZ	play
a	DT	a
crucial	JJ	crucial
role	NN	role
in	IN	in
spinal	JJ	spinal
motor	NN	motor
neuron	NN	neuron
degeneration	NN	degeneration
induced	VBN	induce
by	IN	by
overactivation	NN	<unknown>
of	IN	of
AMPA	NP	<unknown>
receptors	NNS	receptor
in	IN	in
vivo	RB	vivo
.	SENT	.
These	DT	these
mechanisms	NNS	mechanism
could	MD	could
be	VB	be
involved	VBN	involve
in	IN	in
<span class='disease'>
ALS	JJ	<unknown>
</span>
motor	NN	motor
neuron	NN	neuron
degeneration	NN	degeneration
.	SENT	.
<td class='article_title' rowspan='2'>
Long-term	JJ	long-term
survival	NN	survival
in	IN	in
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
after	IN	after
stem	NN	stem
cell	NN	cell
transplantation	NN	transplantation
into	IN	into
the	DT	the
frontal	JJ	frontal
motor	NN	motor
cortex	NN	cortex
.	SENT	.
</td>
<td class='article_title' rowspan='2'>
Reduced	VBN	reduce
survival	NN	survival
in	IN	in
patients	NNS	patient
with	IN	with
ALS	NN	<unknown>
with	IN	with
upper	JJ	upper
airway	NN	airway
obstructive	NN	obstructive
events	NNS	event
on	IN	on
non-invasive	JJ	non-invasive
ventilation	NN	ventilation
.	SENT	.
</td>
Non-invasive	JJ	non-invasive
ventilation	NN	ventilation
(	(	(
NIV	NP	<unknown>
)	)	)
is	VBZ	be
part	NN	part
of	IN	of
standard	JJ	standard
care	NN	care
in	IN	in
<span class='disease'>
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
(	(	(
<span class='disease'>
ALS	NN	<unknown>
</span>
)	)	)
.	SENT	.
Intolerance	NN	intolerance
or	CC	or
unavailability	NN	unavailability
of	IN	of
NIV	NP	<unknown>
,	,	,
as	RB	as
well	RB	well
as	IN	as
the	DT	the
quality	NN	quality
of	IN	of
correction	NN	correction
of	IN	of
<span class='symptom'>
nocturnal	JJ	nocturnal
hypoventilation	NN	<unknown>
</span>
,	,	,
has	VBZ	have
a	DT	a
direct	JJ	direct
<span class='gene'>
impact	NN	impact
</span>
on	IN	on
prognosis.We	NP	<unknown>
describe	VBP	describe
the	DT	the
importance	NN	importance
of	IN	of
NIV	NP	<unknown>
failure	NN	failure
due	JJ	due
to	TO	to
upper	JJ	upper
airway	NN	airway
obstructive	NN	obstructive
events	NNS	event
,	,	,
the	DT	the
clinical	JJ	clinical
characteristics	NNS	characteristic
,	,	,
as	RB	as
well	RB	well
as	IN	as
their	PP$	their
<span class='gene'>
impact	NN	impact
</span>
on	IN	on
the	DT	the
prognosis	NN	prognosis
of	IN	of
<span class='disease'>
ALS	JJ	<unknown>
</span>
.Retrospective	JJ	<unknown>
analysis	NN	analysis
of	IN	of
the	DT	the
data	NNS	datum
of	IN	of
190	CD	@card@
patients	NNS	patient
with	IN	with
<span class='disease'>
ALS	NP	<unknown>
</span>
and	CC	and
NIV	NP	<unknown>
in	IN	in
a	DT	a
single	JJ	single
centre	NN	centre
for	IN	for
the	DT	the
period	NN	period
2011-2014	CD	@card@
.	SENT	.
179	CD	@card@
patients	NNS	patient
tolerating	VBG	tolerate
NIV	NP	<unknown>
for	IN	for
more	JJR	more
than	IN	than
4	CD	4
h	NN	h
per	IN	per
night	NN	night
without	IN	without
leaks	NNS	leak
were	VBD	be
analysed.Among	JJ	<unknown>
the	DT	the
179	CD	@card@
patients	NNS	patient
,	,	,
after	IN	after
correction	NN	correction
of	IN	of
leaks	NNS	leak
,	,	,
73	CD	@card@
remained	VBD	remain
inadequately	RB	inadequately
ventilated	VBN	ventilate
at	IN	at
night	NN	night
(	(	(
defined	VBN	define
as	IN	as
more	JJR	more
than	IN	than
5	CD	5
%	NN	%
of	IN	of
the	DT	the
night	NN	night
spent	VBN	spend
at	IN	at
<90	JJ	<unknown>
%	NN	%
of	IN	of
SpO2	NP	<unknown>
)	)	)
,	,	,
as	IN	as
a	DT	a
result	NN	result
of	IN	of
obstructive	JJ	obstructive
events	NNS	event
in	IN	in
67	CD	@card@
%	NN	%
of	IN	of
cases	NNS	case
(n=48)	JJ	<unknown>
.	SENT	.
Patients	NNS	patient
who	WP	who
remained	VBD	remain
inadequately	RB	inadequately
ventilated	VBN	ventilate
after	IN	after
optimal	JJ	optimal
adjustment	NN	adjustment
of	IN	of
ventilator	NN	ventilator
settings	NNS	setting
presented	VBN	present
with	IN	with
shorter	JJR	short
survival	NN	survival
than	IN	than
adequately	RB	adequately
ventilated	VBN	ventilate
patients	NNS	patient
.	SENT	.
Unexpectedly	RB	unexpectedly
,	,	,
patients	NNS	patient
with	IN	with
upper	JJ	upper
airway	NN	airway
obstructive	NN	obstructive
events	NNS	event
without	IN	without
nocturnal	JJ	nocturnal
desaturation	NN	<unknown>
and	CC	and
in	IN	in
whom	WP	whom
no	DT	no
adjustment	NN	adjustment
of	IN	of
treatment	NN	treatment
was	VBD	be
therefore	RB	therefore
performed	VBN	perform
also	RB	also
presented	VBN	present
with	IN	with
shorter	JJR	short
survival	NN	survival
.	SENT	.
On	IN	on
initiation	NN	initiation
of	IN	of
NIV	NP	<unknown>
,	,	,
no	DT	no
difference	NN	difference
was	VBD	be
demonstrated	VBN	demonstrate
between	IN	between
patients	NNS	patient
with	IN	with
and	CC	and
without	IN	without
upper	JJ	upper
airway	NN	airway
obstructive	NN	obstructive
events	NNS	event
.	SENT	.
In	IN	in
all	DT	all
patients	NNS	patient
,	,	,
<span class='symptom'>
upper	JJ	upper
airway	NN	airway
obstruction	NN	obstruction
</span>
was	VBD	be
concomitant	JJ	concomitant
with	IN	with
reduction	NN	reduction
of	IN	of
ventilatory	JJ	ventilatory
drive.This	NN	<unknown>
study	NN	study
shows	VBZ	show
that	IN	that
<span class='symptom'>
upper	JJ	upper
airway	NN	airway
obstruction	NN	obstruction
</span>
during	IN	during
NIV	NP	<unknown>
occurs	VBZ	occur
in	IN	in
patients	NNS	patient
with	IN	with
<span class='disease'>
ALS	NN	<unknown>
</span>
and	CC	and
is	VBZ	be
associated	VBN	associate
with	IN	with
poorer	JJR	poor
prognosis	NN	prognosis
.	SENT	.
Such	JJ	such
events	NNS	event
should	MD	should
be	VB	be
identified	VBN	identify
as	IN	as
they	PP	they
can	MD	can
be	VB	be
corrected	VBN	correct
by	IN	by
adjusting	VBG	adjust
ventilator	NN	ventilator
settings	NNS	setting
.	SENT	.
<td class='article_title' rowspan='2'>
[	SYM	[
The	DT	the
pathogenesis	NN	pathogenesis
of	IN	of
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
and	CC	and
frontal	JJ	frontal
lobe	NN	lobe
dementia	NN	dementia
is	VBZ	be
unraveling	VBG	unravel
:	:	:
pathology	NN	pathology
of	IN	of
the	DT	the
nucleus	NN	nucleus
and	CC	and
glutamate	NN	glutamate
sensitivity	NN	sensitivity
]	SYM	]
.	SENT	.
</td>
The	DT	the
mechanisms	NNS	mechanism
of	IN	of
neurodegenerative	JJ	<unknown>
diseases	NNS	disease
have	VBP	have
begun	VBN	begin
to	TO	to
become	VB	become
unraveled	JJ	unraveled
,	,	,
thanks	NNS	thank
to	TO	to
the	DT	the
progress	NN	progress
in	IN	in
stem	NN	stem
cell	NN	cell
research	NN	research
.	SENT	.
The	DT	the
repeat	NN	repeat
expansion	NN	expansion
in	IN	in
the	DT	the
C90RF72	NP	<unknown>
gene	NN	gene
was	VBD	be
identified	VBN	identify
in	IN	in
2011	CD	@card@
as	IN	as
the	DT	the
most	RBS	most
common	JJ	common
genetic	JJ	genetic
cause	NN	cause
of	IN	of
both	DT	both
<span class='disease'>
ALS	NN	<unknown>
</span>
and	CC	and
<span class='symptom'>
frontal	JJ	frontal
lobe	NN	lobe
dementia	NN	dementia
</span>
.	SENT	.
Only	RB	only
over	IN	over
a	DT	a
couple	NN	couple
of	IN	of
years	NNS	year
the	DT	the
disease	NN	disease
mechanisms	NNS	mechanism
of	IN	of
this	DT	this
mutation	NN	mutation
have	VBP	have
been	VBN	be
revealed	VBN	reveal
and	CC	and
treatment	NN	treatment
trials	NNS	trial
have	VBP	have
already	RB	already
been	VBN	be
conducted	VBN	conduct
in	IN	in
nerve	NN	nerve
cell	NN	cell
cultures	NNS	culture
differentiated	VBN	differentiate
from	IN	from
patients	NNS	patient
'	POS	'
stem	NN	stem
cells	NNS	cell
.	SENT	.
We	PP	we
discuss	VBP	discuss
the	DT	the
role	NN	role
of	IN	of
the	DT	the
repeat	NN	repeat
expansion	NN	expansion
in	IN	in
the	DT	the
C90RF72	JJ	<unknown>
gene	NN	gene
in	IN	in
the	DT	the
epidemiology	NN	epidemiology
of	IN	of
the	DT	the
diseases	NNS	disease
and	CC	and
the	DT	the
resulting	VBG	result
disturbances	NNS	disturbance
in	IN	in
nerve	NN	nerve
cell	NN	cell
function	NN	function
.	SENT	.
<td class='article_title' rowspan='2'>
The	DT	the
selective	JJ	selective
anatomical	JJ	anatomical
vulnerability	NN	vulnerability
of	IN	of
ALS	NN	<unknown>
:	:	:
'	''	'
disease-defining	NN	<unknown>
'	''	'
and	CC	and
'	''	'
disease-defying	VBG	<unknown>
'	''	'
brain	NN	brain
regions	NNS	region
.	SENT	.
</td>
A	DT	a
large	JJ	large
multiparametric	JJ	<unknown>
MRI	NP	MRI
study	NN	study
has	VBZ	have
been	VBN	be
undertaken	VBN	undertake
to	TO	to
evaluate	VB	evaluate
anatomical	JJ	anatomical
patterns	NNS	pattern
of	IN	of
basal	JJ	basal
ganglia	NNS	ganglion
,	,	,
white	JJ	white
matter	NN	matter
and	CC	and
cortical	JJ	cortical
grey	JJ	grey
matter	NN	matter
involvement	NN	involvement
in	IN	in
<span class='disease'>
ALS	NN	<unknown>
</span>
.	SENT	.
Unaffected	JJ	unaffected
brain	NN	brain
regions	NNS	region
are	VBP	be
mapped	VBN	map
in	IN	in
patients	NNS	patient
with	IN	with
significant	JJ	significant
disability	NN	disability
.	SENT	.
Multiple	JJ	multiple
white	JJ	white
matter	NN	matter
diffusivity	NN	diffusivity
measures	NNS	measure
,	,	,
cortical	JJ	cortical
grey	JJ	grey
matter	NN	matter
density	NN	density
alterations	NNS	alteration
,	,	,
basal	JJ	basal
ganglia	NNS	ganglion
volumes	NNS	volume
and	CC	and
subcortical	JJ	subcortical
grey	JJ	grey
matter	NN	matter
atrophy	NN	atrophy
patterns	NNS	pattern
are	VBP	be
evaluated	VBN	evaluate
.	SENT	.
Results	NNS	result
demonstrated	VBD	demonstrate
a	DT	a
strikingly	RB	strikingly
selective	JJ	selective
anatomical	JJ	anatomical
vulnerability	NN	vulnerability
pattern	NN	pattern
in	IN	in
<span class='disease'>
ALS	NNS	<unknown>
</span>
that	WDT	that
preferentially	RB	preferentially
affects	VBZ	affect
specific	JJ	specific
grey	JJ	grey
matter	NN	matter
structures	NNS	structure
,	,	,
commissural	JJ	commissural
white	JJ	white
matter	NN	matter
tracts	NNS	tract
and	CC	and
basal	JJ	basal
ganglia	NNS	ganglion
regions	NNS	region
,	,	,
suggestive	JJ	suggestive
of	IN	of
networkwise	JJ	<unknown>
<span class='symptom'>
neurodegeneration	NN	<unknown>
</span>
in	IN	in
<span class='disease'>
ALS	NN	<unknown>
</span>
.	SENT	.
In	IN	in
conclusion	NN	conclusion
,	,	,
<span class='disease'>
ALS	JJ	<unknown>
</span>
pathology	NN	pathology
exhibits	VBZ	exhibit
predilection	NN	predilection
for	IN	for
selective	JJ	selective
and	CC	and
inter-connected	JJ	<unknown>
anatomical	JJ	anatomical
sites	NNS	site
that	WDT	that
can	MD	can
be	VB	be
comprehensively	RB	comprehensively
characterized	VBN	characterize
in	IN	in
vivo	JJ	vivo
by	IN	by
multiparametric	JJ	<unknown>
neuroimaging	NN	<unknown>
.	SENT	.
The	DT	the
systematic	JJ	systematic
characterization	NN	characterization
of	IN	of
unaffected	JJ	unaffected
brain	NN	brain
regions	NNS	region
in	IN	in
<span class='disease'>
ALS	NN	<unknown>
</span>
has	VBZ	have
implications	NNS	implication
for	IN	for
the	DT	the
development	NN	development
of	IN	of
classifier	NN	classifier
analyses	NNS	analysis
and	CC	and
elucidation	NN	elucidation
of	IN	of
disease	NN	disease
biology	NN	biology
.	SENT	.
The	DT	the
involvement	NN	involvement
and	CC	and
sparing	VBG	spare
of	IN	of
contiguous	JJ	contiguous
brain	NN	brain
regions	NNS	region
raises	VBZ	raise
important	JJ	important
pathophysiological	JJ	<unknown>
,	,	,
phylogenetic	JJ	phylogenetic
and	CC	and
ontogenetic	JJ	ontogenetic
questions	NNS	question
regarding	VBG	regard
<span class='disease'>
ALS	JJ	<unknown>
</span>
pathogenesis	NN	pathogenesis
and	CC	and
disease	NN	disease
spread	NN	spread
.	SENT	.
<td class='article_title' rowspan='2'>
Nuclear	JJ	nuclear
transport	NN	transport
dysfunction	NN	dysfunction
:	:	:
a	DT	a
common	JJ	common
theme	NN	theme
in	IN	in
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
and	CC	and
frontotemporal	JJ	<unknown>
dementia	NN	dementia
.	SENT	.
</td>
<span class='disease'>
Amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
(	(	(
<span class='disease'>
ALS	NN	<unknown>
</span>
)	)	)
and	CC	and
<span class='disease'>
frontotemporal	JJ	<unknown>
dementia	NN	dementia
</span>
(	(	(
<span class='disease'>
FTD	JJ	<unknown>
</span>
)	)	)
are	VBP	be
neurodegenerative	JJ	<unknown>
diseases	NNS	disease
with	IN	with
overlapping	VBG	overlap
genetic	JJ	genetic
factors	NNS	factor
and	CC	and
pathology	NN	pathology
.	SENT	.
On	IN	on
the	DT	the
cellular	JJ	cellular
level	NN	level
,	,	,
a	DT	a
majority	NN	majority
of	IN	of
<span class='disease'>
ALS	NN	<unknown>
</span>
and	CC	and
<span class='disease'>
FTD	NN	<unknown>
</span>
cases	NNS	case
are	VBP	be
characterized	VBN	characterize
by	IN	by
nuclear	JJ	nuclear
clearance	NN	clearance
and	CC	and
cytoplasmic	JJ	cytoplasmic
aggregation	NN	aggregation
of	IN	of
otherwise	RB	otherwise
nuclear	JJ	nuclear
proteins	NNS	protein
,	,	,
TAR	NP	<unknown>
DNA-binding	NP	<unknown>
protein	NN	protein
43	CD	@card@
(	(	(
TDP-43	NP	<unknown>
)	)	)
or	CC	or
fused	VBN	fuse
in	IN	in
<span class='symptom'>
sarcoma	NN	sarcoma
</span>
(	(	(
<span class='gene'>
FUS	NP	<unknown>
</span>
)	)	)
.	SENT	.
Recent	JJ	Recent
studies	NNS	study
investigating	VBG	investigate
cellular	JJ	cellular
pathways	NNS	pathway
perturbed	VBN	perturb
by	IN	by
genetic	JJ	genetic
risk	NN	risk
factors	NNS	factor
for	IN	for
ALS/FTD	NNS	<unknown>
converge	VBP	converge
on	IN	on
nucleocytoplasmic	JJ	<unknown>
transport	NN	transport
dysfunction	NN	dysfunction
as	IN	as
a	DT	a
mechanism	NN	mechanism
leading	VBG	lead
to	TO	to
disease	NN	disease
pathophysiology	NN	<unknown>
.	SENT	.
This	DT	this
article	NN	article
is	VBZ	be
protected	VBN	protect
by	IN	by
copyright	NN	copyright
.	SENT	.
All	DT	all
rights	NNS	right
reserved	VBD	reserve
.	SENT	.
<td class='article_title' rowspan='2'>
Blood	NP	Blood
Levels	NP	Levels
of	IN	of
Trace	NP	Trace
Metals	NP	Metals
and	CC	and
Amyotrophic	NP	<unknown>
Lateral	NP	<unknown>
Sclerosis	NP	<unknown>
.	SENT	.
</td>
Some	DT	some
trace	NN	trace
metals	NNS	metal
may	MD	may
increase	VB	increase
risk	NN	risk
of	IN	of
<span class='disease'>
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
(	(	(
<span class='disease'>
ALS	NP	<unknown>
</span>
)	)	)
,	,	,
whereas	IN	whereas
others	NNS	other
may	MD	may
be	VB	be
beneficial	JJ	beneficial
.	SENT	.
Our	PP$	our
goal	NN	goal
was	VBD	be
to	TO	to
examine	VB	examine
associations	NNS	association
of	IN	of
<span class='disease'>
ALS	NN	<unknown>
</span>
with	IN	with
blood	NN	blood
levels	NNS	level
of	IN	of
selenium	NN	selenium
(	(	(
Se	NP	Se
)	)	)
,	,	,
zinc	NN	zinc
(	(	(
Zn	NP	<unknown>
)	)	)
,	,	,
copper	NN	copper
(	(	(
Cu	NP	<unknown>
)	)	)
,	,	,
and	CC	and
manganese	NN	manganese
(Mn)	NN	<unknown>
.	SENT	.
We	PP	we
conducted	VBD	conduct
a	DT	a
case-control	NN	<unknown>
study	NN	study
of	IN	of
163	CD	@card@
neurologist	NN	neurologist
confirmed	VBD	confirm
patients	NNS	patient
from	IN	from
the	DT	the
National	NP	National
Registry	NP	Registry
of	IN	of
Veterans	NPS	Veterans
with	IN	with
<span class='disease'>
ALS	NP	<unknown>
</span>
and	CC	and
229	CD	@card@
frequency-matched	JJ	<unknown>
veteran	JJ	veteran
controls	NNS	control
.	SENT	.
We	PP	we
measured	VBD	measure
metal	NN	metal
levels	NNS	level
in	IN	in
blood	NN	blood
using	VBG	use
inductively	RB	inductively
coupled	VBN	couple
plasma	NN	plasma
mass	NN	mass
spectrometry	NN	spectrometry
and	CC	and
estimated	JJ	estimated
odds	NNS	odd
ratios	NNS	ratio
(	(	(
ORs	NP	<unknown>
)	)	)
and	CC	and
95	CD	@card@
%	NN	%
confidence	NN	confidence
intervals	NNS	interval
(	(	(
CIs	NP	<unknown>
)	)	)
for	IN	for
associations	NNS	association
between	IN	between
<span class='disease'>
ALS	NN	<unknown>
</span>
and	CC	and
a	DT	a
doubling	NN	doubling
of	IN	of
metal	NN	metal
levels	NNS	level
using	VBG	use
unconditional	JJ	unconditional
logistic	JJ	logistic
regression	NN	regression
,	,	,
adjusting	VBG	adjust
for	IN	for
age	NN	age
,	,	,
gender	NN	gender
,	,	,
and	CC	and
race/ethnicity	NN	<unknown>
.	SENT	.
<span class='disease'>
ALS	FW	als
</span>
was	VBD	be
inversely	RB	inversely
associated	VBN	associate
with	IN	with
both	DT	both
Se	NP	Se
(	(	(
OR=0.4	NP	<unknown>
,	,	,
95	CD	@card@
%	NN	%
CI	NP	<unknown>
:	:	:
0.2-0.8	LS	@card@
)	)	)
and	CC	and
Zn	NP	<unknown>
(	(	(
OR=0.4	NP	<unknown>
,	,	,
95	CD	@card@
%	NN	%
CI	NP	<unknown>
:	:	:
0.2-0.8)	NN	<unknown>
.	SENT	.
Inverse	JJ	inverse
associations	NNS	association
with	IN	with
Se	NP	Se
were	VBD	be
stronger	JJR	strong
in	IN	in
patients	NNS	patient
with	IN	with
bulbar	JJ	bulbar
compared	VBN	compare
to	TO	to
spinal	JJ	spinal
onset	NN	onset
,	,	,
worse	JJR	bad
function	NN	function
,	,	,
longer	RBR	longer
diagnostic	JJ	diagnostic
delay	NN	delay
,	,	,
and	CC	and
longer	JJR	long
collection	NN	collection
delay	NN	delay
;	:	;
inverse	JJ	inverse
associations	NNS	association
with	IN	with
Zn	NP	<unknown>
were	VBD	be
stronger	JJR	strong
for	IN	for
those	DT	those
with	IN	with
worse	JJR	bad
function	NN	function
and	CC	and
longer	JJR	long
collection	NN	collection
delay	NN	delay
.	SENT	.
In	IN	in
contrast	NN	contrast
,	,	,
<span class='disease'>
ALS	NN	<unknown>
</span>
was	VBD	be
positively	RB	positively
associated	VBN	associate
with	IN	with
Cu	NP	<unknown>
(	(	(
OR=3.4	NP	<unknown>
,	,	,
95	CD	@card@
%	NN	%
CI	NP	<unknown>
:	:	:
1.5-7.9)	JJ	<unknown>
.	SENT	.
For	IN	for
Mn	NP	<unknown>
,	,	,
no	DT	no
linear	JJ	linear
trend	NN	trend
was	VBD	be
evident	JJ	evident
(	(	(
OR=0.9	NP	<unknown>
,	,	,
95	CD	@card@
%	NN	%
CI	NP	<unknown>
:	:	:
0.6-1.3	CD	@card@
,	,	,
Ptrend=0.51)	NP	<unknown>
.	SENT	.
Associations	NNS	association
of	IN	of
Se	NP	Se
,	,	,
Zn	NP	<unknown>
,	,	,
Cu	NP	<unknown>
,	,	,
and	CC	and
Mn	NP	<unknown>
with	IN	with
<span class='disease'>
ALS	NP	<unknown>
</span>
were	VBD	be
independent	JJ	independent
of	IN	of
one	CD	one
another	DT	another
.	SENT	.
Adjustment	NN	adjustment
for	IN	for
lead	JJ	lead
levels	NNS	level
attenuated	VBN	attenuate
the	DT	the
positive	JJ	positive
association	NN	association
of	IN	of
<span class='disease'>
ALS	NN	<unknown>
</span>
with	IN	with
Cu	NP	<unknown>
but	CC	but
did	VBD	do
not	RB	not
change	VB	change
associations	NNS	association
with	IN	with
Se	NP	Se
,	,	,
Zn	NP	<unknown>
,	,	,
or	CC	or
Mn	NP	<unknown>
.	SENT	.
In	IN	in
conclusion	NN	conclusion
,	,	,
Se	NP	Se
and	CC	and
Zn	NP	<unknown>
were	VBD	be
inversely	RB	inversely
associated	VBN	associate
with	IN	with
<span class='disease'>
ALS	NN	<unknown>
</span>
,	,	,
particularly	RB	particularly
among	IN	among
those	DT	those
with	IN	with
worse	JJR	bad
function	NN	function
,	,	,
suggesting	VBG	suggest
that	DT	that
supplementation	NN	supplementation
with	IN	with
these	DT	these
metals	NNS	metal
may	MD	may
benefit	VB	benefit
such	JJ	such
patients	NNS	patient
,	,	,
while	IN	while
Cu	NP	<unknown>
was	VBD	be
positively	RB	positively
associated	VBN	associate
with	IN	with
<span class='disease'>
ALS	NN	<unknown>
</span>
.	SENT	.
Deficiencies	NNS	deficiency
of	IN	of
Se	NP	Se
and	CC	and
Zn	NP	<unknown>
and	CC	and
excess	JJ	excess
Cu	NP	<unknown>
may	MD	may
have	VB	have
a	DT	a
role	NN	role
in	IN	in
<span class='disease'>
ALS	JJ	<unknown>
</span>
etiology	NN	etiology
.	SENT	.
<td class='article_title' rowspan='2'>
Late-onset	NN	late-onset
spastic	JJ	spastic
paraplegia	NN	paraplegia
type	NN	type
10	CD	@card@
(	(	(
SPG10	NP	<unknown>
)	)	)
family	NN	family
presenting	VBG	present
with	IN	with
bulbar	JJ	bulbar
symptoms	NNS	symptom
and	CC	and
fasciculations	NNS	fasciculation
mimicking	VBG	mimick
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
.	SENT	.
</td>
Pathogenic	JJ	pathogenic
mutations	NNS	mutation
in	IN	in
the	DT	the
KIF5A-SPG10	NP	<unknown>
gene	NN	gene
,	,	,
encoding	VBG	encode
the	DT	the
kinesin	NP	<unknown>
HC5A	NP	<unknown>
,	,	,
can	MD	can
be	VB	be
associated	VBN	associate
with	IN	with
autosomal	JJ	autosomal
dominant	JJ	dominant
<span class='disease'>
hereditary	JJ	hereditary
spastic	JJ	spastic
paraplegia	NN	paraplegia
</span>
(ADHSP)	NN	<unknown>
.	SENT	.
It	PP	it
accounts	VBZ	account
for	IN	for
about	RB	about
10	CD	@card@
%	NN	%
of	IN	of
the	DT	the
complicated	JJ	complicated
forms	NNS	form
of	IN	of
ADHSP	NP	<unknown>
.	SENT	.
<span class='symptom'>
Peripheral	JJ	peripheral
neuropathy	NN	neuropathy
</span>
,	,	,
<span class='symptom'>
distal	JJ	distal
upper	JJ	upper
limb	NN	limb
amyotrophy	NN	<unknown>
</span>
,	,	,
and	CC	and
<span class='symptom'>
cognitive	JJ	cognitive
decline	NN	decline
</span>
are	VBP	be
the	DT	the
most	RBS	most
common	JJ	common
additional	JJ	additional
clinical	JJ	clinical
features	NNS	feature
.	SENT	.
We	PP	we
examined	VBD	examine
a	DT	a
66-year-old	JJ	66-year-old
Japanese	JJ	Japanese
woman	NN	woman
manifesting	VBG	manifest
<span class='symptom'>
gait	NN	gait
disturbance	NN	disturbance
</span>
and	CC	and
<span class='symptom'>
spastic	JJ	spastic
dysarthria	NNS	<unknown>
</span>
for	IN	for
6years	NNS	<unknown>
with	IN	with
positive	JJ	positive
family	NN	family
history	NN	history
.	SENT	.
She	PP	she
showed	VBD	show
evidence	NN	evidence
of	IN	of
upper	JJ	upper
and	CC	and
lower	JJR	low
motor	NN	motor
neuron	NN	neuron
involvement	NN	involvement
and	CC	and
<span class='symptom'>
fasciculations	NNS	fasciculation
</span>
,	,	,
thus	RB	thus
mimicking	VBG	mimick
<span class='disease'>
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
(	(	(
<span class='disease'>
ALS	NN	<unknown>
</span>
)	)	)
.	SENT	.
Genetic	JJ	genetic
analysis	NN	analysis
revealed	VBD	reveal
a	DT	a
heterozygous	JJ	heterozygous
variant	NN	variant
in	IN	in
<span class='gene'>
KIF5A	NP	<unknown>
</span>
(	(	(
c.484C>T	NP	<unknown>
,	,	,
p.Arg162Trp	NP	<unknown>
)	)	)
in	IN	in
2	CD	2
symptomatic	JJ	symptomatic
members	NNS	member
.	SENT	.
The	DT	the
mutation	NN	mutation
was	VBD	be
also	RB	also
identified	VBN	identify
in	IN	in
4	CD	4
asymptomatic	JJ	asymptomatic
members	NNS	member
,	,	,
including	VBG	include
2	CD	2
elderly	JJ	elderly
members	NNS	member
aged	VBN	age
over	IN	over
78years	NNS	<unknown>
.	SENT	.
Electromyography	NN	<unknown>
in	IN	in
the	DT	the
2	CD	2
symptomatic	JJ	symptomatic
members	NNS	member
revealed	VBD	reveal
evidence	NN	evidence
of	IN	of
lower	JJR	low
motor	NN	motor
neuron	NN	neuron
involvement	NN	involvement
and	CC	and
<span class='symptom'>
fasciculation	NN	fasciculation
</span>
potentials	NNS	potential
in	IN	in
distal	JJ	distal
muscles	NNS	muscle
.	SENT	.
This	DT	this
report	NN	report
describes	VBZ	describe
the	DT	the
first	JJ	first
known	JJ	known
Asian	JJ	Asian
family	NN	family
with	IN	with
a	DT	a
<span class='gene'>
KIF5A	NP	<unknown>
</span>
mutation	NN	mutation
and	CC	and
broadens	VBZ	broaden
the	DT	the
clinical	JJ	clinical
and	CC	and
electrophysiological	JJ	electrophysiological
spectrum	NN	spectrum
associated	VBN	associate
with	IN	with
KIF5A-SPG10	NP	<unknown>
mutations	NNS	mutation
.	SENT	.
Given	VBN	give
that	IN	that
our	PP$	our
cases	NNS	case
showed	VBD	show
<span class='symptom'>
pseudobulbar	JJ	<unknown>
palsy	NN	palsy
</span>
,	,	,
<span class='symptom'>
fasciculation	NN	fasciculation
</span>
and	CC	and
altered	JJ	altered
penetrance	NN	penetrance
,	,	,
KIF5A-SPG10	NP	<unknown>
might	MD	might
well	RB	well
be	VB	be
considered	VBN	consider
as	IN	as
a	DT	a
differential	JJ	differential
diagnosis	NN	diagnosis
of	IN	of
sporadic	JJ	sporadic
<span class='disease'>
ALS	NN	<unknown>
</span>
.	SENT	.
<td class='article_title' rowspan='2'>
Connexin	NP	<unknown>
43	CD	@card@
in	IN	in
astrocytes	NNS	astrocyte
contributes	VBZ	contribute
to	TO	to
motor	VB	motor
neuron	NN	neuron
toxicity	NN	toxicity
in	IN	in
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
.	SENT	.
</td>
<span class='disease'>
Amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
(	(	(
<span class='disease'>
ALS	NN	<unknown>
</span>
)	)	)
is	VBZ	be
a	DT	a
<span class='symptom'>
neurodegenerative	JJ	<unknown>
disease	NN	disease
</span>
characterized	VBN	characterize
by	IN	by
progressive	JJ	progressive
loss	NN	loss
of	IN	of
motor	NN	motor
neurons	NNS	neuron
in	IN	in
the	DT	the
CNS	NP	<unknown>
.	SENT	.
Astrocytes	NNS	astrocyte
play	VBP	play
a	DT	a
critical	JJ	critical
role	NN	role
in	IN	in
disease	NN	disease
progression	NN	progression
of	IN	of
<span class='disease'>
ALS	NN	<unknown>
</span>
.	SENT	.
Astrocytes	NNS	astrocyte
are	VBP	be
interconnected	VBN	interconnect
through	IN	through
a	DT	a
family	NN	family
of	IN	of
gap	NN	gap
junction	NN	junction
proteins	NNS	protein
known	VBN	know
as	IN	as
connexins	NNS	<unknown>
(Cx)	JJ	<unknown>
.	SENT	.
Cx43	NP	<unknown>
is	VBZ	be
a	DT	a
major	JJ	major
astrocyte	NN	astrocyte
connexin	NN	<unknown>
conducting	VBG	conduct
crucial	JJ	crucial
homeostatic	JJ	homeostatic
functions	NNS	function
in	IN	in
the	DT	the
CNS	NP	<unknown>
.	SENT	.
Under	IN	under
pathological	JJ	pathological
conditions	NNS	condition
,	,	,
connexin	NN	<unknown>
expression	NN	expression
and	CC	and
functions	NNS	function
are	VBP	be
altered	VBN	alter
.	SENT	.
Here	RB	here
we	PP	we
report	VBP	report
that	IN	that
an	DT	an
abnormal	JJ	abnormal
increase	NN	increase
in	IN	in
Cx43	NP	<unknown>
expression	NN	expression
serves	VBZ	serve
as	IN	as
one	CD	one
of	IN	of
the	DT	the
mechanisms	NNS	mechanism
for	IN	for
astrocyte-mediated	JJ	<unknown>
toxicity	NN	toxicity
in	IN	in
<span class='disease'>
ALS	NN	<unknown>
</span>
.	SENT	.
We	PP	we
observed	VBD	observe
a	DT	a
progressive	JJ	progressive
increase	NN	increase
in	IN	in
Cx43	NP	<unknown>
expression	NN	expression
in	IN	in
the	DT	the
SOD1(G93A)	NP	<unknown>
mouse	NN	mouse
model	NN	model
of	IN	of
<span class='disease'>
ALS	NN	<unknown>
</span>
during	IN	during
the	DT	the
disease	NN	disease
course	NN	course
.	SENT	.
Notably	RB	notably
,	,	,
this	DT	this
increase	NN	increase
in	IN	in
Cx43	NP	<unknown>
was	VBD	be
also	RB	also
detected	VBN	detect
in	IN	in
the	DT	the
motor	NN	motor
cortex	NN	cortex
and	CC	and
spinal	JJ	spinal
cord	NN	cord
of	IN	of
<span class='disease'>
ALS	JJ	<unknown>
</span>
patients	NNS	patient
.	SENT	.
Astrocytes	NNS	astrocyte
isolated	VBN	isolate
from	IN	from
SOD1(G93A)	NP	<unknown>
mice	NNS	mouse
as	RB	as
well	RB	well
as	IN	as
human	JJ	human
induced	VBN	induce
pluripotent	JJ	<unknown>
stem	NN	stem
cell	NN	cell
(iPSC)-derived	JJ	<unknown>
astrocytes	NNS	astrocyte
showed	VBD	show
an	DT	an
increase	NN	increase
in	IN	in
Cx43	NP	<unknown>
protein	NN	protein
,	,	,
which	WDT	which
was	VBD	be
found	VBN	find
to	TO	to
be	VB	be
an	DT	an
endogenous	JJ	endogenous
phenomenon	NN	phenomenon
independent	JJ	independent
of	IN	of
neuronal	JJ	<unknown>
co-culture	NN	<unknown>
.	SENT	.
Increased	VBN	increase
Cx43	JJ	<unknown>
expression	NN	expression
led	VBN	lead
to	TO	to
important	JJ	important
functional	JJ	functional
consequences	NNS	consequence
when	WRB	when
tested	VBN	test
in	IN	in
SOD1(G93A)	NP	<unknown>
astrocytes	NNS	astrocyte
when	WRB	when
compared	VBN	compare
to	TO	to
control	VB	control
astrocytes	NNS	astrocyte
over-expressing	VBG	<unknown>
wild-type	NP	<unknown>
<span class='gene'>
SOD1	NP	<unknown>
</span>
(	(	(
SOD1(WT)	NP	<unknown>
)	)	)
.	SENT	.
We	PP	we
observed	VBD	observe
SOD1(G93A)	NP	<unknown>
astrocytes	NNS	astrocyte
exhibited	VBD	exhibit
enhanced	JJ	enhanced
gap	NN	gap
junction	NN	junction
coupling	NN	coupling
,	,	,
increased	VBD	increase
hemichannel-mediated	JJ	<unknown>
activity	NN	activity
,	,	,
and	CC	and
elevated	JJ	elevated
intracellular	JJ	intracellular
calcium	NN	calcium
levels	NNS	level
.	SENT	.
Finally	RB	finally
,	,	,
we	PP	we
tested	VBD	test
the	DT	the
<span class='gene'>
impact	NN	impact
</span>
of	IN	of
increased	VBN	increase
expression	NN	expression
of	IN	of
Cx43	NP	<unknown>
on	IN	on
MN	JJ	<unknown>
survival	NN	survival
and	CC	and
observed	VBD	observe
that	DT	that
use	NN	use
of	IN	of
both	CC	both
a	DT	a
pan	NN	pan
Cx43	NN	<unknown>
blocker	NN	blocker
and	CC	and
Cx43	JJ	<unknown>
hemichannel	NN	<unknown>
blocker	NN	blocker
conferred	VBD	confer
neuroprotection	NN	<unknown>
to	TO	to
MNs	NNS	<unknown>
cultured	VBN	culture
with	IN	with
SOD1(G93A)	NP	<unknown>
astrocytes	NNS	astrocyte
.	SENT	.
These	DT	these
novel	NN	novel
findings	NNS	finding
show	VBP	show
a	DT	a
previously	RB	previously
unrecognized	JJ	unrecognized
role	NN	role
of	IN	of
Cx43	NP	<unknown>
in	IN	in
ALS-related	JJ	<unknown>
motor	NN	motor
neuron	NN	neuron
loss	NN	loss
.	SENT	.
GLIA	NN	glia
2016.	CD	@ord@
<td class='article_title' rowspan='2'>
Age	NP	Age
of	IN	of
onset	NN	onset
differentially	RB	differentially
influences	VBZ	influence
the	DT	the
progression	NN	progression
of	IN	of
regional	JJ	regional
dysfunction	NN	dysfunction
in	IN	in
sporadic	JJ	sporadic
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
.	SENT	.
</td>
The	DT	the
clinical	JJ	clinical
courses	NNS	course
of	IN	of
sporadic	JJ	sporadic
<span class='disease'>
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
(	(	(
<span class='disease'>
ALS	NN	<unknown>
</span>
)	)	)
show	VBP	show
extensive	JJ	extensive
variability	NN	variability
.	SENT	.
Our	PP$	our
objective	NN	objective
was	VBD	be
to	TO	to
elucidate	VB	elucidate
how	WRB	how
age	NN	age
of	IN	of
onset	NN	onset
influences	VBZ	influence
the	DT	the
progression	NN	progression
of	IN	of
regional	JJ	regional
symptoms	NNS	symptom
and	CC	and
functional	JJ	functional
losses	NNS	loss
in	IN	in
sporadic	JJ	sporadic
<span class='disease'>
ALS	NN	<unknown>
</span>
.	SENT	.
We	PP	we
included	VBD	include
648	CD	@card@
patients	NNS	patient
with	IN	with
sporadic	JJ	sporadic
<span class='disease'>
ALS	NN	<unknown>
</span>
from	IN	from
a	DT	a
multicenter	NN	multicenter
prospective	JJ	prospective
<span class='disease'>
ALS	NN	<unknown>
</span>
cohort	NN	cohort
.	SENT	.
We	PP	we
investigated	VBD	investigate
the	DT	the
distribution	NN	distribution
of	IN	of
initial	JJ	initial
symptoms	NNS	symptom
and	CC	and
analyzed	VBD	analyze
the	DT	the
time	NN	time
from	IN	from
onset	NN	onset
to	TO	to
events	NNS	event
affecting	VBG	affect
activities	NNS	activity
of	IN	of
daily	JJ	daily
living	NN	living
(	(	(
ADL	NP	<unknown>
)	)	)
as	RB	as
well	RB	well
as	IN	as
the	DT	the
longitudinal	JJ	longitudinal
changes	NNS	change
in	IN	in
each	DT	each
regional	JJ	regional
functional	JJ	functional
rating	NN	rating
score	NN	score
among	IN	among
four	CD	four
groups	NNS	group
with	IN	with
different	JJ	different
ages	NNS	age
of	IN	of
onset	NN	onset
.	SENT	.
The	DT	the
frequencies	NNS	frequency
of	IN	of
<span class='symptom'>
dysarthria	NN	<unknown>
</span>
and	CC	and
<span class='symptom'>
dysphagia	NN	dysphagia
</span>
as	IN	as
initial	JJ	initial
symptoms	NNS	symptom
were	VBD	be
higher	JJR	high
in	IN	in
the	DT	the
older	JJR	old
age	NN	age
groups	NNS	group
,	,	,
whereas	IN	whereas
<span class='symptom'>
weakness	NN	weakness
</span>
of	IN	of
upper	JJ	upper
limbs	NNS	limb
was	VBD	be
the	DT	the
most	RBS	most
common	JJ	common
initial	JJ	initial
symptom	NN	symptom
in	IN	in
the	DT	the
youngest	JJS	young
age	NN	age
group	NN	group
.	SENT	.
The	DT	the
survival	NN	survival
times	NNS	time
and	CC	and
the	DT	the
times	NNS	time
from	IN	from
onset	NN	onset
to	TO	to
<span class='symptom'>
loss	NN	loss
of	IN	of
speech	NN	speech
</span>
and	CC	and
swallowing	VBG	swallow
were	VBD	be
significantly	RB	significantly
shorter	JJR	short
in	IN	in
the	DT	the
older	JJR	old
age	NN	age
group	NN	group
(	(	(
p	NN	p
<	SYM	<
0.001	CD	@card@
)	)	)
,	,	,
although	IN	although
the	DT	the
times	NNS	time
from	IN	from
onset	NN	onset
to	TO	to
loss	NN	loss
of	IN	of
upper	JJ	upper
limb	NN	limb
function	NN	function
were	VBD	be
not	RB	not
significantly	RB	significantly
different	JJ	different
among	IN	among
the	DT	the
age	NN	age
groups	NNS	group
.	SENT	.
According	VBG	accord
to	TO	to
joint	JJ	joint
modeling	NN	modeling
analysis	NN	analysis
,	,	,
the	DT	the
bulbar	JJ	bulbar
score	NN	score
declined	VBD	decline
faster	RBR	faster
in	IN	in
the	DT	the
older	JJR	old
age	NN	age
groups	NNS	group
(	(	(
<50	NN	<unknown>
vs.	IN	vs.
60-69	CD	@card@
years	NNS	year
:	:	:
p	NN	p
=	SYM	=
0.029	CD	@card@
,	,	,
<50	NN	<unknown>
vs.	CC	vs.
≥70	NN	<unknown>
years	NNS	year
:	:	:
p	NN	p
<	SYM	<
0.001	CD	@card@
)	)	)
,	,	,
whereas	IN	whereas
there	EX	there
was	VBD	be
no	DT	no
significant	JJ	significant
correlation	NN	correlation
between	IN	between
the	DT	the
age	NN	age
of	IN	of
onset	NN	onset
and	CC	and
decline	NN	decline
in	IN	in
the	DT	the
upper	JJ	upper
limb	NN	limb
score	NN	score
.	SENT	.
Our	PP$	our
results	NNS	result
showed	VBD	show
that	DT	that
age	NN	age
of	IN	of
onset	NN	onset
had	VBD	have
a	DT	a
significant	JJ	significant
influence	NN	influence
on	IN	on
survival	NN	survival
time	NN	time
and	CC	and
the	DT	the
progression	NN	progression
of	IN	of
bulbar	JJ	bulbar
symptoms	NNS	symptom
,	,	,
but	CC	but
had	VBD	have
no	DT	no
influence	NN	influence
on	IN	on
upper	JJ	upper
limb	NN	limb
function	NN	function
in	IN	in
sporadic	JJ	sporadic
<span class='disease'>
ALS	NN	<unknown>
</span>
.	SENT	.
<td class='article_title' rowspan='2'>
Ginsenoside	NP	<unknown>
Re	NP	Re
Attenuates	NP	<unknown>
Neuroinflammation	NP	<unknown>
in	IN	in
a	DT	a
Symptomatic	NP	<unknown>
ALS	NP	<unknown>
Animal	NP	<unknown>
Model	NP	Model
.	SENT	.
</td>
<span class='disease'>
Amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
(	(	(
<span class='disease'>
ALS	NN	<unknown>
</span>
)	)	)
is	VBZ	be
a	DT	a
<span class='symptom'>
neurodegenerative	JJ	<unknown>
disease	NN	disease
</span>
characterized	VBN	characterize
by	IN	by
the	DT	the
progressive	JJ	progressive
loss	NN	loss
of	IN	of
upper	JJ	upper
and	CC	and
lower	JJR	low
motor	NN	motor
neurons	NNS	neuron
,	,	,
which	WDT	which
cause	VBP	cause
<span class='symptom'>
paralysis	NN	paralysis
</span>
and	CC	and
respiratory	JJ	respiratory
dysfunction	NN	dysfunction
.	SENT	.
There	EX	there
is	VBZ	be
currently	RB	currently
no	DT	no
permanently	RB	permanently
effective	JJ	effective
drug	NN	drug
for	IN	for
patients	NNS	patient
with	IN	with
<span class='disease'>
ALS	NN	<unknown>
</span>
.	SENT	.
Ginsenoside	NP	<unknown>
Re	NP	Re
(	(	(
G-Re	NP	<unknown>
)	)	)
,	,	,
one	CD	one
of	IN	of
the	DT	the
most	RBS	most
active	JJ	active
ingredients	NNS	ingredient
of	IN	of
ginseng	NN	ginseng
,	,	,
has	VBZ	have
pharmacological	JJ	pharmacological
activities	NNS	activity
that	WDT	that
affect	VBP	affect
a	DT	a
number	NN	number
of	IN	of
targets	NNS	target
.	SENT	.
To	TO	To
investigate	VB	investigate
the	DT	the
effects	NNS	effect
of	IN	of
G-Re	NP	<unknown>
on	IN	on
neuroinflammation	NN	<unknown>
,	,	,
we	PP	we
used	VBD	use
G-Re	NP	<unknown>
(	(	(
2.5[Formula	NP	<unknown>
:	:	:
see	VBP	see
text][Formula	NN	<unknown>
:	:	:
see	VB	see
text]g/g	NN	<unknown>
)	)	)
at	IN	at
the	DT	the
Joksamni	NP	<unknown>
acupressure	NN	<unknown>
point	NN	point
(	(	(
ST36	NP	<unknown>
)	)	)
once	IN	once
every	DT	every
other	JJ	other
day	NN	day
for	IN	for
one	CD	one
week	NN	week
.	SENT	.
To	TO	To
evaluate	VB	evaluate
G-Re	NP	<unknown>
function	NN	function
in	IN	in
symptomatic	JJ	symptomatic
human-superoxide	NN	<unknown>
dismutase	NN	dismutase
1	CD	1
(	(	(
hSOD1[Formula	NN	<unknown>
:	:	:
see	VB	see
text	NN	text
]	SYM	]
transgenic	JJ	transgenic
mice	NNS	mouse
,	,	,
immunohistochemistry	NN	<unknown>
and	CC	and
Western	JJ	Western
blot	NN	blot
analysis	NN	analysis
were	VBD	be
performed	VBN	perform
with	IN	with
the	DT	the
spinal	JJ	spinal
cord	NN	cord
of	IN	of
symptomatic	JJ	symptomatic
hSOD1(G93A)	JJ	<unknown>
transgenic	JJ	transgenic
mice	NNS	mouse
.	SENT	.
Here	RB	here
,	,	,
we	PP	we
report	VBP	report
that	IN	that
G-Re	NP	<unknown>
exhibits	VBZ	exhibit
potent	JJ	potent
neuroprotective	JJ	<unknown>
effects	NNS	effect
against	IN	against
neuroinflammation	NN	<unknown>
in	IN	in
a	DT	a
murine	JJ	murine
model	NN	model
of	IN	of
<span class='disease'>
ALS	NN	<unknown>
</span>
.	SENT	.
G-Re	NP	<unknown>
treatment	NN	treatment
reduced	VBD	reduce
the	DT	the
loss	NN	loss
of	IN	of
motor	NN	motor
neurons	NNS	neuron
and	CC	and
active-microglia-related	JJ	<unknown>
expression	NN	expression
of	IN	of
Iba-1	NP	<unknown>
in	IN	in
the	DT	the
spinal	JJ	spinal
cord	NN	cord
of	IN	of
symptomatic	JJ	symptomatic
hSOD1(G93A)	JJ	<unknown>
transgenic	JJ	transgenic
mice	NNS	mouse
.	SENT	.
In	IN	in
addition	NN	addition
,	,	,
compared	VBN	compare
with	IN	with
age-matched	JJ	<unknown>
hSOD1(G93A)	NN	<unknown>
mice	NNS	mouse
,	,	,
G-Re-treated	JJ	<unknown>
hSOD1(G93A)	NN	<unknown>
mice	NNS	mouse
showed	VBD	show
a	DT	a
significant	JJ	significant
reduction	NN	reduction
in	IN	in
expression	NN	expression
of	IN	of
pro-inflammatory	JJ	<unknown>
proteins	NNS	protein
such	JJ	such
as	IN	as
<span class='gene'>
CD14	NP	<unknown>
</span>
and	CC	and
TNF-[Formula	NP	<unknown>
:	:	:
see	VBP	see
text	NN	text
]	SYM	]
protein	NN	protein
related	VBN	relate
to	TO	to
<span class='gene'>
TLR4	JJ	<unknown>
</span>
signaling	VBG	signal
pathway	NN	pathway
.	SENT	.
G-Re	NN	<unknown>
administration	NN	administration
also	RB	also
led	VBD	lead
to	TO	to
a	DT	a
decrease	NN	decrease
in	IN	in
cell	NN	cell
death-related	JJ	<unknown>
phospho-p38	NN	<unknown>
protein	NN	protein
levels	NNS	level
,	,	,
and	CC	and
had	VBD	have
an	DT	an
antioxidative	JJ	<unknown>
effect	NN	effect
by	IN	by
reducing	VBG	reduce
HO1	JJ	<unknown>
expression	NN	expression
.	SENT	.
Together	RB	together
,	,	,
our	PP$	our
data	NNS	datum
suggest	VBP	suggest
that	IN	that
G-Re	NP	<unknown>
could	MD	could
have	VB	have
potent	JJ	potent
anti-neuroinflammatory	JJ	<unknown>
effects	NNS	effect
on	IN	on
<span class='disease'>
ALS	NN	<unknown>
</span>
by	IN	by
inhibiting	VBG	inhibit
the	DT	the
<span class='gene'>
TLR4	NP	<unknown>
</span>
pathway	NN	pathway
.	SENT	.
<td class='article_title' rowspan='2'>
CCNF	NN	<unknown>
mutations	NNS	mutation
in	IN	in
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
and	CC	and
frontotemporal	JJ	<unknown>
dementia	NN	dementia
.	SENT	.
</td>
<span class='disease'>
Amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
(	(	(
<span class='disease'>
ALS	NN	<unknown>
</span>
)	)	)
and	CC	and
<span class='disease'>
frontotemporal	JJ	<unknown>
dementia	NN	dementia
</span>
(	(	(
<span class='disease'>
FTD	JJ	<unknown>
</span>
)	)	)
are	VBP	be
overlapping	JJ	overlapping
,	,	,
fatal	JJ	fatal
neurodegenerative	JJ	<unknown>
disorders	NNS	disorder
in	IN	in
which	WDT	which
the	DT	the
molecular	JJ	molecular
and	CC	and
pathogenic	JJ	pathogenic
basis	NN	basis
remains	VBZ	remain
poorly	RB	poorly
understood	VBN	understand
.	SENT	.
Ubiquitinated	JJ	<unknown>
protein	NN	protein
aggregates	NNS	aggregate
,	,	,
of	IN	of
which	WDT	which
TDP-43	NP	<unknown>
is	VBZ	be
a	DT	a
major	JJ	major
component	NN	component
,	,	,
are	VBP	be
a	DT	a
characteristic	JJ	characteristic
pathological	JJ	pathological
feature	NN	feature
of	IN	of
most	JJS	most
<span class='disease'>
ALS	JJ	<unknown>
</span>
and	CC	and
<span class='disease'>
FTD	JJ	<unknown>
</span>
patients	NNS	patient
.	SENT	.
Here	RB	here
we	PP	we
use	VBP	use
genome-wide	JJ	<unknown>
linkage	NN	linkage
analysis	NN	analysis
in	IN	in
a	DT	a
large	JJ	large
ALS/FTD	NN	<unknown>
kindred	JJ	kindred
to	TO	to
identify	VB	identify
a	DT	a
novel	JJ	novel
disease	NN	disease
locus	NN	locus
on	IN	on
chromosome	NN	chromosome
16p13.3	JJ	<unknown>
.	SENT	.
Whole-exome	NP	<unknown>
sequencing	NP	sequencing
identified	VBD	identify
a	DT	a
<span class='gene'>
CCNF	NP	<unknown>
</span>
missense	NN	<unknown>
mutation	NN	mutation
at	IN	at
this	DT	this
locus	NN	locus
.	SENT	.
Interrogation	NN	interrogation
of	IN	of
international	JJ	international
cohorts	NNS	cohort
identified	VBD	identify
additional	JJ	additional
novel	NN	novel
<span class='gene'>
CCNF	NN	<unknown>
</span>
variants	NNS	variant
in	IN	in
familial	JJ	familial
and	CC	and
sporadic	JJ	sporadic
<span class='disease'>
ALS	NN	<unknown>
</span>
and	CC	and
<span class='disease'>
FTD	NN	<unknown>
</span>
.	SENT	.
Enrichment	NN	enrichment
of	IN	of
rare	JJ	rare
protein-altering	JJ	<unknown>
<span class='gene'>
CCNF	NP	<unknown>
</span>
variants	NNS	variant
was	VBD	be
evident	JJ	evident
in	IN	in
a	DT	a
large	JJ	large
sporadic	JJ	sporadic
<span class='disease'>
ALS	NN	<unknown>
</span>
replication	NN	replication
cohort	NN	cohort
.	SENT	.
<span class='gene'>
CCNF	NP	<unknown>
</span>
encodes	VBZ	encode
<span class='gene'>
cyclin	NN	<unknown>
F	NN	F
</span>
,	,	,
a	DT	a
component	NN	component
of	IN	of
an	DT	an
E3	NP	<unknown>
ubiquitin-protein	NN	<unknown>
ligase	NN	<unknown>
complex	NN	complex
(	(	(
SCF(	NP	<unknown>
<span class='gene'>
Cyclin	NP	<unknown>
F	NP	F
</span>
))	NN	<unknown>
.	SENT	.
Expression	NN	expression
of	IN	of
mutant	JJ	mutant
<span class='gene'>
CCNF	NN	<unknown>
</span>
in	IN	in
neuronal	JJ	<unknown>
cells	NNS	cell
caused	VBD	cause
abnormal	JJ	abnormal
ubiquitination	NN	<unknown>
and	CC	and
accumulation	NN	accumulation
of	IN	of
ubiquitinated	JJ	<unknown>
proteins	NNS	protein
,	,	,
including	VBG	include
TDP-43	NP	<unknown>
and	CC	and
a	DT	a
SCF(	NP	<unknown>
<span class='gene'>
Cyclin	NP	<unknown>
F	NP	F
</span>
)	)	)
substrate	NN	substrate
.	SENT	.
This	DT	this
implicates	VBZ	implicate
common	JJ	common
mechanisms	NNS	mechanism
,	,	,
linked	VBN	link
to	TO	to
protein	NN	protein
homeostasis	NN	homeostasis
,	,	,
underlying	VBG	underlie
neuronal	JJ	<unknown>
degeneration	NN	degeneration
.	SENT	.
<td class='article_title' rowspan='2'>
INaP	NP	<unknown>
selective	JJ	selective
inhibition	NN	inhibition
reverts	VBZ	revert
precocious	JJ	precocious
inter-	NN	<unknown>
and	CC	and
motorneurons	NNS	<unknown>
hyperexcitability	NN	<unknown>
in	IN	in
the	DT	the
Sod1-G93R	NP	<unknown>
zebrafish	NN	<unknown>
ALS	NN	<unknown>
model	NN	model
.	SENT	.
</td>
The	DT	the
pathogenic	JJ	pathogenic
role	NN	role
of	IN	of
<span class='gene'>
SOD1	JJ	<unknown>
</span>
mutations	NNS	mutation
in	IN	in
<span class='disease'>
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
(	(	(
<span class='disease'>
ALS	NP	<unknown>
</span>
)	)	)
was	VBD	be
investigated	VBN	investigate
using	VBG	use
a	DT	a
zebrafish	NN	<unknown>
disease	NN	disease
model	NN	model
stably	RB	stably
expressing	VBG	express
the	DT	the
ALS-linked	JJ	<unknown>
G93R	NP	<unknown>
mutation	NN	mutation
.	SENT	.
In	IN	in
addition	NN	addition
to	TO	to
the	DT	the
main	JJ	main
pathological	JJ	pathological
features	NNS	feature
of	IN	of
<span class='disease'>
ALS	NNS	<unknown>
</span>
shown	VBN	show
by	IN	by
adult	JJ	adult
fish	NN	fish
,	,	,
we	PP	we
found	VBD	find
remarkably	RB	remarkably
precocious	JJ	precocious
alterations	NNS	alteration
in	IN	in
the	DT	the
development	NN	development
of	IN	of
motor	NN	motor
nerve	NN	nerve
circuitry	NN	circuitry
and	CC	and
embryo	NN	embryo
behavior	NN	behavior
,	,	,
and	CC	and
suggest	VBP	suggest
that	IN	that
these	DT	these
alterations	NNS	alteration
are	VBP	be
prompted	VBN	prompt
by	IN	by
interneuron	NN	interneuron
and	CC	and
motor	NN	motor
neuron	NN	neuron
hyperexcitability	NN	<unknown>
triggered	VBN	trigger
by	IN	by
anomalies	NNS	anomaly
in	IN	in
the	DT	the
persistent	JJ	persistent
pacemaker	NN	pacemaker
sodium	NN	sodium
current	JJ	current
INaP	NN	<unknown>
.	SENT	.
The	DT	the
riluzole-induced	JJ	<unknown>
modulation	NN	modulation
of	IN	of
INaP	NP	<unknown>
reduced	VBD	reduce
spinal	JJ	spinal
neuron	NN	neuron
excitability	NN	excitability
,	,	,
reverted	VBD	revert
the	DT	the
behavioral	JJ	behavioral
phenotypes	NNS	phenotype
and	CC	and
improved	VBN	improve
the	DT	the
deficits	NNS	deficit
in	IN	in
motor	NN	motor
nerve	NN	nerve
circuitry	NN	circuitry
development	NN	development
,	,	,
thus	RB	thus
shedding	VBG	shed
new	JJ	new
light	NN	light
on	IN	on
the	DT	the
use	NN	use
of	IN	of
riluzole	NN	<unknown>
in	IN	in
the	DT	the
management	NN	management
of	IN	of
<span class='disease'>
ALS	NN	<unknown>
</span>
.	SENT	.
Our	PP$	our
findings	NNS	finding
provide	VBP	provide
a	DT	a
valid	JJ	valid
phenotype-based	JJ	<unknown>
tool	NN	tool
for	IN	for
unbiased	JJ	unbiased
in	IN	in
vivo	JJ	vivo
drug	NN	drug
screening	NN	screening
that	WDT	that
can	MD	can
be	VB	be
used	VBN	use
to	TO	to
develop	VB	develop
new	JJ	new
therapies	NNS	therapy
.	SENT	.
<td class='article_title' rowspan='2'>
Corrigendum	NN	corrigendum
:	:	:
Adipose-derived	NP	<unknown>
Stem	NP	Stem
Cell	NP	<unknown>
Conditioned	NP	<unknown>
Media	NP	Media
Extends	NP	<unknown>
Survival	NP	<unknown>
time	NN	time
of	IN	of
a	DT	a
mouse	NN	mouse
model	NN	model
of	IN	of
Amyotrophic	NP	<unknown>
Lateral	NP	<unknown>
Sclerosis	NP	<unknown>
.	SENT	.
</td>
<td class='article_title' rowspan='2'>
C9orf72	NP	<unknown>
is	VBZ	be
differentially	RB	differentially
expressed	VBN	express
in	IN	in
the	DT	the
central	JJ	central
nervous	JJ	nervous
system	NN	system
and	CC	and
myeloid	JJ	myeloid
cells	NNS	cell
and	CC	and
consistently	RB	consistently
reduced	VBN	reduce
in	IN	in
C9orf72	NP	<unknown>
,	,	,
MAPT	NP	<unknown>
and	CC	and
GRN	NP	<unknown>
mutation	NN	mutation
carriers	NNS	carrier
.	SENT	.
</td>
A	DT	a
non-coding	JJ	<unknown>
hexanucleotide	NN	<unknown>
repeat	NN	repeat
expansion	NN	expansion
(	(	(
HRE	NP	HRE
)	)	)
in	IN	in
<span class='gene'>
C9orf72	NP	<unknown>
</span>
is	VBZ	be
a	DT	a
common	JJ	common
cause	NN	cause
of	IN	of
<span class='disease'>
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
(	(	(
<span class='disease'>
ALS	NN	<unknown>
</span>
)	)	)
and	CC	and
<span class='disease'>
frontotemporal	JJ	<unknown>
dementia	NN	dementia
</span>
(	(	(
<span class='disease'>
FTD	NN	<unknown>
</span>
)	)	)
acting	VBG	act
through	IN	through
a	DT	a
loss	NN	loss
of	IN	of
function	NN	function
mechanism	NN	mechanism
due	JJ	due
to	TO	to
haploinsufficiency	NN	<unknown>
of	IN	of
<span class='gene'>
C9orf72	NP	<unknown>
</span>
or	CC	or
a	DT	a
gain	NN	gain
of	IN	of
function	NN	function
mediated	VBN	mediate
by	IN	by
aggregates	NNS	aggregate
of	IN	of
bidirectionally	RB	<unknown>
transcribed	VBN	transcribe
HRE-RNAs	NP	<unknown>
translated	VBN	translate
into	IN	into
di-peptide	NN	<unknown>
repeat	NN	repeat
(	(	(
DPR	NP	<unknown>
)	)	)
proteins	NNS	protein
.	SENT	.
To	TO	To
fully	RB	fully
understand	VB	understand
regulation	NN	regulation
of	IN	of
<span class='gene'>
C9orf72	JJ	<unknown>
</span>
expression	NN	expression
we	PP	we
surveyed	VBD	survey
the	DT	the
<span class='gene'>
C9orf72	JJ	<unknown>
</span>
locus	NN	locus
using	VBG	use
Cap	NP	Cap
Analysis	NP	Analysis
of	IN	of
Gene	NP	Gene
Expression	NP	<unknown>
sequence	NN	sequence
data	NNS	datum
(CAGEseq)	NN	<unknown>
.	SENT	.
We	PP	we
observed	VBD	observe
<span class='gene'>
C9orf72	NP	<unknown>
</span>
was	VBD	be
generally	RB	generally
lowly	RB	lowly
expressed	VBN	express
with	IN	with
the	DT	the
exception	NN	exception
of	IN	of
a	DT	a
subset	NN	subset
of	IN	of
myeloid	JJ	myeloid
cells	NNS	cell
,	,	,
particularly	RB	particularly
CD14+	NP	<unknown>
monocytes	NNS	monocyte
that	WDT	that
showed	VBD	show
up	RP	up
to	TO	to
seven	CD	seven
fold	NN	fold
higher	JJR	high
expression	NN	expression
as	IN	as
compared	VBN	compare
to	TO	to
central	JJ	central
nervous	JJ	nervous
system	NN	system
(	(	(
CNS	NP	<unknown>
)	)	)
and	CC	and
other	JJ	other
tissues	NNS	tissue
.	SENT	.
The	DT	the
expression	NN	expression
profile	NN	profile
at	IN	at
the	DT	the
<span class='gene'>
C9orf72	NP	<unknown>
</span>
locus	NN	locus
showed	VBD	show
a	DT	a
complex	JJ	complex
architecture	NN	architecture
with	IN	with
differential	JJ	differential
expression	NN	expression
of	IN	of
the	DT	the
transcription	NN	transcription
start	NN	start
sites	NNS	site
(	(	(
TSSs	NP	<unknown>
)	)	)
for	IN	for
the	DT	the
annotated	VBN	annotate
<span class='gene'>
C9orf72	JJ	<unknown>
</span>
transcripts	NNS	transcript
between	IN	between
myeloid	JJ	myeloid
and	CC	and
CNS	NP	<unknown>
tissues	NNS	tissue
suggesting	VBG	suggest
cell	NN	cell
and/or	CC	and/or
tissue	NN	tissue
specific	JJ	specific
functions	NNS	function
.	SENT	.
We	PP	we
further	RBR	further
detected	VBD	detect
novel	NN	novel
TSSs	NP	<unknown>
in	IN	in
both	CC	both
the	DT	the
sense	NN	sense
and	CC	and
antisense	NN	antisense
strand	NN	strand
at	IN	at
the	DT	the
<span class='gene'>
C9orf72	NP	<unknown>
</span>
locus	NN	locus
and	CC	and
confirmed	VBD	confirm
their	PP$	their
existence	NN	existence
in	IN	in
brain	NN	brain
tissues	NNS	tissue
and	CC	and
CD14+	JJ	<unknown>
monocytes	NNS	monocyte
.	SENT	.
Interestingly	RB	interestingly
,	,	,
our	PP$	our
experiments	NNS	experiment
showed	VBD	show
a	DT	a
consistent	JJ	consistent
decrease	NN	decrease
of	IN	of
<span class='gene'>
C9orf72	NP	<unknown>
</span>
coding	VBG	code
transcripts	NNS	transcript
not	RB	not
only	RB	only
in	IN	in
brain	NN	brain
tissue	NN	tissue
and	CC	and
monocytes	NNS	monocyte
from	IN	from
C9orf72-HRE	NP	<unknown>
patients	NNS	patient
,	,	,
but	CC	but
also	RB	also
in	IN	in
brains	NNS	brain
from	IN	from
<span class='gene'>
MAPT	NP	<unknown>
</span>
and	CC	and
<span class='gene'>
GRN	NP	<unknown>
</span>
mutation	NN	mutation
carriers	NNS	carrier
together	RB	together
with	IN	with
an	DT	an
increase	NN	increase
in	IN	in
antisense	NN	antisense
transcripts	NNS	transcript
suggesting	VBG	suggest
these	DT	these
could	MD	could
play	VB	play
a	DT	a
role	NN	role
in	IN	in
regulation	NN	regulation
of	IN	of
<span class='gene'>
C9orf72	NP	<unknown>
</span>
.	SENT	.
We	PP	we
found	VBD	find
that	IN	that
the	DT	the
non-HRE	NP	<unknown>
related	JJ	related
expression	NN	expression
changes	NNS	change
cannot	MD	can
be	VB	be
explained	VBN	explain
by	IN	by
promoter	NN	promoter
methylation	NN	methylation
but	CC	but
by	IN	by
the	DT	the
presence	NN	presence
of	IN	of
the	DT	the
C9orf72-HRE	NP	<unknown>
risk	NN	risk
haplotype	NN	<unknown>
and	CC	and
unknown	JJ	unknown
functional	JJ	functional
interactions	NNS	interaction
between	IN	between
<span class='gene'>
C9orf72	NP	<unknown>
</span>
,	,	,
<span class='gene'>
MAPT	NP	<unknown>
</span>
and	CC	and
<span class='gene'>
GRN	NP	<unknown>
</span>
.	SENT	.
<td class='article_title' rowspan='2'>
A	DT	a
mapping	NN	mapping
review	NN	review
of	IN	of
international	JJ	international
guidance	NN	guidance
on	IN	on
the	DT	the
management	NN	management
and	CC	and
care	NN	care
of	IN	of
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
(ALS)	NN	<unknown>
.	SENT	.
</td>
Management	NN	management
of	IN	of
<span class='disease'>
ALS	NN	<unknown>
</span>
is	VBZ	be
suboptimal	JJ	suboptimal
.	SENT	.
Consequently	RB	consequently
,	,	,
quality	NN	quality
improvement	NN	improvement
interventions	NNS	intervention
are	VBP	be
needed	VBN	need
to	TO	to
improve	VB	improve
<span class='disease'>
ALS	JJ	<unknown>
</span>
care	NN	care
.	SENT	.
An	DT	an
evidence-based	JJ	<unknown>
insight	NN	insight
into	IN	into
how	WRB	how
patients	NNS	patient
should	MD	should
be	VB	be
managed	VBN	manage
is	VBZ	be
essential	JJ	essential
when	WRB	when
developing	VBG	develop
quality	NN	quality
improvement	NN	improvement
interventions	NNS	intervention
.	SENT	.
Therefore	RB	therefore
,	,	,
this	DT	this
study	NN	study
aimed	VBN	aim
to	TO	to
map	VB	map
,	,	,
categorize	VB	categorize
and	CC	and
summarize	VB	summarize
international	JJ	international
guidance	NN	guidance
on	IN	on
the	DT	the
management	NN	management
and	CC	and
care	NN	care
of	IN	of
<span class='disease'>
ALS	NN	<unknown>
</span>
and	CC	and
to	TO	to
identify	VB	identify
gaps	NNS	gap
in	IN	in
this	DT	this
guidance	NN	guidance
by	IN	by
means	NNS	mean
of	IN	of
a	DT	a
mapping	NN	mapping
review	NN	review
.	SENT	.
Literature	NN	literature
was	VBD	be
searched	VBN	search
for	IN	for
clinical	JJ	clinical
practice	NN	practice
guidelines	NNS	guideline
,	,	,
quality	NN	quality
indicators	NNS	indicator
and	CC	and
evidence-based	JJ	<unknown>
clinical	JJ	clinical
summaries	NNS	summary
.	SENT	.
A	DT	a
content	JJ	content
analysis	NN	analysis
and	CC	and
meta-synthesis	NN	<unknown>
of	IN	of
the	DT	the
included	VBN	include
literature	NN	literature
was	VBD	be
performed	VBN	perform
.	SENT	.
Interventions	NNS	intervention
and	CC	and
outcomes	NNS	outcome
used	VBN	use
in	IN	in
the	DT	the
management	NN	management
and	CC	and
care	NN	care
of	IN	of
<span class='disease'>
ALS	NP	<unknown>
</span>
were	VBD	be
identified	VBN	identify
and	CC	and
categorized	VBN	categorize
.	SENT	.
Furthermore	RB	furthermore
,	,	,
the	DT	the
amount	NN	amount
of	IN	of
guidance	NN	guidance
underpinning	VBG	underpin
these	DT	these
interventions	NNS	intervention
and	CC	and
outcomes	NNS	outcome
was	VBD	be
analysed	VBN	analyse
.	SENT	.
Six	CD	Six
clinical	JJ	clinical
practice	NN	practice
guidelines	NNS	guideline
,	,	,
one	PP	one
set	VBD	set
of	IN	of
quality	NN	quality
indicators	NNS	indicator
and	CC	and
three	CD	three
evidence-based	JJ	<unknown>
clinical	JJ	clinical
summaries	NNS	summary
were	VBD	be
identified	VBN	identify
.	SENT	.
The	DT	the
results	NNS	result
demonstrated	VBD	demonstrate
that	IN	that
certain	JJ	certain
domains	NNS	domain
in	IN	in
<span class='disease'>
ALS	JJ	<unknown>
</span>
care	NN	care
,	,	,
mainly	RB	mainly
disease-specific	JJ	<unknown>
domains	NNS	domain
such	JJ	such
as	IN	as
breathing	VBG	breathe
and	CC	and
swallowing	VBG	swallow
,	,	,
are	VBP	be
extensively	RB	extensively
addressed	VBN	address
in	IN	in
the	DT	the
literature	NN	literature
whereas	IN	whereas
other	JJ	other
subjects	NNS	subject
,	,	,
such	JJ	such
as	IN	as
care	NN	care
coordination	NN	coordination
,	,	,
receive	VB	receive
little	JJ	little
attention	NN	attention
.	SENT	.
In	IN	in
conclusion	NN	conclusion
,	,	,
this	DT	this
mapping	NN	mapping
review	NN	review
provides	VBZ	provide
a	DT	a
scientific	JJ	scientific
basis	NN	basis
for	IN	for
targeting	VBG	target
and	CC	and
developing	VBG	develop
the	DT	the
clinical	JJ	clinical
content	NN	content
of	IN	of
a	DT	a
quality	NN	quality
improvement	NN	improvement
intervention	NN	intervention
for	IN	for
the	DT	the
management	NN	management
of	IN	of
<span class='disease'>
ALS	NN	<unknown>
</span>
.	SENT	.
<td class='article_title' rowspan='2'>
Single	JJ	single
and	CC	and
modeled	VBN	model
multifrequency	NN	<unknown>
electrical	JJ	electrical
impedance	NN	impedance
myography	NN	myography
parameters	NNS	parameter
and	CC	and
their	PP$	their
relationship	NN	relationship
to	TO	to
force	VB	force
production	NN	production
in	IN	in
the	DT	the
ALS	JJ	<unknown>
SOD1G93A	NP	<unknown>
mouse	NN	mouse
.	SENT	.
</td>
The	DT	the
relationship	NN	relationship
between	IN	between
muscle	NN	muscle
force	NN	force
production	NN	production
in	IN	in
<span class='disease'>
ALS	NP	<unknown>
</span>
SOD1G93A	NP	<unknown>
mice	NNS	mouse
and	CC	and
single	JJ	single
and	CC	and
modeled	VBN	model
multifrequency	NN	<unknown>
electrical	JJ	electrical
impedance	NN	impedance
myography	NN	myography
(	(	(
EIM	NP	<unknown>
)	)	)
parameters	NNS	parameter
is	VBZ	be
unknown	JJ	unknown
.	SENT	.
We	PP	we
evaluated	VBD	evaluate
the	DT	the
relationship	NN	relationship
between	IN	between
multifrequency	JJ	<unknown>
EIM	NP	<unknown>
data	NNS	datum
and	CC	and
paw	NN	paw
grip	NN	grip
and	CC	and
in	IN	in
situ	NN	<unknown>
force	NN	force
measurements	NNS	measurement
,	,	,
as	RB	as
well	RB	well
to	TO	to
standard	JJ	standard
measures	NNS	measure
including	VBG	include
body	NN	body
weight	NN	weight
and	CC	and
compound	JJ	compound
motor	NN	motor
action	NN	action
potential	NN	potential
(	(	(
CMAP	NP	<unknown>
)	)	)
amplitude.Twenty-nine	NP	<unknown>
<span class='gene'>
SOD1	NP	<unknown>
</span>
G93A	NP	<unknown>
mice	NNS	mouse
aged	VBN	age
13-18	CD	@card@
weeks	NNS	week
(	(	(
approximately	RB	approximately
4-5	CD	@card@
per	IN	per
week	NN	week
)	)	)
and	CC	and
a	DT	a
group	NN	group
of	IN	of
similarly	RB	similarly
aged	VBN	age
wild-type	NN	<unknown>
mice	NNS	mouse
(	(	(
N	NP	N
=	SYM	=
7	CD	7
)	)	)
were	VBD	be
studied	VBN	study
with	IN	with
single	JJ	single
and	CC	and
multifrequency	NN	<unknown>
EIM	NP	<unknown>
,	,	,
CMAP	NP	<unknown>
,	,	,
front	NN	front
and	CC	and
hind-limb	NN	<unknown>
paw	NN	paw
grip	NN	grip
measures	NNS	measure
,	,	,
and	CC	and
in	IN	in
situ	NN	<unknown>
force	NN	force
measurements	NNS	measurement
of	IN	of
the	DT	the
gastrocnemius.Significant	JJ	<unknown>
differences	NNS	difference
among	IN	among
WT	NP	<unknown>
,	,	,
presymptomatic	JJ	<unknown>
,	,	,
and	CC	and
symptomatic	JJ	symptomatic
<span class='disease'>
ALS	JJ	<unknown>
</span>
animals	NNS	animal
were	VBD	be
identified	VBN	identify
for	IN	for
all	DT	all
standard	JJ	standard
measures	NNS	measure
and	CC	and
single	JJ	single
50	CD	@card@
kHz	NN	<unknown>
frequency	NN	frequency
EIM	NP	<unknown>
parameters	NNS	parameter
.	SENT	.
Of	IN	of
the	DT	the
modeled	VBN	model
multifrequency	NN	<unknown>
measures	NNS	measure
,	,	,
the	DT	the
center	NN	center
frequency	NN	frequency
,	,	,
fc	NN	<unknown>
,	,	,
an	DT	an
index	NN	index
of	IN	of
cell	NN	cell
size	NN	size
,	,	,
showed	VBD	show
the	DT	the
strongest	JJS	strong
relationship	NN	relationship
to	TO	to
force	VB	force
output	NN	output
.	SENT	.
The	DT	the
two	CD	two
other	JJ	other
multifrequency	NN	<unknown>
parameters	NNS	parameter
corresponding	JJ	corresponding
to	TO	to
cell	NN	cell
size	NN	size
distribution	NN	distribution
and	CC	and
cell	NN	cell
density	NN	density
showed	VBD	show
consistent	JJ	consistent
although	IN	although
mostly	RB	mostly
non-significant	JJ	<unknown>
differences.Reductions	NNS	<unknown>
in	IN	in
force	NN	force
are	VBP	be
reflected	VBN	reflect
in	IN	in
single	JJ	single
50	CD	@card@
kHz	NN	<unknown>
impedance	NN	impedance
values	NNS	value
and	CC	and
in	IN	in
the	DT	the
fc	NN	<unknown>
.	SENT	.
These	DT	these
data	NNS	datum
support	VBP	support
the	DT	the
construct	NN	construct
validity	NN	validity
of	IN	of
EIM	NP	<unknown>
as	IN	as
an	DT	an
assessment	NN	assessment
tool	NN	tool
of	IN	of
muscle	NN	muscle
dysfunction	NN	dysfunction
in	IN	in
diseases	NNS	disease
associated	VBN	associate
with	IN	with
motor	NN	motor
neuron	NN	neuron
loss	NN	loss
.	SENT	.
<td class='article_title' rowspan='2'>
Patient-ventilator	NN	<unknown>
asynchrony	NN	<unknown>
,	,	,
leaks	NNS	leak
and	CC	and
sleep	NN	sleep
in	IN	in
patients	NNS	patient
with	IN	with
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
.	SENT	.
</td>
Sleeping	VBG	sleep
with	IN	with
non-invasive	JJ	non-invasive
ventilation	NN	ventilation
(	(	(
NIV	NP	<unknown>
)	)	)
in	IN	in
<span class='disease'>
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
appears	VBZ	appear
to	TO	to
be	VB	be
accompanied	VBN	accompany
by	IN	by
a	DT	a
high	JJ	high
patient-ventilator	NN	<unknown>
asynchrony	NN	<unknown>
(	(	(
<span class='disease'>
PVA	NP	<unknown>
</span>
)	)	)
index	NN	index
.	SENT	.
This	DT	this
prospective	JJ	prospective
observational	JJ	observational
cohort	NN	cohort
study	NN	study
quantifies	VBZ	quantify
<span class='disease'>
PVA	NP	<unknown>
</span>
and	CC	and
leaks	NNS	leak
,	,	,
and	CC	and
searches	NNS	search
for	IN	for
effects	NNS	effect
of	IN	of
these	DT	these
events	NNS	event
on	IN	on
sleep	NN	sleep
after	IN	after
polysomnographic	JJ	<unknown>
NIV	NP	<unknown>
titration	NN	titration
.	SENT	.
Full-video	NP	<unknown>
polysomnography	NN	<unknown>
,	,	,
with	IN	with
incorporation	NN	incorporation
of	IN	of
transcutaneous	JJ	transcutaneous
carbon	NN	carbon
dioxide	NN	dioxide
and	CC	and
ventilator	NN	ventilator
software	NN	software
,	,	,
was	VBD	be
used	VBN	use
to	TO	to
analyse	VB	analyse
sleep	NN	sleep
epoch-by-epoch	NN	<unknown>
and	CC	and
respiratory	JJ	respiratory
events	NNS	event
and	CC	and
<span class='disease'>
PVA	NP	<unknown>
</span>
breath-by-breath	NN	<unknown>
in	IN	in
35	CD	@card@
patients	NNS	patient
(	(	(
17	CD	@card@
non-bulbar)	NN	<unknown>
.	SENT	.
After	IN	after
diagnostic	JJ	diagnostic
polysomnography	NN	<unknown>
,	,	,
NIV	NP	<unknown>
was	VBD	be
titrated	VBN	titrate
during	IN	during
three	CD	three
consecutive	JJ	consecutive
nights	NNS	night
.	SENT	.
Sleep	NP	Sleep
,	,	,
<span class='disease'>
PVA	NP	<unknown>
</span>
and	CC	and
leaks	NNS	leak
were	VBD	be
evaluated	VBN	evaluate
at	IN	at
discharge	NN	discharge
and	CC	and
after	IN	after
one	CD	one
month	NN	month
.	SENT	.
Results	NNS	result
showed	VBD	show
that	IN	that
non-bulbar	JJ	<unknown>
patients	NNS	patient
improved	VBN	improve
in	IN	in
sleep	NN	sleep
architecture	NN	architecture
and	CC	and
oxygen	NN	oxygen
and	CC	and
carbon	NN	carbon
dioxide	NN	dioxide
levels	NNS	level
while	IN	while
bulbar	JJ	bulbar
patients	NNS	patient
only	RB	only
improved	VBN	improve
oxygen	NN	oxygen
saturation	NN	saturation
.	SENT	.
<span class='disease'>
PVA	NP	<unknown>
</span>
remained	VBD	remain
present	JJ	present
at	IN	at
discharge	NN	discharge
(	(	(
non-bulbar	NN	<unknown>
54	CD	@card@
(	(	(
21-101	CD	@card@
)	)	)
and	CC	and
bulbar	JJ	bulbar
31	CD	@card@
(9-39)/h	NN	<unknown>
sleep	NN	sleep
)	)	)
and	CC	and
one	CD	one
month	NN	month
(	(	(
non-bulbar	NN	<unknown>
31	CD	@card@
(	(	(
9-39	CD	@card@
)	)	)
and	CC	and
bulbar	JJ	bulbar
32	CD	@card@
(17-55)/h	NN	<unknown>
sleep	NN	sleep
)	)	)
,	,	,
with	IN	with
ineffective	JJ	ineffective
effort	NN	effort
as	IN	as
most	JJS	most
prominent	JJ	prominent
asynchrony	NN	<unknown>
.	SENT	.
Leaks	NNS	leak
also	RB	also
persisted	VBD	persist
after	IN	after
titration	NN	titration
(	(	(
non-bulbar	NN	<unknown>
16.6	CD	@card@
(	(	(
3.1-44.6	CD	@card@
)	)	)
and	CC	and
bulbar	JJ	bulbar
5.1	CD	@card@
(	(	(
0.0-19.5	CD	@card@
)	)	)
%	NN	%
of	IN	of
total	JJ	total
sleep	NN	sleep
time	NN	time
(	(	(
<span class='gene'>
TST	NP	<unknown>
</span>
)	)	)
)	)	)
and	CC	and
one	CD	one
month	NN	month
(	(	(
non-bulbar	NN	<unknown>
7.7	CD	@card@
(	(	(
1.4-29.3	CD	@card@
)	)	)
and	CC	and
bulbar	JJ	bulbar
12.7	CD	@card@
(	(	(
0.0-35.2	CD	@card@
)	)	)
%	NN	%
<span class='gene'>
TST	NP	<unknown>
</span>
)	)	)
.	SENT	.
<span class='disease'>
PVA	NP	<unknown>
</span>
and	CC	and
leaks	NNS	leak
have	VBP	have
none	NN	none
to	TO	to
minor	JJ	minor
effect	NN	effect
on	IN	on
sleep	NN	sleep
architecture	NN	architecture
.	SENT	.
In	IN	in
conclusion	NN	conclusion
,	,	,
although	IN	although
<span class='disease'>
PVA	NP	<unknown>
</span>
and	CC	and
leaks	NNS	leak
remain	VBP	remain
present	JJ	present
after	IN	after
meticulous	JJ	meticulous
NIV	NP	<unknown>
titration	NN	titration
,	,	,
these	DT	these
events	NNS	event
seem	VBP	seem
not	RB	not
to	TO	to
interfere	VB	interfere
with	IN	with
sleep	NN	sleep
.	SENT	.
<td class='article_title' rowspan='2'>
CHCHD10	NP	<unknown>
is	VBZ	be
not	RB	not
a	DT	a
frequent	JJ	frequent
causative	JJ	causative
gene	NN	gene
in	IN	in
Chinese	JJ	Chinese
ALS	JJ	<unknown>
patients	NNS	patient
.	SENT	.
</td>
<span class='disease'>
Amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
(	(	(
<span class='disease'>
ALS	NN	<unknown>
</span>
)	)	)
is	VBZ	be
a	DT	a
devastating	JJ	devastating
neurodegenerative	JJ	<unknown>
disorder	NN	disorder
characterized	VBN	characterize
by	IN	by
the	DT	the
death	NN	death
of	IN	of
motor	NN	motor
neurons	NNS	neuron
.	SENT	.
Recently	RB	recently
,	,	,
mutations	NNS	mutation
in	IN	in
<span class='gene'>
CHCHD10	NP	<unknown>
</span>
have	VBP	have
been	VBN	be
reported	VBN	report
to	TO	to
cause	VB	cause
<span class='disease'>
ALS	NN	<unknown>
</span>
in	IN	in
Western	JJ	Western
populations	NNS	population
.	SENT	.
In	IN	in
the	DT	the
present	JJ	present
study	NN	study
,	,	,
direct	JJ	direct
DNA	NP	DNA
sequencing	NP	sequencing
has	VBZ	have
been	VBN	be
performed	VBN	perform
on	IN	on
<span class='gene'>
CHCHD10	NP	<unknown>
</span>
in	IN	in
a	DT	a
cohort	NN	cohort
of	IN	of
294	CD	@card@
<span class='disease'>
ALS	JJ	<unknown>
</span>
patients	NNS	patient
of	IN	of
Chinese	JJ	Chinese
Han	NP	Han
origin	NN	origin
.	SENT	.
No	DT	no
mutations	NNS	mutation
were	VBD	be
identified	VBN	identify
in	IN	in
<span class='gene'>
CHCHD10	NP	<unknown>
</span>
in	IN	in
<span class='disease'>
ALS	JJ	<unknown>
</span>
cases	NNS	case
of	IN	of
Chinese	JJ	Chinese
ancestry	NN	ancestry
.	SENT	.
We	PP	we
propose	VBP	propose
<span class='gene'>
CHCHD10	NP	<unknown>
</span>
might	MD	might
not	RB	not
be	VB	be
a	DT	a
frequent	JJ	frequent
causal	JJ	causal
gene	NN	gene
among	IN	among
Chinese	NP	Chinese
with	IN	with
<span class='disease'>
ALS	NP	<unknown>
</span>
.	SENT	.
<td class='article_title' rowspan='2'>
Cortical	JJ	cortical
drive	NN	drive
to	TO	to
breathe	VB	breathe
in	IN	in
amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
:	:	:
a	DT	a
dyspnoea-worsening	JJ	<unknown>
defence	NN	defence
?	SENT	?
</td>
<span class='disease'>
Amyotrophic	JJ	<unknown>
lateral	JJ	lateral
sclerosis	NN	sclerosis
</span>
(	(	(
<span class='disease'>
ALS	NN	<unknown>
</span>
)	)	)
is	VBZ	be
a	DT	a
<span class='symptom'>
neurodegenerative	JJ	<unknown>
disease	NN	disease
</span>
causing	VBG	cause
diaphragm	NN	diaphragm
<span class='symptom'>
weakness	NN	weakness
</span>
that	WDT	that
can	MD	can
be	VB	be
partially	RB	partially
compensated	VBN	compensate
by	IN	by
inspiratory	JJ	inspiratory
neck	NN	neck
muscle	NN	muscle
recruitment	NN	recruitment
.	SENT	.
This	DT	this
disappears	VBZ	disappear
during	IN	during
sleep	NN	sleep
,	,	,
which	WDT	which
is	VBZ	be
compatible	JJ	compatible
with	IN	with
a	DT	a
cortical	JJ	cortical
contribution	NN	contribution
to	TO	to
the	DT	the
drive	NN	drive
to	TO	to
breathe	VB	breathe
.	SENT	.
We	PP	we
hypothesised	VBD	hypothesise
that	IN	that
<span class='disease'>
ALS	JJ	<unknown>
</span>
patients	NNS	patient
with	IN	with
<span class='symptom'>
respiratory	JJ	respiratory
failure	NN	failure
</span>
exhibit	NN	exhibit
respiratory-related	JJ	<unknown>
cortical	JJ	cortical
activity	NN	activity
,	,	,
relieved	VBN	relieve
by	IN	by
noninvasive	JJ	noninvasive
ventilation	NN	ventilation
(	(	(
NIV	NP	<unknown>
)	)	)
and	CC	and
related	VBN	relate
to	TO	to
dyspnoea.We	NP	<unknown>
studied	VBD	study
14	CD	@card@
<span class='disease'>
ALS	NN	<unknown>
</span>
patients	NNS	patient
with	IN	with
<span class='symptom'>
respiratory	JJ	respiratory
failure	NN	failure
</span>
.	SENT	.
Electroencephalographic	JJ	electroencephalographic
recordings	NNS	recording
(	(	(
EEGs	NP	<unknown>
)	)	)
and	CC	and
electromyographic	JJ	<unknown>
recordings	NNS	recording
of	IN	of
inspiratory	JJ	inspiratory
neck	NN	neck
muscles	NNS	muscle
were	VBD	be
performed	VBN	perform
during	IN	during
spontaneous	JJ	spontaneous
breathing	NN	breathing
and	CC	and
NIV	NP	<unknown>
.	SENT	.
Dyspnoea	NN	dyspnoea
was	VBD	be
evaluated	VBN	evaluate
using	VBG	use
the	DT	the
Multidimensional	NP	multidimensional
<span class='symptom'>
Dyspnea	NP	<unknown>
</span>
Profile.Eight	NP	<unknown>
patients	NNS	patient
exhibited	VBD	exhibit
slow	JJ	slow
EEG	NP	<unknown>
negativities	NNS	negativity
preceding	VBG	precede
inspiration	NN	inspiration
(	(	(
pre-inspiratory	NN	<unknown>
potentials	NNS	potential
)	)	)
during	IN	during
spontaneous	JJ	spontaneous
breathing	NN	breathing
.	SENT	.
Pre-inspiratory	JJ	<unknown>
potentials	NNS	potential
were	VBD	be
attenuated	VBN	attenuate
during	IN	during
NIV	NP	<unknown>
(p=0.04)	NN	<unknown>
.	SENT	.
Patients	NNS	patient
without	IN	without
pre-inspiratory	NN	<unknown>
potentials	NNS	potential
presented	VBD	present
more	JJR	more
advanced	JJ	advanced
forms	NNS	form
of	IN	of
<span class='disease'>
ALS	NN	<unknown>
</span>
and	CC	and
more	JJR	more
severe	JJ	severe
<span class='symptom'>
respiratory	JJ	respiratory
impairment	NN	impairment
</span>
,	,	,
but	CC	but
less	RBR	less
severe	JJ	severe
dyspnoea	NN	dyspnoea
.	SENT	.
Patients	NNS	patient
with	IN	with
pre-inspiratory	NN	<unknown>
potentials	NNS	potential
had	VBD	have
stronger	JJR	strong
inspiratory	JJ	inspiratory
neck	NN	neck
muscle	NN	muscle
activation	NN	activation
and	CC	and
more	JJR	more
severe	JJ	severe
dyspnoea	NN	dyspnoea
during	IN	during
spontaneous	JJ	spontaneous
breathing.ALS-related	JJ	<unknown>
diaphragm	NN	diaphragm
<span class='symptom'>
weakness	NN	weakness
</span>
can	MD	can
engage	VB	engage
cortical	JJ	cortical
resources	NNS	resource
to	TO	to
augment	VB	augment
the	DT	the
neural	JJ	neural
drive	NN	drive
to	TO	to
breathe	VB	breathe
.	SENT	.
This	DT	this
might	MD	might
reflect	VB	reflect
a	DT	a
compensatory	JJ	compensatory
mechanism	NN	mechanism
,	,	,
with	IN	with
the	DT	the
intensity	NN	intensity
of	IN	of
dyspnoea	NN	dyspnoea
a	DT	a
negative	JJ	negative
consequence	NN	consequence
.	SENT	.
Disease	NN	disease
progression	NN	progression
and	CC	and
the	DT	the
corresponding	JJ	corresponding
neural	JJ	neural
loss	NN	loss
could	MD	could
abolish	VB	abolish
this	DT	this
phenomenon	NN	phenomenon
.	SENT	.
A	DT	a
putative	JJ	putative
cognitive	JJ	cognitive
cost	NN	cost
should	MD	should
be	VB	be
investigated	VBN	investigate
.	SENT	.
